SWGDRUG IR-SPEC Library - JDX Converter

<!DOCTYPE html><!--[if IE 6]><html id="ie6" lang="en-US" prefix="og: https://ogp.me/ns#"><![endif]--><!--[if IE 7]><html id="ie7" lang="en-US" prefix="og: https://ogp.me/ns#"><![endif]--><!--[if IE 8]><html id="ie8" lang="en-US" prefix="og: https://ogp.me/ns#"><![endif]--><!--[if !(IE 6) | !(IE 7) | !(IE 8) ]><!--><html lang="en-US" prefix="og: https://ogp.me/ns#"><!--<![endif]--><head> <meta charset="UTF-8"/> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <link rel="pingback" href="https://www.theralife.com/xmlrpc.php"/> <!--[if lt IE 9]> <script src="https://www.theralife.com/wp-content/themes/Divi/js/html5.js" type="text/javascript"></script> <![endif]--> <script type="lazyJs" >
		document.documentElement.className = 'js';
	</script> <title>New Ocular Rosacea Treatment - TheraLife | TheraLife</title><meta name="description" content="Ocular Rosacea, get total relief with TheraLife Eye Enhanced. Oral treatment that works. All-natural formula works from the inside out - lasting relief."/><meta name="robots" content="follow, index, max-snippet:-1, max-video-preview:-1, max-image-preview:large"/><link rel="canonical" href="https://www.theralife.com/effective-treatment-ocular-rosacea/"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="article"/><meta property="og:title" content="New Ocular Rosacea Treatment - TheraLife | TheraLife"/><meta property="og:description" content="Ocular Rosacea, get total relief with TheraLife Eye Enhanced. Oral treatment that works. All-natural formula works from the inside out - lasting relief."/><meta property="og:url" content="https://www.theralife.com/effective-treatment-ocular-rosacea/"/><meta property="og:site_name" content="TheraLife"/><meta property="article:publisher" content="https://www.facebook.com/theralifeinc/"/><meta property="article:section" content="autoimmune"/><meta property="og:updated_time" content="2023-06-27T23:01:44+00:00"/><meta property="og:image" content="https://www.theralife.com/wp-content/uploads/2021/11/Blepharitis.jpg"/><meta property="og:image:secure_url" content="https://www.theralife.com/wp-content/uploads/2021/11/Blepharitis.jpg"/><meta property="og:image:width" content="600"/><meta property="og:image:height" content="400"/><meta property="og:image:alt" content="Dry Eyes At Night"/><meta property="og:image:type" content="image/jpeg"/><meta property="article:published_time" content="2017-08-24T18:50:54+00:00"/><meta property="article:modified_time" content="2023-06-27T23:01:44+00:00"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="New Ocular Rosacea Treatment - TheraLife | TheraLife"/><meta name="twitter:description" content="Ocular Rosacea, get total relief with TheraLife Eye Enhanced. Oral treatment that works. All-natural formula works from the inside out - lasting relief."/><meta name="twitter:image" content="https://www.theralife.com/wp-content/uploads/2021/11/Blepharitis.jpg"/><meta name="twitter:label1" content="Written by"/><meta name="twitter:data1" content="Lily Yang"/><meta name="twitter:label2" content="Time to read"/><meta name="twitter:data2" content="13 minutes"/><link rel='dns-prefetch' href='//fonts.googleapis.com'/><link rel="alternate" type="application/rss+xml" title="TheraLife » Feed" href="https://www.theralife.com/feed/"/><link rel="alternate" type="application/rss+xml" title="TheraLife » Comments Feed" href="https://www.theralife.com/comments/feed/"/><link rel="alternate" type="application/rss+xml" title="TheraLife » New Treatment for Ocular Rosacea-TheraLife Comments Feed" href="https://www.theralife.com/effective-treatment-ocular-rosacea/feed/"/><script type="lazyJs" >
/* <![CDATA[ */
window._wpemojiSettings = {"baseUrl":"https:\/\/s.w.org\/images\/core\/emoji\/15.1.0\/72x72\/","ext":".png","svgUrl":"https:\/\/s.w.org\/images\/core\/emoji\/15.1.0\/svg\/","svgExt":".svg","source":{"concatemoji":"https:\/\/www.theralife.com\/wp-includes\/js\/wp-emoji-release.min.js"}};
/*! This file is auto-generated */
!function(i,n){var o,s,e;function c(e){try{var t={supportTests:e,timestamp:(new Date).valueOf()};sessionStorage.setItem(o,JSON.stringify(t))}catch(e){}}function p(e,t,n){e.clearRect(0,0,e.canvas.width,e.canvas.height),e.fillText(t,0,0);var t=new Uint32Array(e.getImageData(0,0,e.canvas.width,e.canvas.height).data),r=(e.clearRect(0,0,e.canvas.width,e.canvas.height),e.fillText(n,0,0),new Uint32Array(e.getImageData(0,0,e.canvas.width,e.canvas.height).data));return t.every(function(e,t){return e===r[t]})}function u(e,t,n){switch(t){case"flag":return n(e,"\ud83c\udff3\ufe0f\u200d\u26a7\ufe0f","\ud83c\udff3\ufe0f\u200b\u26a7\ufe0f")?!1:!n(e,"\ud83c\uddfa\ud83c\uddf3","\ud83c\uddfa\u200b\ud83c\uddf3")&&!n(e,"\ud83c\udff4\udb40\udc67\udb40\udc62\udb40\udc65\udb40\udc6e\udb40\udc67\udb40\udc7f","\ud83c\udff4\u200b\udb40\udc67\u200b\udb40\udc62\u200b\udb40\udc65\u200b\udb40\udc6e\u200b\udb40\udc67\u200b\udb40\udc7f");case"emoji":return!n(e,"\ud83d\udc26\u200d\ud83d\udd25","\ud83d\udc26\u200b\ud83d\udd25")}return!1}function f(e,t,n){var r="undefined"!=typeof WorkerGlobalScope&&self instanceof WorkerGlobalScope?new OffscreenCanvas(300,150):i.createElement("canvas"),a=r.getContext("2d",{willReadFrequently:!0}),o=(a.textBaseline="top",a.font="600 32px Arial",{});return e.forEach(function(e){o[e]=t(a,e,n)}),o}function t(e){var t=i.createElement("script");t.src=e,t.defer=!0,i.head.appendChild(t)}"undefined"!=typeof Promise&&(o="wpEmojiSettingsSupports",s=["flag","emoji"],n.supports={everything:!0,everythingExceptFlag:!0},e=new Promise(function(e){i.addEventListener("DOMContentLoaded",e,{once:!0})}),new Promise(function(t){var n=function(){try{var e=JSON.parse(sessionStorage.getItem(o));if("object"==typeof e&&"number"==typeof e.timestamp&&(new Date).valueOf()<e.timestamp+604800&&"object"==typeof e.supportTests)return e.supportTests}catch(e){}return null}();if(!n){if("undefined"!=typeof Worker&&"undefined"!=typeof OffscreenCanvas&&"undefined"!=typeof URL&&URL.createObjectURL&&"undefined"!=typeof Blob)try{var e="postMessage("+f.toString()+"("+[JSON.stringify(s),u.toString(),p.toString()].join(",")+"));",r=new Blob([e],{type:"text/javascript"}),a=new Worker(URL.createObjectURL(r),{name:"wpTestEmojiSupports"});return void(a.onmessage=function(e){c(n=e.data),a.terminate(),t(n)})}catch(e){}c(n=f(s,u,p))}t(n)}).then(function(e){for(var t in e)n.supports[t]=e[t],n.supports.everything=n.supports.everything&&n.supports[t],"flag"!==t&&(n.supports.everythingExceptFlag=n.supports.everythingExceptFlag&&n.supports[t]);n.supports.everythingExceptFlag=n.supports.everythingExceptFlag&&!n.supports.flag,n.DOMReady=!1,n.readyCallback=function(){n.DOMReady=!0}}).then(function(){return e}).then(function(){var e;n.supports.everything||(n.readyCallback(),(e=n.source||{}).concatemoji?t(e.concatemoji):e.wpemoji&&e.twemoji&&(t(e.twemoji),t(e.wpemoji)))}))}((window,document),window._wpemojiSettings);
/* ]]> */
</script><meta content="Divi Child Theme v.1.0.0" name="generator"/><style id='wp-emoji-styles-inline-css' type='text/css'> img.wp-smiley, img.emoji { display: inline !important; border: none !important; box-shadow: none !important; height: 1em !important; width: 1em !important; margin: 0 0.07em !important; vertical-align: -0.1em !important; background: none !important; padding: 0 !important; }</style><link rel="preload" href="/wp-content/w3-webp/uploads/2016/12/TheraLife-Logo.webp" as="image" fetchpriority="high"><link rel="preload" href="/wp-content/w3-webp/uploads/2021/11/Blepharitis.webp" as="image" fetchpriority="high"><link rel="preload" href="/wp-content/w3-webp/uploads/2020/07/Theralife-image-1-300x167.webp" as="image" fetchpriority="high"><link rel="preload" href="/wp-content/w3-webp/uploads/2018/03/TheralIfe-Dry-Eye-One-Month-Starter-Kit-Blephariti.webp" as="image" fetchpriority="high"><link rel="preload" href="/wp-content/w3-webp/uploads/2015/04/drbutton.webp" as="image" fetchpriority="high"><link rel="preload" href="/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTSGmu1aB.woff2" as="font" type="font/woff2" crossorigin fetchpriority="high"><link rel="preload" href="/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2" as="font" type="font/woff2" crossorigin fetchpriority="high"><link rel="preload" href="/wp-content/cache/w3-cache/fonts/s/opensans/v43/memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2" as="font" type="font/woff2" crossorigin fetchpriority="high"><link rel="preload" href="/wp-content/cache/w3-cache/fonts/s/raleway/v36/1Ptug8zYS_SKggPNyC0ITw.woff2" as="font" type="font/woff2" crossorigin fetchpriority="high">
<style id="w3speedster-critical-css">@font-face {  font-family: 'ETmonarch';  font-style: normal;  font-weight: normal;  font-display: swap;  src: url('data:font/woff2;base64,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') format('woff2'); } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:400; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTSGmu1aB.woff2') format('woff2'); unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:400; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:700; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTSGmu1aB.woff2') format('woff2'); unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:700; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:italic; font-weight:300; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:italic; font-weight:400; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:italic; font-weight:500; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:italic; font-weight:600; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:italic; font-weight:700; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:italic; font-weight:800; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:300; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTSGmu1aB.woff2') format('woff2'); unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:300; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:500; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTSGmu1aB.woff2') format('woff2'); unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:500; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:600; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTSGmu1aB.woff2') format('woff2'); unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:600; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:800; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTSGmu1aB.woff2') format('woff2'); unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF; } @font-face{ font-family:'Open Sans'; font-style:normal; font-weight:800; font-stretch:100%; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/opensans/v43/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Raleway'; font-style:normal; font-weight:100; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/raleway/v36/1Ptug8zYS_SKggPNyC0ITw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Raleway'; font-style:normal; font-weight:200; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/raleway/v36/1Ptug8zYS_SKggPNyC0ITw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Raleway'; font-style:normal; font-weight:300; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/raleway/v36/1Ptug8zYS_SKggPNyC0ITw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Raleway'; font-style:normal; font-weight:400; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/raleway/v36/1Ptug8zYS_SKggPNyC0ITw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Raleway'; font-style:normal; font-weight:500; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/raleway/v36/1Ptug8zYS_SKggPNyC0ITw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Raleway'; font-style:normal; font-weight:600; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/raleway/v36/1Ptug8zYS_SKggPNyC0ITw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Raleway'; font-style:normal; font-weight:700; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/raleway/v36/1Ptug8zYS_SKggPNyC0ITw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Raleway'; font-style:normal; font-weight:800; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/raleway/v36/1Ptug8zYS_SKggPNyC0ITw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face{ font-family:'Raleway'; font-style:normal; font-weight:900; font-display:swap; src:url('/wp-content/cache/w3-cache/fonts/s/raleway/v36/1Ptug8zYS_SKggPNyC0ITw.woff2') format('woff2'); unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD; } @font-face {  font-family: 'ETmodules';  font-style: normal;  font-weight: 400;  font-display: swap;  src: url('data:font/woff2;base64,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') format('woff2'); }body:not(.editor-styles-wrapper) .wp-block-cover:not(.wp-block-cover:has(.wp-block-cover__background+.wp-block-cover__inner-container)).has-background-dim:not(.has-background-gradient):before{z-index:1}ul{box-sizing:border-box}:where(p.has-text-color:not(.has-link-color)) a{color:inherit}:where(.wp-block-post-comments-form) textarea{border:1px solid #949494;font-family:inherit;font-size:1em}:where(.wp-block-post-comments-form) textarea{padding:calc(.667em + 2px)}.entry-content{counter-reset:footnotes}:root{--wp--preset--font-size--normal:16px;--wp--preset--font-size--huge:42px}.screen-reader-text{border:0;clip-path:inset(50%);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px;word-wrap:normal!important}.screen-reader-text:focus{background-color:#ddd;clip-path:none;color:#444;display:block;font-size:1em;height:auto;left:5px;line-height:normal;padding:15px 23px 14px;text-decoration:none;top:5px;width:auto;z-index:100000}:root{--wp--preset--aspect-ratio--square:1;--wp--preset--aspect-ratio--4-3:4/3;--wp--preset--aspect-ratio--3-4:3/4;--wp--preset--aspect-ratio--3-2:3/2;--wp--preset--aspect-ratio--2-3:2/3;--wp--preset--aspect-ratio--16-9:16/9;--wp--preset--aspect-ratio--9-16:9/16;--wp--preset--color--black:#000000;--wp--preset--color--cyan-bluish-gray:#abb8c3;--wp--preset--color--white:#ffffff;--wp--preset--color--pale-pink:#f78da7;--wp--preset--color--vivid-red:#cf2e2e;--wp--preset--color--luminous-vivid-orange:#ff6900;--wp--preset--color--luminous-vivid-amber:#fcb900;--wp--preset--color--light-green-cyan:#7bdcb5;--wp--preset--color--vivid-green-cyan:#00d084;--wp--preset--color--pale-cyan-blue:#8ed1fc;--wp--preset--color--vivid-cyan-blue:#0693e3;--wp--preset--color--vivid-purple:#9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple:linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan:linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange:linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red:linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray:linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum:linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple:linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux:linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk:linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean:linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass:linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight:linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small:13px;--wp--preset--font-size--medium:20px;--wp--preset--font-size--large:36px;--wp--preset--font-size--x-large:42px;--wp--preset--spacing--20:0.44rem;--wp--preset--spacing--30:0.67rem;--wp--preset--spacing--40:1rem;--wp--preset--spacing--50:1.5rem;--wp--preset--spacing--60:2.25rem;--wp--preset--spacing--70:3.38rem;--wp--preset--spacing--80:5.06rem;--wp--preset--shadow--natural:6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep:12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp:6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined:6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp:6px 6px 0px rgba(0, 0, 0, 1)}:root{--wp--style--global--content-size:823px;--wp--style--global--wide-size:1080px}body{padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px}.et_monarch .et_social_networks,.et_monarch .et_social_networks span,.et_monarch .et_social_networks a,.et_monarch .et_social_networks i,.et_monarch .et_social_networks ul,.et_monarch .et_social_networks li,.et_monarch .widget_monarchwidget li,.et_monarch .widget_monarchwidget li:before,.et_monarch .widget_monarchwidget li:after,.et_monarch .et_social_pinterest_window h3{font-family:'Open Sans', helvetica, arial, sans-serif;line-height:1em;text-transform:none;font-weight:normal;margin:0;padding:0;border:0;outline:0;font-size:100%;vertical-align:baseline;background-image:none;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;-webkit-transform:translate3d(0,0,0);transform:translate3d(0,0,0);-moz-transform:translate3d(0,0,0);-o-transform:translate3d(0,0,0);-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_monarch .et_social_networks{font-family:'Open Sans', helvetica, arial, sans-serif;line-height:1em;font-weight:400;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_monarch .et_social_pinterest_window h3{font-family:'Open Sans', helvetica, arial, sans-serif;font-size:26px;line-height:1.1em;color:#333;font-weight:400;letter-spacing:.5px;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_monarch .et_social_networks span,.et_monarch .et_social_circle i.et_social_icon,i.et_social_icon:before,i.et_social_icon:after,.et_monarch .et_social_networks li,.et_monarch .et_social_networks li a{transition:all 0.3s;-moz-transition:all 0.3s;-webkit-transition:all 0.3s}.et_monarch .et_social_circle .et_social_icons_container li i:before{transition:none !important;-webkit-transition:none !important;-moz-transition:none !important}.et_monarch .et_social_circle .et_social_icons_container li i:after,.et_monarch .et_social_circle .et_social_icons_container li i:before,.et_monarch .et_social_circle .et_social_icons_container li:hover i:after,.et_monarch .et_social_circle .et_social_icons_container li:hover i:before{transition:left 0.3s, right 0.3s, margin 0.3s, opacity 0.3s !important;-moz-transition:left 0.3s, right 0.3s, margin 0.3s, opacity 0.3s !important;-webkit-transition:left 0.3s, right 0.3s, margin 0.3s, opacity 0.3s !important}.et_monarch .et_social_icon{color:#FFF}.et_monarch .et_social_networks,.et_monarch .widget_monarchwidget a{text-shadow:none !important}.et_monarch .et_social_icon,.et_monarch .et_social_icon:before,.et_monarch .et_social_icon:after{font-family:'ETmonarch';speak:none;font-style:normal;font-size:16px;line-height:16px;font-weight:normal;font-variant:normal;text-transform:none;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;text-align:center;display:block}.et_monarch .et_social_icon_printfriendly:before,.et_monarch .et_social_icon_printfriendly:after{content:"\e627"}.et_monarch .et_social_icon_youtube:before,.et_monarch .et_social_icon_youtube:after{content:"\e62c"}.et_monarch .et_social_icon_googleplus:before,.et_monarch .et_social_icon_googleplus:after{content:"\e626"}.et_monarch .et_social_icon_linkedin:before,.et_monarch .et_social_icon_linkedin:after{content:"\e631"}.et_monarch .et_social_icon_pinterest:before,.et_monarch .et_social_icon_pinterest:after{content:"\e63a"}.et_monarch .et_social_icon_facebook:before,.et_monarch .et_social_icon_facebook:after{content:"\e63f"}.et_monarch .et_social_icon_twitter:before,.et_monarch .et_social_icon_twitter:after{content:"\e640"}.et_monarch .et_social_facebook,.et_monarch .et_social_facebook,.et_monarch .et_social_networks.et_social_circle .et_social_facebook i{background-color:#3a579a}.et_monarch li.et_social_facebook:hover,.et_monarch .et_social_networks.et_social_circle li.et_social_facebook:hover i{background-color:#314a83}.et_monarch .widget_monarchwidget li.et_social_facebook{background-color:#3a579a !important}.et_monarch .widget_monarchwidget li.et_social_facebook:hover{background-color:#314a83 !important}.et_monarch .et_social_twitter,.et_monarch .et_social_twitter,.et_monarch .et_social_networks.et_social_circle .et_social_twitter i{background-color:#00abf0}.et_monarch .widget_monarchwidget li.et_social_twitter:hover,.et_monarch li.et_social_twitter:hover,.et_monarch .et_social_networks.et_social_circle li.et_social_twitter:hover i{background-color:#0092cc}.et_monarch .widget_monarchwidget li.et_social_twitter{background-color:#00abf0 !important}.et_monarch .widget_monarchwidget li.et_social_twitter:hover{background-color:#0092cc !important}.et_monarch .et_social_pinterest,.et_monarch .et_social_networks.et_social_circle .et_social_pinterest i{background-color:#cd1c1f}.et_monarch li.et_social_pinterest:hover,.et_monarch .et_social_networks.et_social_circle li.et_social_pinterest:hover i{background-color:#ae181a}.et_monarch .widget_monarchwidget li.et_social_pinterest{background-color:#cd1c1f !important}.et_monarch .widget_monarchwidget li.et_social_pinterest:hover{background-color:#ae181a !important}.et_monarch .et_social_googleplus,.et_monarch .et_social_networks.et_social_circle .et_social_googleplus i{background-color:#df4a32}.et_monarch li.et_social_googleplus:hover,.et_monarch .et_social_networks.et_social_circle li.et_social_googleplus:hover i{background-color:#be3f2b}.et_monarch .et_social_linkedin,.et_monarch .et_social_networks.et_social_circle .et_social_linkedin i{background-color:#127bb6}.et_monarch li.et_social_linkedin:hover,.et_monarch .et_social_networks.et_social_circle li.et_social_linkedin:hover i{background-color:#0f699b}.et_monarch .widget_monarchwidget li.et_social_linkedin{background-color:#127bb6 !important}.et_monarch .widget_monarchwidget li.et_social_linkedin:hover{background-color:#0f699b !important}.et_monarch .et_social_printfriendly,.et_monarch .et_social_networks.et_social_circle .et_social_printfriendly i{background-color:#75aa33}.et_monarch li.et_social_printfriendly:hover,.et_monarch .et_social_networks.et_social_circle li.et_social_printfriendly:hover i{background-color:#64912b}.et_monarch .et_social_youtube{background-color:#a8240f}.et_monarch li.et_social_youtube:hover{background-color:#8f1f0d}.et_monarch .widget_monarchwidget li.et_social_youtube{background-color:#a8240f !important}.et_monarch .widget_monarchwidget li.et_social_youtube:hover{background-color:#8f1f0d !important}.et_monarch .widget_monarchwidget .et_social_icons_container li:hover .et_social_icon{color:#ffffff}.widget_monarchwidget li{background-image:none !important;list-style:none;padding:0 !important;margin-bottom:0 !important;border:none !important}.widget_monarchwidget li,.et_monarch .widget_monarchwidget li:after{border:none !important}.widget_monarchwidget li:before{display:none}.et_monarch .et_social_icon{position:relative;z-index:100}.et_monarch .et_social_networks span.et_social_overlay{height:100%;width:100%;background-color:rgba( 0, 0, 0, 0.1 );bottom:0;left:0;z-index:1;position:absolute}.et_monarch .et_social_inline_bottom{margin-top:40px}.widget_monarchwidget{width:auto;float:none !important}.et_monarch .et_social_networks{width:100%;display:inline-block}.et_monarch .et_social_networks .et_social_icons_container{padding:0 !important;margin:0 !important;line-height:1em !important;display:inline-block;width:inherit}.et_monarch .et_social_networks li,.et_monarch .widget_monarchwidget .et_social_networks li{float:left;position:relative;margin:2% 0 0 2%;overflow:hidden;min-height:40px;line-height:0}.et_monarch .et_social_networks li a{line-height:0}.et_monarch .et_social_networks li,.et_monarch .et_social_networks li a,.et_monarch .et_social_icon{display:block;overflow:hidden;-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}.et_monarch .et_social_networks span,.et_monarch .et_social_networks li i{position:relative;z-index:2}.et_monarch .et_social_networks .et_social_icon,.et_monarch .et_social_networks .et_social_icon:before,.et_monarch .et_social_networks .et_social_icon:after{width:40px;height:40px;line-height:40px;display:inline-block;-webkit-border-radius:100px;-moz-border-radius:100px;border-radius:100px}.et_monarch .et_social_slide.et_social_top li:hover .et_social_icon{background-color:rgba( 0, 0, 0, 0.2 )}.et_monarch .et_social_icon:after{display:none}.et_monarch .et_social_slide .et_social_icon:after{display:inline-block;position:absolute;top:-40px;left:0}.et_monarch .et_social_slide li:hover .et_social_icon:before{opacity:0;margin-top:40px}.et_monarch .et_social_slide li:hover .et_social_icon:after{top:0}.et_monarch .et_social_slide li:hover .et_social_overlay{background-color:rgba( 0, 0, 0, 0 );margin:0 0 0 100px}.et_monarch .et_social_top.et_social_circle li a{padding:0 !important}.et_monarch .et_social_icon:before,.et_monarch .et_social_icon:after{position:relative;width:100%}.et_monarch .et_social_icon:after{display:none}.et_monarch .et_social_circle .et_social_icon:before,.et_monarch .et_social_circle .et_social_icon:after{width:100% !important;-webkit-border-radius:100px;-moz-border-radius:100px;border-radius:100px}.et_monarch .et_social_circle li{width:40px;-webkit-border-radius:100px;-moz-border-radius:100px;border-radius:100px;margin-bottom:10px;left:0}.et_monarch .et_social_top ul,.et_monarch .et_social_top li,.et_monarch .et_social_top span,.et_monarch .et_social_top a,.et_monarch .et_social_top .et_social_icons_container{text-align:center}.et_monarch .et_social_top li a{padding:10px}.et_monarch .et_social_top span{display:block;margin:0}.et_monarch .et_social_top span.et_social_overlay{background-color:rgba( 0, 0, 0, 0 )}.et_monarch .et_social_top .et_social_icon{background-color:rgba( 0, 0, 0, 0.1 )}.et_monarch .et_social_networks.et_social_circle li{background-color:transparent !important;-webkit-border-radius:0;-moz-border-radius:0;border-radius:0}.et_monarch .et_social_rounded.et_social_networks li{-webkit-border-radius:4px;-moz-border-radius:4px;border-radius:4px;overflow:hidden}.et_monarch .et_social_circle .et_social_overlay{display:none}.et_monarch .et_social_autowidth li{width:auto;margin:0 2% 2% 0 !important}.et_monarch .et_social_autowidth li:first-child{margin-left:0;clear:both}.et_monarch .et_social_icons_container a{text-decoration:none !important}.et_monarch .et_social_close:after{font-family:'etmonarch';speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;font-size:16px}.et_monarch span.et_social_close{cursor:pointer}.et_monarch span.et_social_close{position:absolute;right:10px;top:0;line-height:40px}.et_monarch span.et_social_close:after{content:"\e60C";color:#cccccc}.et_monarch .et_social_inline_bottom{margin-top:30px}.et_monarch .et_social_pin_images_outer{display:none;z-index:9999999999;position:absolute}.et_monarch .et_social_pin_images_outer:after{content:"";background-color:rgba(0,0,0,.6);top:0;left:0;width:100%;height:100%;position:fixed;z-index:999999}.et_monarch .et_social_pinterest_window{background:white;position:fixed;top:20%;left:50%;padding:20px;width:500px;height:400px;z-index:9999999;margin-left:-250px;-webkit-border-radius:7px;-moz-border-radius:7px;border-radius:7px}.et_monarch .et_social_pinterest_window span.et_social_close{cursor:pointer}.et_monarch .et_social_pin_images{overflow:auto;max-height:370px;z-index:999;position:relative}@media only screen and ( max-width:767px ){.et_monarch .et_social_networks li{margin:2% 0 0 2% !important;width:49% !important;clear:none !important}.et_monarch .et_social_networks li:nth-child(2n+1){margin-left:0 !important;clear:both !important}.et_monarch .et_social_networks li:nth-child(-n+2){margin-top:0 !important}.et_monarch .et_social_pinterest_window{height:80%;width:80%;top:10px;margin-left:0px;z-index:99999999;left:6%}.et_monarch .et_social_pin_images{max-height:90%}.et_monarch .et_social_autowidth.et_social_networks li:nth-child(n){width:auto !important;margin:0 2% 2% 0 !important;clear:none !important}}@media only screen and ( max-width:479px ){.et_monarch .et_social_networks li{width:100% !important;margin-left:0 !important;clear:both !important}.et_monarch .et_social_networks li:first-child{margin-top:0 !important}.et_monarch .et_social_networks li:nth-child(n+2){margin:2% 0 0 0 !important}.et_monarch .et_social_autowidth.et_social_networks li:nth-child(n){width:auto !important;margin:0 2% 2% 0 !important;clear:none !important}}@-webkit-keyframes et_social_fadeIn{0%{opacity:0}100%{opacity:1}}@-webkit-keyframes et_social_fadeOut{0%{opacity:1}100%{opacity:0}}@-webkit-keyframes et_social_fadeInRight{0%{opacity:0;-webkit-transform:translateX(-30%)}100%{opacity:1;-webkit-transform:translateX(0)}}@-webkit-keyframes et_social_fadeInBottom{0%{opacity:0;-webkit-transform:translateY(-30%)}100%{opacity:1;-webkit-transform:translateY(0)}}@-webkit-keyframes et_social_fadeInTop{0%{opacity:0;-webkit-transform:translateY(30%)}100%{opacity:1;-webkit-transform:translateY(0)}}@-webkit-keyframes et_social_slideTop{0%{-webkit-transform:translateY(0)}100%{-webkit-transform:translateY(0)}}@-webkit-keyframes et_social_swing{20%{-webkit-transform:rotate3d(0, 0, 1, 15deg);transform:rotate3d(0, 0, 1, 15deg)}40%{-webkit-transform:rotate3d(0, 0, 1, -10deg);transform:rotate3d(0, 0, 1, -10deg)}60%{-webkit-transform:rotate3d(0, 0, 1, 5deg);transform:rotate3d(0, 0, 1, 5deg)}80%{-webkit-transform:rotate3d(0, 0, 1, -5deg);transform:rotate3d(0, 0, 1, -5deg)}100%{-webkit-transform:rotate3d(0, 0, 1, 0deg);transform:rotate3d(0, 0, 1, 0deg)}}@-webkit-keyframes et_social_tada{0%{-webkit-transform:scale3d(1, 1, 1);transform:scale3d(1, 1, 1)}10%,20%{-webkit-transform:scale3d(.9, .9, .9) rotate3d(0, 0, 1, -3deg);transform:scale3d(.9, .9, .9) rotate3d(0, 0, 1, -3deg)}30%,50%,70%,90%{-webkit-transform:scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, 3deg);transform:scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, 3deg)}40%,60%,80%{-webkit-transform:scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, -3deg);transform:scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, -3deg)}100%{-webkit-transform:scale3d(1, 1, 1);transform:scale3d(1, 1, 1)}}@-webkit-keyframes et_social_bounce{0%,20%,53%,80%,100%{-webkit-transition-timing-function:cubic-bezier(0.215, 0.610, 0.355, 1.000);transition-timing-function:cubic-bezier(0.215, 0.610, 0.355, 1.000);-webkit-transform:translate3d(0,0,0);transform:translate3d(0,0,0)}40%,43%{-webkit-transition-timing-function:cubic-bezier(0.755, 0.050, 0.855, 0.060);transition-timing-function:cubic-bezier(0.755, 0.050, 0.855, 0.060);-webkit-transform:translate3d(0, -30px, 0);transform:translate3d(0, -30px, 0)}70%{-webkit-transition-timing-function:cubic-bezier(0.755, 0.050, 0.855, 0.060);transition-timing-function:cubic-bezier(0.755, 0.050, 0.855, 0.060);-webkit-transform:translate3d(0, -15px, 0);transform:translate3d(0, -15px, 0)}90%{-webkit-transform:translate3d(0,-4px,0);transform:translate3d(0,-4px,0)}}@-webkit-keyframes et_social_flipInX{0%{-webkit-transform:perspective(400px) rotate3d(1, 0, 0, 90deg);transform:perspective(400px) rotate3d(1, 0, 0, 90deg);-webkit-transition-timing-function:ease-in;transition-timing-function:ease-in;opacity:0}40%{-webkit-transform:perspective(400px) rotate3d(1, 0, 0, -20deg);transform:perspective(400px) rotate3d(1, 0, 0, -20deg);-webkit-transition-timing-function:ease-in;transition-timing-function:ease-in}60%{-webkit-transform:perspective(400px) rotate3d(1, 0, 0, 10deg);transform:perspective(400px) rotate3d(1, 0, 0, 10deg);opacity:1}80%{-webkit-transform:perspective(400px) rotate3d(1, 0, 0, -5deg);transform:perspective(400px) rotate3d(1, 0, 0, -5deg)}100%{-webkit-transform:perspective(400px);transform:perspective(400px)}}@-webkit-keyframes et_social_zoomIn{0%{opacity:0;-webkit-transform:scale3d(.3, .3, .3);transform:scale3d(.3, .3, .3)}50%{opacity:1}}@-webkit-keyframes et_social_lightSpeedIn{0%{-webkit-transform:translate3d(30%, 0, 0) skewX(-10deg);transform:translate3d(30%, 0, 0) skewX(-10deg);opacity:0}60%{-webkit-transform:skewX(5deg);transform:skewX(5deg);opacity:1}80%{-webkit-transform:skewX(-5deg);transform:skewX(-5deg);opacity:1}100%{-webkit-transform:none;transform:none;opacity:1}}a,b,body,div,em,font,form,h1,h2,h3,h4,html,i,img,label,li,p,small,span,strong,ul{margin:0;padding:0;border:0;outline:0;font-size:100%;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;vertical-align:baseline;background:transparent}body{line-height:1}ul{list-style:none}article,footer,header,nav,section{display:block}body{font-family:Open Sans,Arial,sans-serif;font-size:14px;color:#666;background-color:#fff;line-height:1.7em;font-weight:500;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}body.et_cover_background{background-size:cover!important;background-position:top!important;background-repeat:no-repeat!important;background-attachment:fixed}a{color:#2ea3f2}a,a:hover{text-decoration:none}p{padding-bottom:1em}p:not(.has-background):last-of-type{padding-bottom:0}strong{font-weight:700}em,i{font-style:italic}h1,h2,h3,h4{color:#333;padding-bottom:10px;line-height:1em;font-weight:500}h2 a,h3 a{color:inherit}h1{font-size:30px}h2{font-size:26px}h3{font-size:22px}h4{font-size:18px}input{-webkit-appearance:none}input[type=checkbox]{-webkit-appearance:checkbox}input[type=text],textarea{background-color:#fff;border:1px solid #bbb;padding:2px;color:#4e4e4e}input[type=text]:focus,textarea:focus{border-color:#2d3940;color:#3e3e3e}input[type=text],textarea{margin:0}textarea{padding:4px}button,input,textarea{font-family:inherit}img{max-width:100%;height:auto}.et-search-form{border-color:#2ea3f2}#main-content{background-color:#fff}.container{width:80%;max-width:1080px;margin:auto}body:not(.et-tb) #main-content .container,body:not(.et-tb-has-header) #main-content .container{padding-top:58px}.form-submit .et_pb_button:hover{background:rgba(0,0,0,.05)}.form-submit .et_pb_button:hover{padding:.3em 1em}#left-area ul,.entry-content ul{list-style-type:disc;padding:0 0 23px 1em;line-height:26px}#left-area .post-meta{font-size:14px;padding-bottom:15px}#left-area .post-meta a{text-decoration:none;color:#666}.single .post{padding-bottom:25px}.wp-caption{border:1px solid #ddd;text-align:center;background-color:#f3f3f3;margin-bottom:10px;max-width:96%;padding:8px}.wp-caption img{margin:0;padding:0;border:0}.wp-caption p.wp-caption-text{font-size:12px;padding:0 4px 5px;margin:0}.alignleft{float:left}img.alignleft{display:inline;float:left;margin-right:15px}@media (min-width:981px){#left-area{width:79.125%;padding-bottom:23px}#main-content .container:before{content:"";position:absolute;top:0;height:100%;width:1px;background-color:#e2e2e2}}@media (max-width:980px){#page-container{padding-top:80px}#left-area,#sidebar{width:100%!important}#main-content .container:before{display:none!important}}@media print{#page-container{padding-top:0!important}}#sidebar{padding-bottom:28px}#sidebar .et_pb_widget{margin-bottom:30px;width:100%;float:none}@media (min-width:981px) and (max-width:1100px){#sidebar .et_pb_widget{margin-left:0}}@media (min-width:981px){#sidebar{float:left;width:20.875%}.et_right_sidebar #left-area{float:left;padding-right:5.5%}.et_right_sidebar #sidebar{padding-left:30px}.et_right_sidebar #main-content .container:before{right:20.875%!important}}@media (max-width:980px){.et_right_sidebar #left-area,.et_right_sidebar #sidebar{width:auto;float:none;padding-right:0;padding-left:0}.et_right_sidebar #left-area{margin-right:0}.et_right_sidebar #sidebar{margin-left:0;border-left:none}}.single .et_pb_post{margin-bottom:27px}.et_pb_scroll_top.et-pb-icon{text-align:center;background:rgba(0,0,0,.4);text-decoration:none;position:fixed;z-index:99999;bottom:125px;right:0;-webkit-border-top-left-radius:5px;-webkit-border-bottom-left-radius:5px;-moz-border-radius-topleft:5px;-moz-border-radius-bottomleft:5px;border-top-left-radius:5px;border-bottom-left-radius:5px;display:none;cursor:pointer;font-size:30px;padding:5px;color:#fff}.et_pb_scroll_top:before{content:"2"}@media print{#respond{display:none}}.widget_search .screen-reader-text{display:none}.widget_search input#s,.widget_search input#searchsubmit{padding:.7em;height:40px!important;margin:0;font-size:14px;line-height:normal!important;border:1px solid #ddd;color:#666}.widget_search #s{width:100%;border-radius:3px}.widget_search #searchform{position:relative}.widget_search #searchsubmit{background-color:#ddd;-webkit-border-top-right-radius:3px;-webkit-border-bottom-right-radius:3px;-moz-border-radius-topright:3px;-moz-border-radius-bottomright:3px;border-top-right-radius:3px;border-bottom-right-radius:3px;position:absolute;right:0;top:0}#searchsubmit{cursor:pointer}#et-secondary-menu li,#top-menu li{word-wrap:break-word}.nav li ul{border-color:#2ea3f2}.mobile_menu_bar:after,.mobile_menu_bar:before{color:#2ea3f2}#main-header{-webkit-transition:background-color .4s,color .4s,opacity .4s ease-in-out,-webkit-transform .4s;transition:background-color .4s,color .4s,opacity .4s ease-in-out,-webkit-transform .4s;transition:background-color .4s,color .4s,transform .4s,opacity .4s ease-in-out;transition:background-color .4s,color .4s,transform .4s,opacity .4s ease-in-out,-webkit-transform .4s}.container{text-align:left;position:relative}.et_fixed_nav.et_show_nav #page-container{padding-top:80px}.et_fixed_nav.et_show_nav.et_secondary_nav_enabled #page-container{padding-top:111px}.et_fixed_nav #main-header{position:fixed}.et_header_style_left #et-top-navigation{padding-top:33px}.et_header_style_left #et-top-navigation nav>ul>li>a{padding-bottom:33px}.et_header_style_left .logo_container{position:absolute;height:100%;width:100%}.et_header_style_left #et-top-navigation .mobile_menu_bar{padding-bottom:24px}#logo{width:auto;-webkit-transition:all .4s ease-in-out;transition:all .4s ease-in-out;margin-bottom:0;max-height:54%;display:inline-block;float:none;vertical-align:middle;-webkit-transform:translateZ(0)}.logo_container{-webkit-transition:all .4s ease-in-out;transition:all .4s ease-in-out}span.logo_helper{display:inline-block;height:100%;vertical-align:middle;width:0}#top-menu,#top-menu-nav{line-height:0}#et-top-navigation{font-weight:600}.et_fixed_nav #et-top-navigation{-webkit-transition:all .4s ease-in-out;transition:all .4s ease-in-out}.et-cart-info span:before{content:"\e07a";margin-right:10px;position:relative}#top-menu,nav#top-menu-nav{float:left}#top-menu li{display:inline-block;font-size:14px;padding-right:22px}#top-menu>li:last-child{padding-right:0}#top-menu a{color:rgba(0,0,0,.6);text-decoration:none;display:block;position:relative;-webkit-transition:opacity .4s ease-in-out,background-color .4s ease-in-out;transition:opacity .4s ease-in-out,background-color .4s ease-in-out}#top-menu-nav>ul>li>a:hover{opacity:.7;-webkit-transition:all .4s ease-in-out;transition:all .4s ease-in-out}.et-search-form{top:0;bottom:0;right:0;position:absolute;z-index:1000;width:100%}.et-search-form input{width:90%;border:none;color:#333;position:absolute;top:0;bottom:0;right:30px;margin:auto;background:transparent}.et-search-form .et-search-field::-ms-clear{width:0;height:0;display:none}.et_search_form_container{-webkit-animation:none;animation:none;-o-animation:none}.container.et_search_form_container{position:relative;opacity:0;height:1px}span.et_close_search_field{display:block;width:30px;height:30px;z-index:99999;position:absolute;right:0;cursor:pointer;top:0;bottom:0;margin:auto}span.et_close_search_field:after{font-family:ETmodules;content:"\4d";speak:none;font-weight:400;-webkit-font-feature-settings:normal;font-feature-settings:normal;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased;font-size:32px;display:inline-block;-webkit-box-sizing:border-box;box-sizing:border-box}.container.et_menu_container{z-index:99}.et_search_outer{width:100%;overflow:hidden;position:absolute;top:0}form.et-search-form{background:transparent!important}input[type=search]::-webkit-search-cancel-button{-webkit-appearance:none}.et-cart-info{color:inherit}#et-top-navigation{float:right}#top-menu li li{padding:0 20px;margin:0}#top-menu li li a{padding:6px 20px;width:200px}#top-menu .menu-item-has-children>a:first-child:after{font-family:ETmodules;content:"3";font-size:16px;position:absolute;right:0;top:0;font-weight:800}#top-menu .menu-item-has-children>a:first-child{padding-right:20px}#top-menu li .menu-item-has-children>a:first-child{padding-right:40px}#top-menu li .menu-item-has-children>a:first-child:after{right:20px;top:6px}#et_mobile_nav_menu{float:right;display:none}.mobile_menu_bar:before{content:"\61";font-size:32px;left:0;position:relative;top:0;cursor:pointer}body.et_fixed_nav.et_secondary_nav_enabled #main-header{top:30px}@media (min-width:981px){.et_fullwidth_nav .et-search-form,.et_fullwidth_nav .et_close_search_field{right:30px}.et_primary_nav_dropdown_animation_fade #et-top-navigation ul li:hover>ul{-webkit-transition:all .2s ease-in-out;transition:all .2s ease-in-out}.et_fullwidth_nav #main-header .container{width:100%;max-width:100%;padding-right:32px;padding-left:30px}}@media (max-width:980px){.et_fixed_nav.et_show_nav #page-container,.et_fixed_nav.et_show_nav.et_secondary_nav_enabled #page-container{padding-top:80px}#top-menu{display:none}#et-top-navigation{margin-right:0;-webkit-transition:none;transition:none}.et_fixed_nav #main-header{position:absolute}.et_header_style_left #et-top-navigation{padding-top:24px;display:block}.et_fixed_nav #main-header{-webkit-transition:none;transition:none}#logo,#main-header,.container,.logo_container{-webkit-transition:none;transition:none}.et_header_style_left #logo{max-width:50%}.et_header_style_left .et-search-form{width:50%!important;max-width:50%!important}#et_mobile_nav_menu{display:block}}@media (max-width:767px){#et-top-navigation{margin-right:0}}@media (max-width:479px){#et-top-navigation{margin-right:0}}@media print{#main-header,#top-header{position:relative!important;top:auto!important;right:auto!important;bottom:auto!important;left:auto!important}}.footer-widget li:before{border-color:#2ea3f2}#main-footer{background-color:#222}#footer-widgets{padding:6% 0 0}.footer-widget{float:left;color:#fff}.footer-widget .fwidget:last-child{margin-bottom:0!important}#footer-widgets .footer-widget li{padding-left:14px;position:relative}#footer-widgets .footer-widget li:before{border-radius:3px;border-style:solid;border-width:3px;content:"";left:0;position:absolute;top:9px}#footer-widgets .footer-widget a{color:#fff}#footer-widgets .footer-widget li a{color:#fff;text-decoration:none}#footer-widgets .footer-widget li a:hover{color:hsla(0,0%,100%,.7)}#footer-bottom{background-color:#1f1f1f;background-color:rgba(0,0,0,.32);padding:15px 0 5px}#footer-bottom a{-webkit-transition:all .4s ease-in-out;transition:all .4s ease-in-out}#footer-info{text-align:left;color:#666;padding-bottom:10px;float:left}#footer-info a{font-weight:700;color:#666}#footer-info a:hover{opacity:.7}@media (max-width:980px){.footer-widget:nth-child(n){width:46.25%!important;margin:0 7.5% 7.5% 0!important}#footer-widgets .footer-widget .fwidget{margin-bottom:16.21%}#footer-widgets{padding:8% 0}#footer-widgets .footer-widget:nth-child(2n){margin-right:0!important}#footer-widgets .footer-widget:nth-last-child(-n+2){margin-bottom:0!important}#footer-info{text-align:center}#footer-info{float:none}}@media (max-width:767px){#footer-widgets .footer-widget{width:100%!important;margin-right:0!important}#footer-widgets .footer-widget .fwidget,#footer-widgets .footer-widget:nth-child(n){margin-bottom:9.5%!important}#footer-widgets{padding:10% 0}#footer-widgets .footer-widget .fwidget:last-child,#footer-widgets .footer-widget:last-child{margin-bottom:0!important}}@media (max-width:479px){#footer-widgets .footer-widget:nth-child(n),.footer-widget .fwidget{margin-bottom:11.5%!important}#footer-widgets{padding:12% 0}}@-webkit-keyframes fadeInLeft{0%{opacity:0;-webkit-transform:translateX(-100%);transform:translateX(-100%)}to{opacity:1;-webkit-transform:translateX(0);transform:translateX(0)}}@-webkit-keyframes fadeOutRight{0%{opacity:1;-webkit-transform:translateX(0);transform:translateX(0)}to{opacity:0;-webkit-transform:translateX(100%);transform:translateX(100%)}}@-webkit-keyframes fadeOutLeft{0%{opacity:1;-webkit-transform:translateX(0);transform:translateX(0)}to{opacity:0;-webkit-transform:translateX(-70%);transform:translateX(-70%)}}@-webkit-keyframes fadeInRight{0%{opacity:0;-webkit-transform:translateX(100%);transform:translateX(100%)}to{opacity:1;-webkit-transform:translateX(0);transform:translateX(0)}}#et-secondary-menu li{word-wrap:break-word}#top-header{background-color:#2ea3f2}#top-header{font-size:12px;line-height:13px;z-index:100000;color:#fff}#top-header a{color:#fff}#et-secondary-nav,#top-header{-webkit-transition:background-color .4s,opacity .4s ease-in-out,-webkit-transform .4s;transition:background-color .4s,opacity .4s ease-in-out,-webkit-transform .4s;transition:background-color .4s,transform .4s,opacity .4s ease-in-out;transition:background-color .4s,transform .4s,opacity .4s ease-in-out,-webkit-transform .4s}#top-header .container{padding-top:.75em;font-weight:600}#top-header,#top-header #et-info,#top-header .container{line-height:1em}.et_fixed_nav #top-header{top:0;left:0;right:0;position:fixed}#et-info{float:left}#et-info-email,#et-info-phone{position:relative}#et-info-phone:before{content:"\e090";position:relative;top:2px;margin-right:2px}#et-info-phone{margin-right:13px}#et-info-email:before{content:"\e076";margin-right:4px}#et-secondary-menu{float:right}#et-info,#et-secondary-menu>ul>li a{padding-bottom:.75em;display:block}#et-secondary-nav,#et-secondary-nav li{display:inline-block}#et-secondary-nav a{-webkit-transition:background-color .4s,color .4s ease-in-out;transition:background-color .4s,color .4s ease-in-out}#et-secondary-nav li{margin-right:15px}#et-secondary-nav>li:last-child{margin-right:0}#et-info-email:hover,#et-secondary-menu>ul>li>a:hover{opacity:.7;-webkit-transition:all .4s ease-in-out;transition:all .4s ease-in-out}#et-secondary-nav li{position:relative;text-align:right}#et-secondary-nav li:hover{visibility:inherit}#top-header .et-cart-info{margin-left:15px}@media (max-width:980px){#top-header{-webkit-transition:none;transition:none}.et_fixed_nav #top-header{position:absolute}#top-header .container{padding-top:0}#et-info{padding-top:.75em}#et-secondary-menu,#et-secondary-nav{display:none!important}#top-header .et-cart-info{margin-left:0}}@media (max-width:767px){body.et_fixed_nav.et_secondary_nav_two_panels #main-header{top:58px}#et-info,#et-secondary-menu{text-align:center;display:block;float:none}.et_secondary_nav_two_panels #et-secondary-menu{margin-top:12px}}@media (min-width:981px){.et_pb_gutters3 .footer-widget{margin-right:5.5%;margin-bottom:5.5%}.et_pb_gutters3 .footer-widget:last-child{margin-right:0}.et_pb_gutters3.et_pb_footer_columns_1_2__1_4 .footer-widget:first-child{width:47.25%}.et_pb_gutters3.et_pb_footer_columns_1_2__1_4 .footer-widget:first-child .fwidget{margin-bottom:11.64%}.et_pb_gutters3.et_pb_footer_columns_1_2__1_4 .footer-widget:nth-child(-n+3):not(:first-child){width:20.875%}.et_pb_gutters3.et_pb_footer_columns_1_2__1_4 .footer-widget:nth-child(-n+3):not(:first-child) .fwidget{margin-bottom:26.347%}}*{-webkit-box-sizing:border-box;box-sizing:border-box}#et-info-email:before,#et-info-phone:before,.et-cart-info span:before,.et_pb_button:after,.form-submit .et_pb_button:after,.mobile_menu_bar:before{font-family:ETmodules!important;speak:none;font-style:normal;font-weight:400;-webkit-font-feature-settings:normal;font-feature-settings:normal;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;text-shadow:0 0;direction:ltr}.et-pb-icon{content:attr(data-icon)}.et-pb-icon{font-family:ETmodules;speak:none;font-weight:400;-webkit-font-feature-settings:normal;font-feature-settings:normal;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased;font-size:96px;font-style:normal;display:inline-block;-webkit-box-sizing:border-box;box-sizing:border-box;direction:ltr}.et_pb_button{font-size:20px;font-weight:500;padding:.3em 1em;line-height:1.7em!important;background-color:transparent;background-size:cover;background-position:50%;background-repeat:no-repeat;border:2px solid;border-radius:3px;-webkit-transition-duration:.2s;transition-duration:.2s;-webkit-transition-property:all!important;transition-property:all!important}.et_pb_button{position:relative}.et_pb_button:hover{border:2px solid transparent;padding:.3em 2em .3em .7em}.et_pb_button:hover{background-color:hsla(0,0%,100%,.2)}.et_pb_button:after,.et_pb_button:before{font-size:32px;line-height:1em;content:"\35";opacity:0;position:absolute;margin-left:-1em;-webkit-transition:all .2s;transition:all .2s;text-transform:none;-webkit-font-feature-settings:"kern" off;font-feature-settings:"kern" off;font-variant:none;font-style:normal;font-weight:400;text-shadow:none}.et_pb_button:before{display:none}.et_pb_button:hover:after{opacity:1;margin-left:0}.clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.screen-reader-text{border:0;clip:rect(1px,1px,1px,1px);-webkit-clip-path:inset(50%);clip-path:inset(50%);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute!important;width:1px;word-wrap:normal!important}@-webkit-keyframes fadeBottom{0%{opacity:0;-webkit-transform:translateY(10%);transform:translateY(10%)}to{opacity:1;-webkit-transform:translateY(0);transform:translateY(0)}}@-webkit-keyframes fadeLeft{0%{opacity:0;-webkit-transform:translateX(-10%);transform:translateX(-10%)}to{opacity:1;-webkit-transform:translateX(0);transform:translateX(0)}}@-webkit-keyframes fadeRight{0%{opacity:0;-webkit-transform:translateX(10%);transform:translateX(10%)}to{opacity:1;-webkit-transform:translateX(0);transform:translateX(0)}}@-webkit-keyframes fadeTop{0%{opacity:0;-webkit-transform:translateY(-10%);transform:translateY(-10%)}to{opacity:1;-webkit-transform:translateX(0);transform:translateX(0)}}@-webkit-keyframes fadeIn{0%{opacity:0}to{opacity:1}}@-webkit-keyframes multi-view-image-fade{0%{-webkit-transform:scale(1);transform:scale(1);opacity:1}50%{-webkit-transform:scale(1.01);transform:scale(1.01);opacity:1}to{-webkit-transform:scale(1);transform:scale(1);opacity:1}}.et_pb_post{margin-bottom:60px;word-wrap:break-word}.et_pb_post .entry-content{padding-top:30px}.et_pb_post h2 a{text-decoration:none}.et_pb_post .post-meta{font-size:14px;margin-bottom:6px}.et_pb_post .post-meta a{text-decoration:none}.et_pb_post a img{vertical-align:bottom;max-width:100%}@media (min-width:981px) and (max-width:1100px){.et_pb_post{margin-bottom:42px}}@media (max-width:980px){.et_pb_post{margin-bottom:42px}}@media (max-width:767px){.et_pb_post{margin-bottom:42px}}@media (max-width:479px){.et_pb_post{margin-bottom:42px}.et_pb_post h2{font-size:16px;padding-bottom:0}.et_pb_post .post-meta{color:#666;font-size:14px}}@-webkit-keyframes et_pb_fade{to{opacity:1}}@-webkit-keyframes et_pb_fadeTop{0%{-webkit-transform:translate3d(0,-100%,0);transform:translate3d(0,-100%,0)}to{opacity:1;-webkit-transform:none;transform:none}}@-webkit-keyframes et_pb_fadeRight{0%{-webkit-transform:translate3d(100%,0,0);transform:translate3d(100%,0,0)}to{opacity:1;-webkit-transform:none;transform:none}}@-webkit-keyframes et_pb_fadeBottom{0%{-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}to{opacity:1;-webkit-transform:none;transform:none}}@-webkit-keyframes et_pb_fadeLeft{0%{-webkit-transform:translate3d(-100%,0,0);transform:translate3d(-100%,0,0)}to{opacity:1;-webkit-transform:none;transform:none}}@-webkit-keyframes et_pb_slide{to{-webkit-transform:scaleX(1);transform:scaleX(1);opacity:1}}@-webkit-keyframes et_pb_slideTop{to{-webkit-transform:translateZ(0);transform:translateZ(0);opacity:1}}@-webkit-keyframes et_pb_slideRight{to{-webkit-transform:translateZ(0);transform:translateZ(0);opacity:1}}@-webkit-keyframes et_pb_slideBottom{to{-webkit-transform:translateZ(0);transform:translateZ(0);opacity:1}}@-webkit-keyframes et_pb_slideLeft{to{-webkit-transform:translateZ(0);transform:translateZ(0);opacity:1}}@-webkit-keyframes et_pb_bounce{0%,20%,40%,60%,80%,to{-webkit-animation-timing-function:cubic-bezier(.215,.61,.355,1);animation-timing-function:cubic-bezier(.215,.61,.355,1)}0%{-webkit-transform:scale3d(.3,.3,.3);transform:scale3d(.3,.3,.3)}20%{-webkit-transform:scale3d(1.1,1.1,1.1);transform:scale3d(1.1,1.1,1.1)}40%{-webkit-transform:scale3d(.9,.9,.9);transform:scale3d(.9,.9,.9)}60%{-webkit-transform:scale3d(1.03,1.03,1.03);transform:scale3d(1.03,1.03,1.03)}80%{-webkit-transform:scale3d(.97,.97,.97);transform:scale3d(.97,.97,.97)}to{opacity:1;-webkit-transform:scaleX(1);transform:scaleX(1)}}@-webkit-keyframes et_pb_bounceTop{0%,60%,75%,90%,to{-webkit-animation-timing-function:cubic-bezier(.215,.61,.355,1);animation-timing-function:cubic-bezier(.215,.61,.355,1)}0%{-webkit-transform:translate3d(0,-200px,0);transform:translate3d(0,-200px,0)}60%{-webkit-transform:translate3d(0,25px,0);transform:translate3d(0,25px,0)}75%{-webkit-transform:translate3d(0,-10px,0);transform:translate3d(0,-10px,0)}90%{-webkit-transform:translate3d(0,5px,0);transform:translate3d(0,5px,0)}to{-webkit-transform:none;transform:none;opacity:1}}@-webkit-keyframes et_pb_bounceRight{0%,60%,75%,90%,to{-webkit-animation-timing-function:cubic-bezier(.215,.61,.355,1);animation-timing-function:cubic-bezier(.215,.61,.355,1)}0%{-webkit-transform:translate3d(200px,0,0);transform:translate3d(200px,0,0)}60%{-webkit-transform:translate3d(-25px,0,0);transform:translate3d(-25px,0,0)}75%{-webkit-transform:translate3d(10px,0,0);transform:translate3d(10px,0,0)}90%{-webkit-transform:translate3d(-5px,0,0);transform:translate3d(-5px,0,0)}to{-webkit-transform:none;transform:none;opacity:1}}@-webkit-keyframes et_pb_bounceBottom{0%,60%,75%,90%,to{-webkit-animation-timing-function:cubic-bezier(.215,.61,.355,1);animation-timing-function:cubic-bezier(.215,.61,.355,1)}0%{-webkit-transform:translate3d(0,200px,0);transform:translate3d(0,200px,0)}60%{-webkit-transform:translate3d(0,-20px,0);transform:translate3d(0,-20px,0)}75%{-webkit-transform:translate3d(0,10px,0);transform:translate3d(0,10px,0)}90%{-webkit-transform:translate3d(0,-5px,0);transform:translate3d(0,-5px,0)}to{-webkit-transform:translateZ(0);transform:translateZ(0);opacity:1}}@-webkit-keyframes et_pb_bounceLeft{0%,60%,75%,90%,to{-webkit-animation-timing-function:cubic-bezier(.215,.61,.355,1);animation-timing-function:cubic-bezier(.215,.61,.355,1)}0%{-webkit-transform:translate3d(-200px,0,0);transform:translate3d(-200px,0,0)}60%{-webkit-transform:translate3d(25px,0,0);transform:translate3d(25px,0,0)}75%{-webkit-transform:translate3d(-10px,0,0);transform:translate3d(-10px,0,0)}90%{-webkit-transform:translate3d(5px,0,0);transform:translate3d(5px,0,0)}to{-webkit-transform:none;transform:none;opacity:1}}@-webkit-keyframes et_pb_zoom{to{-webkit-transform:scaleX(1);transform:scaleX(1);opacity:1}}@-webkit-keyframes et_pb_zoomTop{to{-webkit-transform:scaleX(1);transform:scaleX(1);opacity:1}}@-webkit-keyframes et_pb_zoomRight{to{-webkit-transform:scaleX(1);transform:scaleX(1);opacity:1}}@-webkit-keyframes et_pb_zoomBottom{to{-webkit-transform:scaleX(1);transform:scaleX(1);opacity:1}}@-webkit-keyframes et_pb_zoomLeft{to{-webkit-transform:scaleX(1);transform:scaleX(1);opacity:1}}@-webkit-keyframes et_pb_flip{to{opacity:1;-webkit-transform:rotateX(0deg);transform:rotateX(0deg)}}@-webkit-keyframes et_pb_flipTop{to{opacity:1;-webkit-transform:rotateX(0deg);transform:rotateX(0deg)}}@-webkit-keyframes et_pb_flipRight{to{opacity:1;-webkit-transform:rotateY(0deg);transform:rotateY(0deg)}}@-webkit-keyframes et_pb_flipBottom{to{opacity:1;-webkit-transform:rotateX(0deg);transform:rotateX(0deg)}}@-webkit-keyframes et_pb_flipLeft{to{opacity:1;-webkit-transform:rotateY(0deg);transform:rotateY(0deg)}}@-webkit-keyframes et_pb_fold{to{opacity:1;-webkit-transform:rotateY(0deg);transform:rotateY(0deg)}}@-webkit-keyframes et_pb_foldTop{to{opacity:1;-webkit-transform:rotateX(0deg);transform:rotateX(0deg)}}@-webkit-keyframes et_pb_foldRight{to{opacity:1;-webkit-transform:rotateY(0deg);transform:rotateY(0deg)}}@-webkit-keyframes et_pb_foldBottom{to{opacity:1;-webkit-transform:rotateX(0deg);transform:rotateX(0deg)}}@-webkit-keyframes et_pb_foldLeft{to{opacity:1;-webkit-transform:rotateY(0deg);transform:rotateY(0deg)}}@-webkit-keyframes et_pb_roll{0%{-webkit-transform-origin:center;transform-origin:center}to{-webkit-transform-origin:center;transform-origin:center;-webkit-transform:none;transform:none;opacity:1}}@-webkit-keyframes et_pb_rollTop{0%{-webkit-transform-origin:top;transform-origin:top}to{-webkit-transform-origin:top;transform-origin:top;-webkit-transform:none;transform:none;opacity:1}}@-webkit-keyframes et_pb_rollRight{0%{-webkit-transform-origin:right;transform-origin:right}to{-webkit-transform-origin:right;transform-origin:right;-webkit-transform:none;transform:none;opacity:1}}@-webkit-keyframes et_pb_rollBottom{0%{-webkit-transform-origin:bottom;transform-origin:bottom}to{-webkit-transform-origin:bottom;transform-origin:bottom;-webkit-transform:none;transform:none;opacity:1}}@-webkit-keyframes et_pb_rollLeft{0%{-webkit-transform-origin:left;transform-origin:left}to{-webkit-transform-origin:left;transform-origin:left;-webkit-transform:none;transform:none;opacity:1}}@-webkit-keyframes fadeOutTop{0%{opacity:1;-webkit-transform:translatey(0);transform:translatey(0)}to{opacity:0;-webkit-transform:translatey(-60%);transform:translatey(-60%)}}@-webkit-keyframes fadeInTop{0%{opacity:0;-webkit-transform:translatey(-60%);transform:translatey(-60%)}to{opacity:1;-webkit-transform:translatey(0);transform:translatey(0)}}@-webkit-keyframes fadeInBottom{0%{opacity:0;-webkit-transform:translatey(60%);transform:translatey(60%)}to{opacity:1;-webkit-transform:translatey(0);transform:translatey(0)}}@-webkit-keyframes fadeOutBottom{0%{opacity:1;-webkit-transform:translatey(0);transform:translatey(0)}to{opacity:0;-webkit-transform:translatey(60%);transform:translatey(60%)}}@-webkit-keyframes Grow{0%{opacity:0;-webkit-transform:scaleY(.5);transform:scaleY(.5)}to{opacity:1;-webkit-transform:scale(1);transform:scale(1)}}@-webkit-keyframes flipInX{0%{-webkit-transform:perspective(400px) rotateX(90deg);transform:perspective(400px) rotateX(90deg);-webkit-animation-timing-function:ease-in;animation-timing-function:ease-in;opacity:0}40%{-webkit-transform:perspective(400px) rotateX(-20deg);transform:perspective(400px) rotateX(-20deg);-webkit-animation-timing-function:ease-in;animation-timing-function:ease-in}60%{-webkit-transform:perspective(400px) rotateX(10deg);transform:perspective(400px) rotateX(10deg);opacity:1}80%{-webkit-transform:perspective(400px) rotateX(-5deg);transform:perspective(400px) rotateX(-5deg)}to{-webkit-transform:perspective(400px);transform:perspective(400px)}}@-webkit-keyframes flipInY{0%{-webkit-transform:perspective(400px) rotateY(90deg);transform:perspective(400px) rotateY(90deg);-webkit-animation-timing-function:ease-in;animation-timing-function:ease-in;opacity:0}40%{-webkit-transform:perspective(400px) rotateY(-20deg);transform:perspective(400px) rotateY(-20deg);-webkit-animation-timing-function:ease-in;animation-timing-function:ease-in}60%{-webkit-transform:perspective(400px) rotateY(10deg);transform:perspective(400px) rotateY(10deg);opacity:1}80%{-webkit-transform:perspective(400px) rotateY(-5deg);transform:perspective(400px) rotateY(-5deg)}to{-webkit-transform:perspective(400px);transform:perspective(400px)}}button::-moz-focus-inner{padding:0;border:0}#main-header{line-height:23px;font-weight:500;top:0;background-color:#fff;width:100%;-webkit-box-shadow:0 1px 0 rgba(0,0,0,.1);box-shadow:0 1px 0 rgba(0,0,0,.1);position:relative;z-index:99999}.nav li li{padding:0 20px;margin:0}.nav li{position:relative;line-height:1em}.nav li li{position:relative;line-height:2em}.nav li ul{position:absolute;padding:20px 0;z-index:9999;width:240px;background:#fff;visibility:hidden;opacity:0;border-top:3px solid #2ea3f2;box-shadow:0 2px 5px rgba(0,0,0,.1);-moz-box-shadow:0 2px 5px rgba(0,0,0,.1);-webkit-box-shadow:0 2px 5px rgba(0,0,0,.1);-webkit-transform:translateZ(0);text-align:left}.nav li:hover>ul{opacity:1;visibility:visible}.nav li li ul{z-index:1000;top:-23px;left:240px}.nav li:hover{visibility:inherit}.nav li li a{font-size:14px;-webkit-transition:opacity .2s ease-in-out,background-color .2s ease-in-out;transition:opacity .2s ease-in-out,background-color .2s ease-in-out}.nav ul li a:hover{background-color:rgba(0,0,0,.03);opacity:.7}.mobile_menu_bar{position:relative;display:block;line-height:0}.mobile_menu_bar:before{content:"a";font-size:32px;position:relative;left:0;top:0;cursor:pointer}.mobile_nav .select_page{display:none}.et_pb_widget{float:left;max-width:100%;word-wrap:break-word}.et_pb_widget a{text-decoration:none;color:#666}.et_pb_widget li a:hover{color:#82c0c7}.et_pb_widget ul li{margin-bottom:.5em}#comment-wrap{padding-top:75px}.form-submit:hover{text-decoration:none}#respond{padding-top:17px}#commentform{padding-bottom:50px}#commentform input[type=text]{width:47%}#commentform textarea{width:100%;box-sizing:border-box;-moz-box-sizing:border-box;-webkit-box-sizing:border-box}#commentform input[type=text],#commentform textarea{padding:12px;color:#999;line-height:1em;background-color:#eee;font-size:18px;border-width:0}.form-submit{text-align:right}.form-submit .et_pb_button{display:inline-block;cursor:pointer;color:#2ea3f2}#reply-title small{display:block;font-size:14px;font-weight:400}@media (max-width:767px){#commentform input[type=text]{width:100%;-webkit-box-sizing:border-box;box-sizing:border-box;margin-left:0}}@-webkit-keyframes slideWidth{0%{width:0}}@-webkit-keyframes et_pb_video_slider_item_fade_out{0%{opacity:1}to{opacity:0}}@-webkit-keyframes et_pb_video_slider_item_overlay_fade_out{0%{-webkit-transform:scale(1);transform:scale(1)}to{-webkit-transform:scale(.8);transform:scale(.8)}}@-webkit-keyframes et_pb_video_slider_item_fade_in{0%{opacity:0;-webkit-transform:scale(.8);transform:scale(.8)}to{opacity:1;-webkit-transform:scale(1);transform:scale(1)}}#top-menu a:hover{background:none;color:#1E8909}.et-cart-info span::before{margin-right:0px}.et-cart-login{margin-left:14px}.et-cart-login span::before{font-family:"ETmodules";font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;content:"\e00e"}input{min-height:35px;width:80%;border-radius:5px}input[type=submit]{color:#fff;padding:10px 20px;background:#2D8701;border:0 none;margin:10px 0 0 0;cursor:pointer;-webkit-border-radius:5px;border-radius:5px}input[type=submit]:hover{background:#444}textarea{width:80%;border-radius:5px}#footer-widgets{padding:1% 0px 0px}.et_pb_gutters3 .footer-widget{margin:1% 5.5% 1% 0px}#footer-bottom{padding:10px 0 5px 0}#monarchwidget-3{margin:1% 0 1% 0}@media only screen and (max-width:1255px){img#logo{height:40px}#top-menu{margin-left:40px}}#element_to_pop_up{display:none;background:none!important;box-shadow:0 0 26px #000;display:none;margin-top:0;border-radius:6px;width:400px;max-width:100%;z-index:999999!important;top:50px}.card-wrapper{background-color:white;border-radius:9px}#element_to_pop_up #close{color:gray;font-size:20px;padding:5px;position:absolute;right:7px;top:7px;cursor:pointer;line-height:10px}.pop-body img{max-width:100%}.pop-footer input{border:1px solid gray;border-radius:4px;padding:3px;width:100%;box-shadow:0 0 0 2px #dbdcde inset}.pop-heading h3{padding:0}.p-pad{padding:18px}.post-date{color:#0598dc;font-size:80%}@media all and (max-width:400px){#element_to_pop_up{left:0!important}}.et_bloom .et_bloom_optin_1 .et_bloom_form_container h2{font-family:"Open Sans", Helvetica, Arial, Lucida, sans-serif}.et_bloom .et_bloom_optin_1 .et_bloom_form_container p,.et_bloom .et_bloom_optin_1 .et_bloom_form_container form input,.et_bloom .et_bloom_optin_1 .et_bloom_form_container form button span{font-family:"Open Sans", Helvetica, Arial, Lucida, sans-serif}body.custom-background{background-color:#f7f7f7}body{font-size:16px}body{color:#444444}h1,h2,h3,h4{color:#1e8909}.mobile_menu_bar:before,.mobile_menu_bar:after,.et_pb_widget li a:hover{color:#2d8701}.form-submit .et_pb_button{color:#2d8701}.et-search-form,.nav li ul,.footer-widget li:before{border-color:#2d8701}a{color:#37af00}.et_secondary_nav_enabled #page-container #top-header{background-color:#2d8701!important}#top-header,#top-header a{font-size:14px}.footer-widget li:before{border-color:#2d8701}#footer-widgets .footer-widget li:before{top:10.6px}h1,h2,h3,h4{font-weight:bold;font-style:normal;text-transform:none;text-decoration:none;line-height:1.5em}@media only screen and (min-width:981px){.et_header_style_left #et-top-navigation{padding:23px 0 0 0}.et_header_style_left #et-top-navigation nav>ul>li>a{padding-bottom:23px}#logo{max-height:75%}}h1{font-size:31px}h2{font-size:26px}h3{font-size:22px}h4{font-size:18px}h1,h2,h3,h4{font-family:'Open Sans',Helvetica,Arial,Lucida,sans-serif}body,input,textarea{font-family:'Open Sans',Helvetica,Arial,Lucida,sans-serif}#main-header,#et-top-navigation{font-family:'Raleway',Helvetica,Arial,Lucida,sans-serif}#top-header .container{font-family:'Open Sans',Helvetica,Arial,Lucida,sans-serif}@media only screen and (max-width:600px){#main-header{top:51.6667px!important}#page-container{padding-top:129px!important}}@media only screen and (min-width:768px){#page-container{padding-top:84px!important}}.infusion-recaptcha{color:#fff;padding:10px 20px;background:#2D8701;border:0 none;margin:10px 0 0 0;cursor:pointer;-webkit-border-radius:5px;border-radius:5px;border:1px solid gray;border-radius:4px;padding:3px;width:100%;box-shadow:0 0 0 2px #dbdcde inset;height:40px}#abqa-widget{height:2em}#commentform .gglcptch{margin:0 0 10px}.gglcptch_v2{min-width:1px;padding:10px 0;clear:both}.et_bloom .et_bloom_optin div,.et_bloom .et_bloom_optin span,.et_bloom .et_bloom_optin h2,.et_bloom .et_bloom_optin p{text-transform:none;font-weight:normal;margin:0;padding:0;border:0;outline:0;font-size:100%;vertical-align:baseline;background-image:none;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_bloom .et_bloom_optin button{background:none}.et_bloom button.et_bloom_submit_subscription{cursor:pointer}.et_bloom button.et_bloom_submit_subscription{position:relative}.et_bloom .et_bloom_subscribe_loader{display:none;background:url('/wp-content/plugins/bloom/images/subscribe-loader.gif') !important;width:16px;height:16px;position:absolute;left:50%;top:50%;margin:-8px auto auto -8px !important}.et_bloom .et_bloom_1_field p.et_bloom_popup_input{width:68%}.et_bloom .et_bloom_bottom_stacked p.et_bloom_popup_input{width:100%;margin-bottom:10px;padding-right:0}.et_bloom .et_bloom_bottom_stacked button.et_bloom_submit_subscription{width:100%}.et_bloom .et_bloom_header_outer{height:auto}.et_bloom .et_bloom_flyin{display:none;position:fixed;bottom:0;z-index:999999;box-sizing:border-box}.et_bloom .et_bloom_flyin_right{right:0;padding-left:10%;max-width:100%}.et_bloom .et_bloom_stacked_flyin.et_bloom_form_container{width:320px}.et_bloom .et_bloom_flyin_right span.et_bloom_close_button{right:auto;left:-10px}.et_bloom .et_bloom_form_container_wrapper{position:relative}.et_bloom .et_bloom_form_container,.et_bloom .et_bloom_form_container div,.et_bloom .et_bloom_form_container span,.et_bloom .et_bloom_form_container h2,.et_bloom .et_bloom_form_container p{font-family:'Open Sans', helvetica, arial, sans-serif;line-height:1em;text-transform:none;font-weight:normal;margin:0;padding:0;border:0;outline:0;font-size:100%;vertical-align:baseline;background-image:none;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_bloom .et_bloom_form_container .clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.et_bloom .et_bloom_form_container{position:relative}.et_bloom .et_bloom_form_container .et_bloom_close_button,.et_bloom .et_bloom_success_checkmark:before{font-family:'ET-Bloom';speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;font-size:16px !important;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_bloom .et_bloom_success_container{height:0;overflow:hidden;opacity:0;position:relative;margin:0 auto !important;z-index:-1}.et_bloom .et_bloom_form_container h2.et_bloom_success_message{line-height:1.4em;position:relative;font-size:14px;display:none;opacity:0;z-index:-1;text-align:center;color:#888;background:#fff;padding:10px 10%;width:80%;max-width:300px;border-radius:5px;margin:auto}.et_bloom h2.et_bloom_success_message:after{content:'';position:absolute;left:50%;top:-5px;margin-left:-3px;width:0;height:0;border-left:5px solid transparent;border-right:5px solid transparent;border-bottom:5px solid #fff}.et_bloom .et_bloom_success_checkmark:before{content:"\e60e";font-size:25px !important;line-height:25px}.et_bloom span.et_bloom_success_checkmark{opacity:0;color:#fff !important;background:#82C016;padding:8px 7px 7px 10px !important;border-radius:30px;left:50%;margin-left:-20px;-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);display:block;height:28px;width:28px;transition:all 1s;-moz-transition:all 1s;-webkit-transition:all 1s;position:absolute;top:30px}.et_bloom .et_bloom_close_button:before{content:"\e60d";position:absolute;top:7px;right:7px}.et_bloom .et_bloom_form_container .et_bloom_close_button{position:absolute;top:-10px;right:-10px;width:30px;height:30px;-webkit-border-radius:30px;-moz-border-radius:30px;border-radius:30px;background-color:#fff;-webkit-box-shadow:0px 2px 4px 0px rgba(0, 0, 0, 0.34);-moz-box-shadow:0px 2px 4px 0px rgba(0, 0, 0, 0.34);box-shadow:0px 2px 4px 0px rgba(0, 0, 0, 0.34);cursor:pointer}.et_bloom .et_bloom_form_container{background-color:#dadfe4;max-width:640px;z-index:999999999;-webkit-box-shadow:0px 0px 60px rgba(0, 0, 0, 0.2);-moz-box-shadow:0px 0px 60px rgba(0, 0, 0, 0.2);box-shadow:0px 0px 60px rgba(0, 0, 0, 0.2);-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_bloom .et_bloom_form_container,.et_bloom .et_bloom_form_container div,.et_bloom .et_bloom_form_container .et_bloom_popup_input,.et_bloom .et_bloom_form_container input{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}.et_bloom .et_bloom_form_container .et_bloom_form_header{background-color:#fff;padding:15px;overflow:hidden;position:relative}.et_bloom .et_bloom_form_container .et_bloom_form_text{max-width:100%;padding:15px;display:table-cell}.et_bloom .et_bloom_form_header h2{font-size:24px !important;padding-bottom:0 !important;font-weight:600 !important;line-height:1.1em !important;color:rgba(0, 0, 0, 0.8);-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_bloom .et_bloom_form_header p{color:rgba(0, 0, 0, 0.5);line-height:1.6em;font-size:14px;margin-top:0.5em}.et_bloom .et_bloom_form_container .et_bloom_form_content{padding:40px 30px;color:rgba(0, 0, 0, 0.5);width:100%;background-color:#E9E9E9;position:relative}.et_bloom .et_bloom_form_container .et_bloom_form_content input{display:block}.et_bloom .et_bloom_form_container .et_bloom_form_content span{color:#444;font-weight:700 !important;margin-bottom:10px !important}.et_bloom .et_bloom_form_container .et_bloom_form_content input{background-color:#fff;width:100%;font-weight:600;color:rgba(0,0,0,0.5);-moz-box-sizing:border-box;-webkit-box-sizing:border-box;box-sizing:border-box;border:none}.et_bloom .et_bloom_form_container .et_bloom_form_content input{padding:14px !important}.et_bloom .et_bloom_form_container .et_bloom_form_content .et_bloom_popup_input input{padding:10px !important}.et_bloom .et_bloom_popup_input input::-webkit-input-placeholder{-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_bloom .et_bloom_popup_input input:-moz-placeholder{-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_bloom .et_bloom_popup_input input::-moz-placeholder{-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_bloom .et_bloom_popup_input input:-ms-input-placeholder{-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.et_bloom .et_bloom_form_container.et_bloom_rounded input,.et_bloom .et_bloom_form_container.et_bloom_rounded button{-moz-border-radius:3px !important;-webkit-border-radius:3px !important;border-radius:3px !important}.et_bloom .et_bloom_form_content .et_bloom_popup_input{float:left;width:34%;padding-right:20px}.et_bloom .et_bloom_form_content button{width:32%;background-color:#46C8C8;color:#FFF;font-weight:600;text-transform:uppercase;letter-spacing:1px;border:none}.et_bloom .et_bloom_form_content input,.et_bloom .et_bloom_form_content button{padding:10px;font-family:'Open Sans', sans-serif;font-size:14px}.et_bloom .et_bloom_button_text{color:#FFF !important;font-weight:600 !important;text-transform:uppercase;letter-spacing:1px;margin-bottom:0 !important}.et_bloom .et_bloom_form_header .et_bloom_form_text{max-width:100%;padding:15px;display:block;clear:both}.et_bloom_form_container .et_bloom_form_content .et_bloom_fields{height:100%}@-webkit-keyframes et_bloom_fadeIn{0%{opacity:0}100%{opacity:1}}@-webkit-keyframes et_bloom_fadeOut{0%{opacity:1}100%{opacity:0}}@-webkit-keyframes et_bloom_fadeInRight{0%{opacity:0;-webkit-transform:translateX(-30%)}100%{opacity:1;-webkit-transform:translateX(0)}}@-webkit-keyframes et_bloom_fadeInBottom{0%{opacity:0;-webkit-transform:translateY(-30%)}100%{opacity:1;-webkit-transform:translateY(0)}}@-webkit-keyframes et_bloom_fadeInTop{0%{opacity:0;-webkit-transform:translateY(30%)}100%{opacity:1;-webkit-transform:translateY(0)}}@-webkit-keyframes et_bloom_slideTop{0%{-webkit-transform:translateY(0)}100%{-webkit-transform:translateY(0)}}@-webkit-keyframes et_bloom_slideDown{0%{-webkit-transform:translateY(0)}100%{-webkit-transform:translateY(100%)}}@-webkit-keyframes et_bloom_swing{20%{-webkit-transform:rotate3d(0, 0, 1, 15deg);transform:rotate3d(0, 0, 1, 15deg)}40%{-webkit-transform:rotate3d(0, 0, 1, -10deg);transform:rotate3d(0, 0, 1, -10deg)}60%{-webkit-transform:rotate3d(0, 0, 1, 5deg);transform:rotate3d(0, 0, 1, 5deg)}80%{-webkit-transform:rotate3d(0, 0, 1, -5deg);transform:rotate3d(0, 0, 1, -5deg)}100%{-webkit-transform:rotate3d(0, 0, 1, 0deg);transform:rotate3d(0, 0, 1, 0deg)}}@-webkit-keyframes et_bloom_tada{0%{-webkit-transform:scale3d(1, 1, 1);transform:scale3d(1, 1, 1)}10%,20%{-webkit-transform:scale3d(.9, .9, .9) rotate3d(0, 0, 1, -3deg);transform:scale3d(.9, .9, .9) rotate3d(0, 0, 1, -3deg)}30%,50%,70%,90%{-webkit-transform:scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, 3deg);transform:scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, 3deg)}40%,60%,80%{-webkit-transform:scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, -3deg);transform:scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, -3deg)}100%{-webkit-transform:scale3d(1, 1, 1);transform:scale3d(1, 1, 1)}}@-webkit-keyframes et_bloom_bounce{0%,20%,53%,80%,100%{-webkit-transition-timing-function:cubic-bezier(0.215, 0.610, 0.355, 1.000);transition-timing-function:cubic-bezier(0.215, 0.610, 0.355, 1.000);-webkit-transform:translate3d(0,0,0);transform:translate3d(0,0,0)}40%,43%{-webkit-transition-timing-function:cubic-bezier(0.755, 0.050, 0.855, 0.060);transition-timing-function:cubic-bezier(0.755, 0.050, 0.855, 0.060);-webkit-transform:translate3d(0, -30px, 0);transform:translate3d(0, -30px, 0)}70%{-webkit-transition-timing-function:cubic-bezier(0.755, 0.050, 0.855, 0.060);transition-timing-function:cubic-bezier(0.755, 0.050, 0.855, 0.060);-webkit-transform:translate3d(0, -15px, 0);transform:translate3d(0, -15px, 0)}90%{-webkit-transform:translate3d(0,-4px,0);transform:translate3d(0,-4px,0)}}@-webkit-keyframes et_bloom_flipInX{0%{-webkit-transform:perspective(400px) rotate3d(1, 0, 0, 90deg);transform:perspective(400px) rotate3d(1, 0, 0, 90deg);-webkit-transition-timing-function:ease-in;transition-timing-function:ease-in;opacity:0}40%{-webkit-transform:perspective(400px) rotate3d(1, 0, 0, -20deg);transform:perspective(400px) rotate3d(1, 0, 0, -20deg);-webkit-transition-timing-function:ease-in;transition-timing-function:ease-in}60%{-webkit-transform:perspective(400px) rotate3d(1, 0, 0, 10deg);transform:perspective(400px) rotate3d(1, 0, 0, 10deg);opacity:1}80%{-webkit-transform:perspective(400px) rotate3d(1, 0, 0, -5deg);transform:perspective(400px) rotate3d(1, 0, 0, -5deg)}100%{-webkit-transform:perspective(400px);transform:perspective(400px)}}@-webkit-keyframes et_bloom_zoomIn{0%{opacity:0;-webkit-transform:scale3d(.3, .3, .3);transform:scale3d(.3, .3, .3)}50%{opacity:1}100%{opacity:1}}@-webkit-keyframes et_bloom_lightSpeedIn{0%{-webkit-transform:translate3d(30%, 0, 0) skewX(-10deg);transform:translate3d(30%, 0, 0) skewX(-10deg);opacity:0}60%{-webkit-transform:skewX(5deg);transform:skewX(5deg);opacity:1}80%{-webkit-transform:skewX(-5deg);transform:skewX(-5deg);opacity:1}100%{-webkit-transform:none;transform:none;opacity:1}}@media only screen and ( max-width:767px ){.et_bloom .et_bloom_form_content{clear:both}}@media screen and ( max-width:767px ){.et_bloom .et_bloom_form_container .et_bloom_popup_input{padding-right:0 !important}.et_bloom .et_bloom_form_container .et_bloom_form_header,.et_bloom .et_bloom_form_container .et_bloom_popup_input,.et_bloom .et_bloom_form_container button{width:100% !important;max-width:100% !important;float:left !important}}@media screen and ( max-width:767px ){.et_bloom .et_bloom_form_container_wrapper{flex-direction:column}.et_bloom .et_bloom_form_text{text-align:center}.et_bloom .et_bloom_flyin{width:100% !important;padding:0 10% !important}.et_bloom .et_bloom_stacked_flyin.et_bloom_form_container{margin:0;width:100%}}</style><style id="w3-bg-load">p[data-bglz],p[data-bglz]::before,p[data-bglz]::after,div[data-bglz],div[data-bglz]::before,div[data-bglz]::after,section[data-bglz],section[data-bglz]::before,section[data-bglz]::after,iframelazy[data-bglz],iframe[data-bglz]{background-image:none !important;}</style><style>video[data-class="LazyLoad"]{opacity: 0;}</style><script>var w3elem = window.innerWidth<768?'touchstart':'click';var w3LazyloadByPx=200, w3LazyloadJs = 1,w3ExcludedJs = 0, w3Inp = 0,w3BlankImgUrl="https://www.theralife.com/wp-content/cache/w3-cache/blank.png",w3CallUrl="https://www.theralife.com/wp-admin/admin-ajax.php?action=w3Call&token=58093a4e055899366f3ff6fd09eeeabe",w3Call=0;var w3pageshow="";function scheduleTask(e,t,n=0){setTimeout(e,n)}!function(){let e=[],t=[];var n=EventTarget.prototype.addEventListener;e.click=[],t.click=[],t.touchstart=[],window.w3Html=[],window.w3Html.eventEcr=[],window.w3Html.class="",window.w3Html["css-preloaded"]=0,window.w3Html["data-css"]=0,window.w3Html["data-css-loaded"]=0;const s=document.querySelector("html");function i(e){t.click.push(e.target)}function o(n,s){if(s>3)return;const i=t[n];for(let d=0;d<i.length;d++){const r=i[d];let c=0;const l=e[n];for(let e=0;e<l.length;e++)if(a(l[e],r)){c=1;break}if(!window.w3Html.eventEcr.includes(r)&&!c&&void 0!==r.click)return window.w3Html.eventEcr.push(r),r.click();window.w3Html.eventEcr.includes(r)||c||void 0!==r.click||["HTML","BODY"].includes(r.parentNode.tagName)||(t[n]=[],t[n].push(r.parentNode),o(n,s+1))}}function a(e,t){return e==t||"string"==typeof t.tagName&&!["HTML","BODY"].includes(t.tagName)&&a(e,t.parentNode)}"onpageshow"in window&&(window.onpageshow=function(e){w3pageshow=e}),EventTarget.prototype.addEventListener=function(e,t,s){["w3-DOMContentLoaded","w3-load"].includes(e)?n.call(this,e,t,"object"==typeof s?{...s,once:!0}:{once:!0}):n.call(this,e,t,s)},w3LazyloadJs||w3JsIsExcluded||(s.addEventListener("click",i,{passive:!0}),window.addEventListener("w3-load",function e(){return-1!=window.w3Html.class.indexOf("jsload")?(document.querySelector("html").removeEventListener("click",i),setTimeout(function(){o("click",0)},100)):setTimeout(function(){e()},50)},{passive:!0}))}();class w3LoadScripts{constructor(e){this.triggerEvents=e,this.eventOptions={passive:!0},this.userEventListener=this.triggerListener.bind(this),this.lazyTrigger,this.styleLoadFired,this.lazyScriptsLoadFired=0,this.scriptsLoadFired=0,this.excluded_js=w3ExcludedJs,this.w3LazyloadJs=w3LazyloadJs,this.w3_fonts="undefined"!=typeof w3GoogleFont?w3GoogleFont:[],this.w3Styles=[],this.w3Scripts={normal:[],async:[],defer:[],lazy:[]},this.allJQueries=[],this.validScriptAttributes=new Set(["src","type","async","defer","crossorigin","integrity","nomodule","referrerpolicy","nonce","id"]),this.htmlElement=document.getElementsByTagName("html")[0]}userEventsAdd(e){const t=this.triggerEvents;for(let n=0;n<t.length;n++)window.addEventListener(t[n],e.userEventListener,e.eventOptions)}userEventsRemove(e){const t=this.triggerEvents;for(let n=0;n<t.length;n++)window.removeEventListener(t[n],e.userEventListener,e.eventOptions)}async triggerListener(e){this.userEventsRemove(this),scheduleTask(()=>this.callEvents(),10,10)}callEvents(){this.lazyScriptsLoadFired=1,this.addHtmlClass("w3_user"),"loading"===document.readyState?this.scriptsLoadFire||document.addEventListener("DOMContentLoaded",this.loadResources.bind(this)):this.scriptsLoadFire||this.loadResources()}async loadStyleResources(){this.styleLoadFired||(this.styleLoadFired=!0,this.registerStyles(),window.w3Html["data-css"]=this.w3Styles.length,this.preloadScripts(this.w3Styles),this.loadStylesPreloaded(),this.loadFonts(this.w3_fonts))}async loadStylesPreloaded(){scheduleTask(()=>{1==window.w3Html["css-preloaded"]?this.loadStyles(this.w3Styles):this.loadStylesPreloaded()},10,10)}async loadResources(){this.loadStyleResources(),this.scriptsLoadFired||(this.scriptsLoadFired=!0,this.exeDocumentWrite(),this.registerScripts(),this.addHtmlClass("w3_start"),"function"==typeof w3EventsOnStartJs&&w3EventsOnStartJs(),scheduleTask(()=>{this.preloadScripts(this.w3Scripts.normal),this.preloadScripts(this.w3Scripts.defer),this.preloadScripts(this.w3Scripts.async)},1e3,0),await this.loadScripts(this.w3Scripts.normal),await this.loadScripts(this.w3Scripts.defer),await this.loadScripts(this.w3Scripts.async),await this.executeDomcontentloaded(),await this.executeWindowLoad(),window.dispatchEvent(new Event("w3-scripts-loaded")),this.addHtmlClass("w3_js"),"function"==typeof w3EventsOnEndJs&&w3EventsOnEndJs(),this.lazyTrigger=setInterval(this.w3TriggerLazyScript,500,this))}async w3TriggerLazyScript(e){e.lazyScriptsLoadFired&&(await e.loadScripts(e.w3Scripts.lazy),e.addHtmlClass("jsload"),clearInterval(e.lazyTrigger))}addHtmlClass(e){this.htmlElement.classList.add(e),window.w3Html.class+=" "+e}registerScripts(){const e=document.querySelectorAll("script[type=lazyJs]"),t=document.querySelectorAll("script[type=lazyExJs]");for(let t=0;t<e.length;t++){const n=e[t];n.hasAttribute("src")?n.hasAttribute("async")&&!1!==n.async?this.w3Scripts.async.push(n):n.hasAttribute("defer")&&!1!==n.defer||"module"===n.getAttribute("data-w3-type")?this.w3Scripts.defer.push(n):this.w3Scripts.normal.push(n):this.w3Scripts.normal.push(n)}for(let e=0;e<t.length;e++)this.w3Scripts.lazy.push(t[e])}registerStyles(){const e=document.querySelectorAll("link[data-href]");for(let t=0;t<e.length;t++)this.w3Styles.push(e[t])}async executeScript(e){return new Promise(t=>{const n=document.createElement("script"),s=e.attributes;for(let e=0;e<s.length;e++){const t=s[e];let i=t.nodeName;"type"!==i&&"data-cfasync"!=i&&("data-w3-type"===i&&(i="type"),(-1!=i.indexOf("data-")||-1==i.indexOf("data-")&&this.validScriptAttributes.has(i))&&n.setAttribute(i,t.nodeValue))}if(e.hasAttribute("src")){n.removeAttribute("defer"),n.setAttribute("async","async");const e=n.getAttribute("type");"text/javascript"!=e&&"application/javascript"!=e&&"module"!=e&&n.setAttribute("type","text/javascript"),n.onload=()=>{n.loaded=!0,t()},n.onerror=()=>{n.loaded=!0,t()},setTimeout(()=>{null==n.loaded&&t()},3e3)}else scheduleTask(()=>{n.text=e.text,t()},10,10);requestAnimationFrame(()=>{null!==e.parentNode?e.parentNode.replaceChild(n,e):document.head.appendChild(n)})})}async executeStyles(e){e.href=e.dataset.href,e.removeAttribute("data-href"),e.rel="stylesheet"}async loadScripts(e){const t=e.shift();return t?(await this.executeScript(t),this.loadScripts(e)):Promise.resolve()}async loadStyles(e){const t=e.shift();return t?(this.executeStyles(t),this.loadStyles(e)):"loaded"}async loadFonts(e){const t=document.createDocumentFragment();for(let n=0;n<e.length;n++){const s=e[n],i=document.createElement("link");i.href=s,i.rel="stylesheet",t.appendChild(i)}document.head.appendChild(t)}preloadScripts(e){const t=document.createDocumentFragment();let n=0;const s=this;for(let i=0;i<e.length;i++){const o=e[i],a=o.getAttribute("src"),d=o.getAttribute("data-href"),r=o.getAttribute("data-w3-type");if(a){const e=document.createElement("link");e.href=a,e.rel="module"==r?"modulepreload":"preload",e.as="script",t.appendChild(e)}else if(d){const i=document.createElement("link");i.href=d,i.rel="preload",i.as="style",n++,e.length==n&&(i.dataset.last=1),t.appendChild(i),i.onload=function(){fetch(this.href,{mode:"no-cors"}).then(e=>e.blob()).then(()=>s.updateCssLoader()).catch(()=>s.updateCssLoader())},i.onerror=function(){s.updateCssLoader()}}}document.head.appendChild(t)}updateCssLoader(){window.w3Html["data-css-loaded"]=window.w3Html["data-css-loaded"]+1,window.w3Html["data-css"]==window.w3Html["data-css-loaded"]&&(window.w3Html["css-preloaded"]=1)}holdEventListeners(){let e={};function t(t,n){const s=Object.getOwnPropertyDescriptor(t,"addEventListener");(null==s||s.writable)&&(!function(t){function n(n){return e[t].eventsToRewrite.indexOf(n)>=0?"w3-"+n:n}e[t]||(e[t]={originalFunctions:{add:t.addEventListener,remove:t.removeEventListener},eventsToRewrite:[]},t.addEventListener=function(){arguments[0]=n(arguments[0]),e[t].originalFunctions.add.apply(t,arguments)},t.removeEventListener=function(){arguments[0]=n(arguments[0]),e[t].originalFunctions.remove.apply(t,arguments)})}(t),e[t].eventsToRewrite.push(n))}function n(e,t){let n=e[t];Object.defineProperty(e,t,{get:()=>n||function(){},set(s){e["w3"+t]=n=s}})}t(document,"DOMContentLoaded"),t(window,"DOMContentLoaded"),t(window,"load"),t(window,"pageshow"),t(document,"readystatechange"),n(document,"onreadystatechange"),n(window,"onload"),n(window,"onpageshow")}bindFunc(e,t,n){-1!=window.w3Html.class.indexOf("w3_js")?e.bind(t)(n):scheduleTask(()=>this.bindFunc(e,t,n),50,50)}holdJquery(e){let t=window.jQuery;Object.defineProperty(window,"jQuery",{get:()=>t,set(n){if(n&&n.fn&&!e.allJQueries.includes(n)){n.fn.ready=n.fn.init.prototype.ready=function(t){if(void 0!==t)return e.scriptsLoadFired?e.domReadyFired?e.bindFunc(t,document,n):document.addEventListener("w3-DOMContentLoaded",()=>e.bindFunc(t,document,n)):document.addEventListener("DOMContentLoaded",()=>t.bind(document)(n)),n(document)};const t=n.fn.on;n.fn.on=n.fn.init.prototype.on=function(){if("ready"==arguments[0]||"w3-DOMContentLoad"==arguments[0]){if(this[0]!==document)return t.apply(this,arguments),this;if("string"!=typeof arguments[1])return e.bindFunc(arguments[1],document,n)}if(this[0]===window){function s(e){return e.split(" ").map(e=>"load"===e||0===e.indexOf("load")?"w3-jquery-load":e).join(" ")}"string"==typeof arguments[0]||arguments[0]instanceof String?arguments[0]=s(arguments[0]):"object"==typeof arguments[0]&&Object.keys(arguments[0]).forEach(e=>{Object.assign(arguments[0],{[s(e)]:arguments[0][e]})[e]})}return t.apply(this,arguments),this},e.allJQueries.push(n)}t=n}})}async executeDomcontentloaded(e){e||(this.domReadyFired=!0),document.w3readyState=document.readyState,await this.repaintFrame(),document.dispatchEvent(new Event("w3-DOMContentLoaded")),await this.repaintFrame(),window.dispatchEvent(new Event("w3-DOMContentLoaded")),await this.repaintFrame(),document.dispatchEvent(new Event("w3-readystatechange")),await this.repaintFrame(),document.w3onreadystatechange&&document.w3onreadystatechange()}async executeWindowLoad(){if(-1!=window.w3Html.class.indexOf("w3_js")){await this.repaintFrame(),scheduleTask(()=>window.dispatchEvent(new Event("w3-load")),100,100),await this.repaintFrame(),window.w3onload&&window.w3onload(),await this.repaintFrame();for(let e=0;e<this.allJQueries.length;e++)this.allJQueries[e](window).trigger("w3-jquery-load");window.dispatchEvent(new Event("w3-pageshow")),await this.repaintFrame(),window.w3onpageshow&&window.w3onpageshow(w3pageshow)}else scheduleTask(()=>this.executeWindowLoad(),10,10)}exeDocumentWrite(){const e=new Map;document.write=document.writeln=function(t){const n=document.currentScript,s=document.createRange(),i=n.parentElement;let o=e.get(n);void 0===o&&(o=n.nextSibling,e.set(n,o));const a=document.createDocumentFragment();s.setStart(a,0),a.appendChild(s.createContextualFragment(t)),i.insertBefore(a,o)}}async repaintFrame(){return new Promise(e=>requestAnimationFrame(e))}async execBeforeW3Load(){await this.executeDomcontentloaded(1),await this.executeWindowLoad()}static execute(){const e=new w3LoadScripts(["keydown","mousemove","touchmove","touchstart","touchend","wheel"]);if(window.addEventListener("DOMContentLoaded",()=>{e.execBeforeW3Load()}),e.holdJquery(e),e.holdEventListeners(),document.w3readyState="loading",e.userEventsAdd(e),window.location.href.indexOf("w3=1")>-1||window.location.href.indexOf("w3%3D1")>-1)return window.addEventListener("load",()=>{scheduleTask(()=>{let t=new Image;t.src=w3BlankImgUrl,document.body.appendChild(t),e.triggerListener()},1e3,1e3)});if(!e.w3LazyloadJs||window.scrollY>50||"complete"==document.readyState||"interactive"==document.readyState)return e.triggerListener();const t=setInterval(function(e){if(null!=document.body){document.body.getBoundingClientRect().top<-30&&scheduleTask(()=>e.triggerListener(),10,10),clearInterval(t)}},500,e)}}w3LoadScripts.execute();</script><link data-href="https://www.theralife.com/wp-content/cache/w3-cache/css/358/wp-includes/css/dist/block-library/style.min.css" rel='stylesheet' id='wp-block-library-css' media='all'><style id='wp-block-library-theme-inline-css' type='text/css'>.wp-block-audio :where(figcaption){color:#555;font-size:13px;text-align:center}.is-dark-theme .wp-block-audio :where(figcaption){color:#ffffffa6}.wp-block-audio{margin:0 0 1em}.wp-block-code{border:1px solid #ccc;border-radius:4px;font-family:Menlo,Consolas,monaco,monospace;padding:.8em 1em}.wp-block-embed :where(figcaption){color:#555;font-size:13px;text-align:center}.is-dark-theme .wp-block-embed :where(figcaption){color:#ffffffa6}.wp-block-embed{margin:0 0 1em}.blocks-gallery-caption{color:#555;font-size:13px;text-align:center}.is-dark-theme .blocks-gallery-caption{color:#ffffffa6}:root :where(.wp-block-image figcaption){color:#555;font-size:13px;text-align:center}.is-dark-theme :root :where(.wp-block-image figcaption){color:#ffffffa6}.wp-block-image{margin:0 0 1em}.wp-block-pullquote{border-bottom:4px solid;border-top:4px solid;color:currentColor;margin-bottom:1.75em}.wp-block-pullquote cite,.wp-block-pullquote footer,.wp-block-pullquote__citation{color:currentColor;font-size:.8125em;font-style:normal;text-transform:uppercase}.wp-block-quote{border-left:.25em solid;margin:0 0 1.75em;padding-left:1em}.wp-block-quote cite,.wp-block-quote footer{color:currentColor;font-size:.8125em;font-style:normal;position:relative}.wp-block-quote:where(.has-text-align-right){border-left:none;border-right:.25em solid;padding-left:0;padding-right:1em}.wp-block-quote:where(.has-text-align-center){border:none;padding-left:0}.wp-block-quote.is-large,.wp-block-quote.is-style-large,.wp-block-quote:where(.is-style-plain){border:none}.wp-block-search .wp-block-search__label{font-weight:700}.wp-block-search__button{border:1px solid #ccc;padding:.375em .625em}:where(.wp-block-group.has-background){padding:1.25em 2.375em}.wp-block-separator.has-css-opacity{opacity:.4}.wp-block-separator{border:none;border-bottom:2px solid;margin-left:auto;margin-right:auto}.wp-block-separator.has-alpha-channel-opacity{opacity:1}.wp-block-separator:not(.is-style-wide):not(.is-style-dots){width:100px}.wp-block-separator.has-background:not(.is-style-dots){border-bottom:none;height:1px}.wp-block-separator.has-background:not(.is-style-wide):not(.is-style-dots){height:2px}.wp-block-table{margin:0 0 1em}.wp-block-table td,.wp-block-table th{word-break:normal}.wp-block-table :where(figcaption){color:#555;font-size:13px;text-align:center}.is-dark-theme .wp-block-table :where(figcaption){color:#ffffffa6}.wp-block-video :where(figcaption){color:#555;font-size:13px;text-align:center}.is-dark-theme .wp-block-video :where(figcaption){color:#ffffffa6}.wp-block-video{margin:0 0 1em}:root :where(.wp-block-template-part.has-background){margin-bottom:0;margin-top:0;padding:1.25em 2.375em}</style><style id='global-styles-inline-css' type='text/css'>:root{--wp--preset--aspect-ratio--square: 1;--wp--preset--aspect-ratio--4-3: 4/3;--wp--preset--aspect-ratio--3-4: 3/4;--wp--preset--aspect-ratio--3-2: 3/2;--wp--preset--aspect-ratio--2-3: 2/3;--wp--preset--aspect-ratio--16-9: 16/9;--wp--preset--aspect-ratio--9-16: 9/16;--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);}:root { --wp--style--global--content-size: 823px;--wp--style--global--wide-size: 1080px; }:where(body) { margin: 0; }.wp-site-blocks > .alignleft { float: left; margin-right: 2em; }.wp-site-blocks > .alignright { float: right; margin-left: 2em; }.wp-site-blocks > .aligncenter { justify-content: center; margin-left: auto; margin-right: auto; }:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}.is-layout-flow > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}.is-layout-flow > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}.is-layout-flow > .aligncenter{margin-left: auto !important;margin-right: auto !important;}.is-layout-constrained > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}.is-layout-constrained > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}.is-layout-constrained > .aligncenter{margin-left: auto !important;margin-right: auto !important;}.is-layout-constrained > :where(:not(.alignleft):not(.alignright):not(.alignfull)){max-width: var(--wp--style--global--content-size);margin-left: auto !important;margin-right: auto !important;}.is-layout-constrained > .alignwide{max-width: var(--wp--style--global--wide-size);}body .is-layout-flex{display: flex;}.is-layout-flex{flex-wrap: wrap;align-items: center;}.is-layout-flex > :is(*, div){margin: 0;}body .is-layout-grid{display: grid;}.is-layout-grid > :is(*, div){margin: 0;}body{padding-top: 0px;padding-right: 0px;padding-bottom: 0px;padding-left: 0px;}:root :where(.wp-element-button, .wp-block-button__link){background-color: #32373c;border-width: 0;color: #fff;font-family: inherit;font-size: inherit;line-height: inherit;padding: calc(0.667em + 2px) calc(1.333em + 2px);text-decoration: none;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;}:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}:root :where(.wp-block-pullquote){font-size: 1.5em;line-height: 1.6;}</style><link data-href="https://www.theralife.com/wp-content/cache/w3-cache/css/358/wp-content/plugins/contact-form-7/includes/css/styles.css" rel='stylesheet' id='contact-form-7-css' media='all'><link data-href="https://www.theralife.com/wp-content/cache/w3-cache/css/358/wp-content/plugins/monarch/css/style.css" rel='stylesheet' id='et_monarch-css-css' media='all'><link data-href="https://www.theralife.com/wp-content/cache/w3-cache/css/358/wp-content/cache/w3-cache/fonts/3378608edd1ca77eec89ed51a7199899.css" rel='stylesheet' id='et-gf-open-sans-css' media='all'><link data-href="https://www.theralife.com/wp-content/cache/w3-cache/css/358/wp-content/plugins/schema-and-structured-data-for-wp/modules/divi-builder/styles/style.min.css" rel='stylesheet' id='extension-styles-css' media='all'><link data-href="https://www.theralife.com/wp-content/cache/w3-cache/css/358/wp-content/cache/w3-cache/fonts/cd0d7d38968ba806757d25e957574b1d.css" rel='stylesheet' id='et-builder-googlefonts-cached-css' media='all'><link data-href="https://www.theralife.com/wp-content/cache/w3-cache/css/358/wp-content/themes/Divi/style-static.min.css" rel='stylesheet' id='divi-style-parent-css' media='all'><link data-href="https://www.theralife.com/wp-content/cache/w3-cache/css/358/wp-content/themes/Divi-Child-2015/style.css" rel='stylesheet' id='divi-style-css' media='all'><script type="lazyJs" src="https://www.theralife.com/wp-content/cache/w3-cache/js/358/wp-includes/js/jquery/jquery.min.js" id="jquery-core-js"></script><script type="lazyJs" src="https://www.theralife.com/wp-content/cache/w3-cache/js/358/wp-includes/js/jquery/jquery-migrate.min.js" id="jquery-migrate-js"></script><script type="lazyJs" src="https://www.theralife.com/wp-content/cache/w3-cache/js/358/wp-content/themes/Divi-Child-2015/jquery.bpopup.min.js" id="bPopup-main-js"></script><script type="lazyJs" src="https://www.theralife.com/wp-content/cache/w3-cache/js/358/wp-content/themes/Divi-Child-2015/jquery.easing.1.3.min.js" id="jquery.easing-js"></script><script type="lazyJs" src="https://www.theralife.com/wp-content/cache/w3-cache/js/358/wp-content/themes/Divi-Child-2015/site-script.js" id="site-script-js"></script><link rel="https://api.w.org/" href="https://www.theralife.com/wp-json/"/><link rel="alternate" title="JSON" type="application/json" href="https://www.theralife.com/wp-json/wp/v2/posts/6262"/><link rel="EditURI" type="application/rsd+xml" title="RSD" href="https://www.theralife.com/xmlrpc.php?rsd"/><meta name="generator" content="WordPress 6.8.1"/><link rel='shortlink' href='https://www.theralife.com/?p=6262'/><link rel="alternate" title="oEmbed (JSON)" type="application/json+oembed" href="https://www.theralife.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fwww.theralife.com%2Feffective-treatment-ocular-rosacea%2F"/><link rel="alternate" title="oEmbed (XML)" type="text/xml+oembed" href="https://www.theralife.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fwww.theralife.com%2Feffective-treatment-ocular-rosacea%2F&format=xml"/><style type="text/css" id="et-bloom-custom-css"> .et_bloom .et_bloom_optin_1 .et_bloom_form_container h2, .et_bloom .et_bloom_optin_1 .et_bloom_form_container h2 span, .et_bloom .et_bloom_optin_1 .et_bloom_form_container h2 strong { font-family: "Open Sans", Helvetica, Arial, Lucida, sans-serif; }.et_bloom .et_bloom_optin_1 .et_bloom_form_container p, .et_bloom .et_bloom_optin_1 .et_bloom_form_container p span, .et_bloom .et_bloom_optin_1 .et_bloom_form_container p strong, .et_bloom .et_bloom_optin_1 .et_bloom_form_container form input, .et_bloom .et_bloom_optin_1 .et_bloom_form_container form button span { font-family: "Open Sans", Helvetica, Arial, Lucida, sans-serif; } </style><style type="text/css" id="et-social-custom-css"> </style><script async="" type="lazyJs" src="//widget.trustpilot.com/bootstrap/v5/tp.widget.bootstrap.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0"/><link rel="shortcut icon" href="https://www.theralife.com/wp-content/uploads/2016/12/favicon.png"/><script type="application/ld+json" class="saswp-schema-markup-output">
[{"@context":"https:\/\/schema.org\/","@type":"Article","@id":"https:\/\/www.theralife.com\/effective-treatment-ocular-rosacea\/#Article","url":"https:\/\/www.theralife.com\/effective-treatment-ocular-rosacea\/","inLanguage":"en-US","mainEntityOfPage":"https:\/\/www.theralife.com\/effective-treatment-ocular-rosacea\/","headline":"New Ocular Rosacea Treatment - TheraLife  | TheraLife","description":"Ocular Rosacea, get total relief with TheraLife Eye Enhanced. Oral treatment  that works. All-natural formula works from the inside out - lasting relief.","articleBody":"Do you have ocular rosacea  Ocular rosacea is an inflammatory skin condition that causes acne-like bumps and the face to become red and flushed. \u00a0Commonly found on the cheeks and nose, people who experience symptoms from Rosacea can experience eye problems. \u00a0Those who suffer from Rosacea also have a high level of inflammation on their cheeks and nose which can affect the eyes. \u00a0When the eyes are affected, Ocular Rosacea can progress from mild discomfort to possible vision loss.  How TheraLife Can Relief Ocular Rosacea Symptoms  With a complete line of natural products that promote healthy eyes, TheraLife is a leader in chronic dry eye relief. Going to the source of dry eyes, underactive tear secretion, TheraLife Eye targets the problem from the inside out. TheraLife Eye provides a natural solution to dry eye relief by promoting the production of the body\u2019s own healing tears.    TheraLife gives the body the ability to heal itself with the ability to make tears, eliminating painful inflammation and dryness. Restore comfortable vision and end reliance on eye drops with TheraLife Eye. Some of the TheraLife products include:    TheraLife Eye Enhanced Starter Kit \u2013 With everything included to provide dry eye relief, this all-in-one kit includes: \u00a04 bottles of TheraLife Eye Enhanced, 1 bottle of Omega-3 Fish Oil, 1 Eye Lid Cleanser, and 1 Hot Compress. \u00a0Highly recommended for Ocular Rosacea sufferers. \u00a0     \tTheraLife Eye Starter Kit \u2013 Including everything needed to start treating chronic dry eyes related to autoimmune conditions, this starter kit includes: \u00a04 bottles of TheraLife Eye Enhanced, 1 bottle of Omega-3 Fish Oil, 1 Eyelid Cleanser, and 1 hot Compress.     Ocular Rosacea and dry eyes treatment when drops don't work.    For those who suffer from Ocular Rosacea, the TheraLife Eye Enhanced Starter Kit is recommended. \u00a0Don\u2019t delay in beginning your path to healthier, pain-free eyes with TheraLife.    Call and talk to a doctor toll free 1-877-917-1989 US\/Canada. \u00a0International \u00a0(650) 949-6080 \u00a0Email inquiries to: \u00a0info@theralife.com  Customer Stories  click link here  Ocular Rosacea Symptoms  Causing a number of eye complications, Rosacea can be the basis for the eyes to:     \tDry   \tBloodshot   \tWatery   \tExperience frequent styes   \tBecome red and swollen   \tCreate blurry vision or difficulty seeing   \tBecome sensitive to light   \tForm a crust on the eyelids and eyelashes   \tBurn or sting   \tDevelop little pimples, called styes, in the rim of the eye or eyelid    Causes of Ocular Rosacea  Research has discovered that 85% of people with Ocular Rosacea have blocked oil glands on the edges of their eyelids (Meibomian Gland Dysfunction). \u00a0\u00a0If these glands become blocked, the eyes become dry, swollen, and irritated. \u00a0This leads to redness and itching in the eyes and crust on the eyelashes.    Although definitely unknown, some scientists believe that tiny spider-like creatures called mites live in the hair follicles on the eyelashes and can block the glands (Blepharitis \u2013 Demodex) . \u00a0    Other scientists believe that there may be a link between rosacea and the bacteria that cause infections in the digestive system. \u00a0Still, other scientists believe that rosacea is caused by a problem with the body\u2019s blood vessels. \u00a0Finally, some believe that genes or the environment can play a part in developing the skin condition.    Those who are fair-skinned are more prone to develop rosacea. \u00a0Some women develop rosacea during menopause. \u00a0Thirteen million Americans have been diagnosed with rosacea, and half of those patients have ocular rosacea.   Complications from Ocular Rosacea  Beginning with mild discomfort and irritation, if left untreated, Ocular Rosacea can cause serious eye complications. \u00a0The cornea of the eye may become damaged, resulting in the loss of vision. \u00a0Treating Ocular Rosacea helps relieve symptoms in addition to preventing serious eye complications such as vision loss or blindness.  Symptom Relief for Ocular Rosacea  Seeking a firm prognosis from an ophthalmologist or dermatologist is advised. \u00a0If the Rosacea is affecting the eyes, an ophthalmologist is a good place to start. \u00a0Otherwise, consult with a dermatologist. \u00a0If symptoms are severe, such as light sensitivity, very red eyes, or a burning sensation, it is highly important to go to an ophthalmologist quickly.     Ocular Rosacea can be treated with a simple hygiene regime. \u00a0Done regularly, the symptoms usually subside and clear up quickly. \u00a0In addition to any medications that a doctor may prescribe, other steps taken to help ease the discomfort and symptoms include:     \tPlace a hot compress over the eyes for at least 10 minutes twice a day to ease discomfort.   \tClean eye lids with a gentle cleanser, such as Avenova or Hypochlor from TheraLife. \u00a0Gently rub the eyelids with the cleanser to remove any crust and clean them thoroughly. \u00a0\u00a0Do not wash off eye lid cleanser afterwards.     Frequently Asked Questions  What is the best treatment for ocular rosacea?  Ocular rosacea can be relieved by ocular hygiene, cleaning eyelids with eyelid cleanser like Avenova,\u00a0 If you also have facial rosacea, it is important to visit a dermatologist and get it under control.\u00a0 TheraLife\u00a0 also has a complete protocol for ocular rosacea recovery.\u00a0 Click here to learn more.   How serious is ocular rosacea?  Ocular rosacea can lead to serious complications such as cornea damage and vision loss.\u00a0 It is very important that you seek help from your eye doctors right away.  Is ocular rosacea an autoimmune disease?  Ocular rosacea is an autoimmune disease, which means your own body is attacking its own cells, in this case cells that are in your eyes.\u00a0 Ocular rosacea involve a lot of inflammation, and therefore, a treatment like TheraLife will greatly reduce inflammation and help you get ocular rosacea under control.  What is the first line treatment for ocular rosacea?  First line of treatment for ocular rosacea is warm compress and eyelid cleansing.\u00a0 If that does not work, your eye doctor will prescribe a steroid eye drop for a short period of time. Follow your eye doctors instructions closely to recover faster.\u00a0 Any questions, call TheraLife and talk to a doctor.  How do you know if you have ocular rosacea?  Symptoms of ocular rosacea are:\u00a0 red eyes, light sensitivity, sandy gritty feeling in the eyes, crusty eyelashes, swollen and red eyelids, development of styes and chalazion.\u00a0 Visit your eye doctor immediately.  Conclusion  Overall, the outlook for ocular rosacea is positive. Even though it can be uncomfortable and annoying, it is not a life-threatening disease, and it won\u2019t cause you to lose your vision. Once you learn the best ways to manage your symptoms and avoid your triggers, you should be able to minimize how much ocular rosacea impacts your life.  References  1.\u00a0Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology:a review of recent findings.\u00a0J Am Acad Dermatol.\u00a02013;69:15\u201326.\u00a0  2.\u00a0Vieira AC, H\u00f6fling-Lima AL, Mannis MJ. Ocular rosacea-a review.\u00a0Arq Bras Oftalmol.\u00a02012;75(5):363\u2013369.\u00a0\u00a0  3.\u00a0Michel JL, Cabibel F. Frequency, severity and treatment of ocular rosacea during cutaneous rosacea.\u00a0Ann Dermatol Venereol.\u00a02003;130(1):20\u201324.\u00a0  4.\u00a0Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F, National Rosacea Society Expert Committee Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea.\u00a0J Am Acad Dermatol.\u00a02004;50(6):907\u2013912.  5.\u00a0Eiseman AS. The ocular manifestations of atopic dermatitis and rosacea.\u00a0Curr Allergy Asthma Rep.\u00a02006;6(4):292\u2013298. [  6.\u00a0Oltz M, Check J. Rosacea and its ocular manifestations.\u00a0Optometry.\u00a02011;82(2):92\u2013103.  7.\u00a0Dahl MV. Rosacea subtypes: a treatment algorithm.\u00a0Cutis.\u00a02004;7421-27(3 Suppl):32\u201334.\u00a0  8.\u00a0Suzuki T. Meibomitis-related keratoconjunctivitis: implications and clinicalsignificance of meibomian gland inflammation.\u00a0Cornea.\u00a02012;31(Suppl 1):S41\u201344.  9.\u00a0Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.\u00a0Invest Ophthalmol Vis Sci.\u00a02001;42(10):2283\u20132292.\u00a0  10.\u00a0Vieira AC, Mannis MJ. Ocular rosacea: common and commonly missed.\u00a0J Am Acad Dermatol.\u00a02013;69(6 Suppl 1):S36\u201341.\u00a0  11.\u00a0M\u00e4\u00e4tt\u00e4 M, Kari O, Tervahartiala T, Peltonen S, Kari M, Saari M, Sorsa T. Tear fluid levels of MMP-8 are elevated in ocular rosacea-treatment effect of oral doxycycline.\u00a0Graefes Arch Clin Exp Ophthalmol.\u00a02006;244(8):957\u2013962.\u00a0  12.\u00a0Gupta AK, Chaudhry MM. Rosacea and its management: an overview.\u00a0J Eur AcadDermatol Venereol.\u00a02005;19(3):273\u2013285.  13.\u00a0Iovieno A, Lambiase A, Micera A, Stampachiacchiere B, Sgrulletta R, Bonini S.\u00a0In vivo\u00a0characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis.\u00a0Eur J Ophthalmol.\u00a02009;19(5):708\u2013716.  14.\u00a0Monk E, Shalita A, Siegel DM. Clinical applications of non-antimicrobial tetracyclines in dermatology.\u00a0Pharmacol Res.\u00a02011;63(2):130\u2013145.  15.\u00a0Pfeffer I, Borelli C, Zierhut M, Schaller M. Treatment of ocular rosacea with 40 mg doxycycline in a slow release form.\u00a0J Dtsch Dermatol Ges.\u00a02011;9(11):904\u2013907.\u00a0  16.\u00a0Bikowski JB. Subantimicrobial dose doxycycline for acne and rosacea.\u00a0Skinmed.\u00a02003;2(4):234\u2013245. [  17.\u00a0Donnenfeld E, Pflugfelder SC. Topical ophthalmic cyclosporine: pharmacology and clinical uses.\u00a0Surv Ophthalmol.\u00a02009;54(3):321\u2013338.\u00a0  18.\u00a0Durrani K, Zakka FR, Ahmed M, Memon M, Siddique SS, Foster CS. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease.\u00a0Surv Ophthalmol.\u00a02011;56(6):474\u2013510.  19.\u00a0Shimazaki J, Den S, Omoto M, Satake Y, Shimmura S, Tsubota K. Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation.\u00a0Am J Ophthalmol.\u00a02011;152(1):33\u201339.\u00a0  20.\u00a0Utine CA, Stern M, Akpek EK. Clinical review: topical ophthalmic use of cyclosporin A.\u00a0Ocul Immunol Inflamm.\u00a02010;18(5):352\u2013361. [  21.\u00a0Bikowski JB. Rosacea: a tiered approach to therapy.\u00a0Cutis.\u00a02000;66(4 Suppl):3\u20136.\u00a0  22.\u00a0Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification.\u00a0J Am Acad Dermatol.\u00a02004;51(3):327\u2013341.\u00a0  23.\u00a0Lazaridou E, Fotiadou C, Ziakas NG, Giannopoulou C, Apalla Z, Ioannides D. Clinical and laboratory study of ocular rosacea in northern Greece.\u00a0J Eur Acad Dermatol Venereol.\u00a02011;25(12):1428\u20131431.\u00a0  24.\u00a0Bakar O, Demircay Z, Toker E, Cakir S. Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin.\u00a0J EurAcad Dermatol Venereol.\u00a02009;23(5):544\u2013549.  25.\u00a0Vieira AC, An HJ, Ozcan S, Kim JH, Lebrilla CB, Mannis MJ. Glycomic analysis of tear and saliva in ocular rosacea patients: the search for a biomarker.\u00a0Ocul Surf.\u00a02012;10(3):184\u2013192  26.\u00a0Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics.\u00a0Cornea.\u00a02003;22(3):230\u2013233. [  27.\u00a0Yaylali V, Ozyurt C. Comparison of tear function tests and impression cytology with the ocular findings in acne rosacea.\u00a0Eur J Ophthalmol.\u00a02002;12(1):11\u201317.\u00a0  28.\u00a0Baudouin C. A new approach for better comprehension of diseases of the ocularsurface.\u00a0J Fr Ophtalmol.\u00a02007;30(3):239\u2013246.\u00a0  29.\u00a0Wladis EJ, Carlson JA, Wang MS, Bhoiwala DP, Adam AP. Toll-like receptors and vascular markers in ocular rosacea.\u00a0Ophthal Plast Reconstr Surg.\u00a02013;29(4):290\u2013293.  30.\u00a0Turner K, Pflugfelder SC, Ji Z, Feuer WJ, Stern M, Reis BL. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion.\u00a0Cornea.\u00a02000;19(4):492\u2013496.\u00a0  31.\u00a0Perry HD, Doshi-Carnevale S, Donnenfeld ED, Solomon R, Biser SA, Bloom AH. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction.\u00a0Cornea.\u00a02006;25(2):171\u2013175.  32.\u00a0Schechter BA, Katz RS, Friedman LS. Efficacy of topical cyclosporine for the treatment of ocular rosacea.\u00a0Adv Ther.\u00a02009;26(6):651\u2013659.\u00a0  33.\u00a0Fallen RS, Gooderham M. Rosacea: update on management and emerging therapies.\u00a0Skin Therapy Lett.\u00a02012;17(10):1\u20134. [  34.\u00a0Valent\u00edn S, Morales A, S\u00e1nchez JL, Rivera A. Safety and efficacy of doxycycline in the treatment of rosacea.\u00a0Clin Cosmet Investig Dermatol.\u00a02009;2:129\u2013140.\u00a0[  35.\u00a0Korting HC, Sch\u00f6llmann C. Tetracycline actions relevant to rosacea treatment.\u00a0Skin Pharmacol Physiol.\u00a02009;22(6):287\u2013294. [    1.\u00a0Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: A review of recent findings.\u00a0J Am Acad Dermatol.\u00a02013;69(Supplement 1):S15\u201326.\u00a0\u00a0  2.\u00a0Steinhoff M, Schmelz M, Schauber J. Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options.\u00a0Acta Derm Venereol.\u00a02016;96:579\u201386.\u00a0\u00a0  3.\u00a0Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, Thiboutot D. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee.\u00a0J Am Acad Dermatol.\u00a02018;78:148\u201355.\u00a0\u00a0  4.\u00a0Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, Powell F. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea.\u00a0J Am Acad Dermatol.\u00a02002;46:584\u20137.\u00a0\u00a0  5.\u00a0Gold LM, Draelos ZD. New and Emerging Treatments for Rosacea.\u00a0Am J Clin Dermatol.\u00a02015;16:457\u201361.\u00a0\u00a0  6.\u00a0Alexis AF, Callender VD, Baldwin HE, Desai SR, Rendon MI, Taylor SC. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: Review and clinical practice experience.\u00a0J Am Acad Dermatol.\u00a02019;80:1722\u20131729.e7.\u00a0\u00a0  7.\u00a0Alinia H, Tuchayi SM, James SM, Cardwell LA, Nanda S, Bahrami N, Awosika O, Richardson I, Huang KE, Feldman SR. Measurement of Disease Severity in a Population of Rosacea Patients.\u00a0Dermatol Clin.\u00a02018;36:97\u2013102.\u00a0\u00a0  8.\u00a0Pati\u00f1o-Ram\u00edrez BE, Rodr\u00edguez-Garc\u00eda A, D\u00edaz JC, Perfecto \u00c1valos Y. Alteraciones de la superficie ocular en pacientes con ros\u00e1cea ocular.\u00a0Rev Mex Oftalmol.\u00a02012;86:86\u201396.\u00a0  9.\u00a0Vieira AC, Mannis MJ. Ocular rosacea: common and commonly missed.\u00a0J Am Acad Dermatol.\u00a02013;69(Suppl 1):S36\u201341.\u00a0\u00a0  10.\u00a0Rainer BM, Kang S, Chien AL. Rosacea: Epidemiology, pathogenesis, and treatment.\u00a0Dermatoendocrinol.\u00a02017;9:e1361574.\u00a0\u00a0\u00a0  11.\u00a0L\u00f3pez-Valverde G, Garcia-Martin E, Larrosa-Pov\u00e9s JM, Polo-Llorens V, Pablo-J\u00falvez LE. Therapeutical Management for Ocular Rosacea.\u00a0Case Rep Ophthalmol.\u00a02016;7:237\u201342.\u00a0\u00a0\u00a0  12.\u00a0Oltz M, Check J. Rosacea and its ocular manifestations.\u00a0Optometry.\u00a02011;82:92\u2013103.\u00a0\u00a0  13.\u00a0Alvarenga LS, Mannis MJ. Ocular Rosacea.\u00a0Ocul Surf.\u00a02005;3:41\u201358.\u00a0\u00a0  14.\u00a0Rodriguez-Garcia A. Ocular Rosacea: Recent Advances in Pathogenesis and Therapy. In 2015. p. 175\u2013199.\u00a0  15.\u00a0Aldrich N, Gerstenblith M, Fu P, Tuttle MS, Varma P, Gotow E, Cooper KD, Mann M, Popkin DL. Genetic vs Environmental Factors That Correlate With Rosacea: A Cohort-Based Survey of Twins.\u00a0JAMA Dermatol.\u00a02015;151:1213\u20139.\u00a0\u00a0  16.\u00a0Woo YR, Lim JH, Cho DH, Park HJ. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition.\u00a0Int J Mol Sci.\u00a02016;17\u00a0https:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmdRetrieve&dbPubMed&list_uids27649161&doptAbstract\u00a0\u00a0\u00a0  17.\u00a0Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, Mess C, Cevikbas F, Rivier M, Carlavan I, D\u00e9ret S, Rosignoli C, Metze D, Luger TA, Voegel JJ. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.\u00a0J Investig Dermatol Symp Proc.\u00a02011;15:2\u201311.\u00a0\u00a0\u00a0  18.\u00a0Tschopp J, Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?\u00a0Nat Rev Immunol.\u00a02010;10:210\u20135.\u00a0\u00a0  19.\u00a0Yamasaki K, Kanada K, Macleod DT, Borkowski AW, Morizane S, Nakatsuji T, Cogen AL, Gallo RL. TLR2 Expression Is Increased in Rosacea and Stimulates Enhanced Serine Protease Production by Keratinocytes.\u00a0J Invest Dermatol.\u00a02011;131:688\u201397.\u00a0\u00a0\u00a0  20.\u00a0Holmes AD, Steinhoff M. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.\u00a0Exp Dermatol.\u00a02017;26:659\u201367.\u00a0\u00a0  21.\u00a0Moura AKA, Guedes F, Rivitti-Machado MC, Sotto MN. Inate immunity in rosacea. Langerhans cells, plasmacytoid dentritic cells, Toll-like receptors and inducible oxide nitric synthase (iNOS) expression in skin specimens: case-control study.\u00a0Arch Dermatol Res.\u00a02018;310:139\u201346.\u00a0\u00a0  22.\u00a0Brown TT, Choi E-YK, Thomas DG, Hristov AC, Chan MP. Comparative analysis of rosacea and cutaneous lupus erythematosus: Histopathologic features, T-cell subsets, and plasmacytoid dendritic cells.\u00a0J Am Acad Dermatol.\u00a02014;71:100\u20137.\u00a0\u00a0  23.\u00a0Buhl T, Sulk M, Nowak P, Buddenkotte J, McDonald I, Aubert J, Carlavan I, D\u00e9ret S, Reiniche P, Rivier M, Voegel JJ, Steinhoff M. Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1\/Th17 Pathways.\u00a0J Invest Dermatol.\u00a02015;135:2198\u2013208.\u00a0\u00a0  24.\u00a0Smith JR, Lanier VB, Braziel RM, Falkenhagen KM, White C, Rosenbaum JT. Expression of vascular endothelial growth factor and its receptors in rosacea.\u00a0Br J Ophthalmol.\u00a02007;91:226\u20139.\u00a0\u00a0\u00a0  25.\u00a0Sulk M, Seeliger S, Aubert J, Schwab VD, Cevikbas F, Rivier M, Nowak P, Voegel JJ, Buddenkotte J, Steinhoff M. Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea.\u00a0J Invest Dermatol.\u00a02012;132:1253\u201362.\u00a0\u00a0\u00a0  26.\u00a0Ghanem VC, Mehra N, Wong S, Mannis MJ. The Prevalence of Ocular Signs in Acne Rosacea: Comparing Patients From Ophthalmology and Dermatology Clinics.\u00a0Cornea.\u00a02003;22:230\u20133.\u00a0\u00a0  27.\u00a0G\u00f6k\u00e7\u0131nar NB, Karabulut AA, Onaran Z, Yumu\u015fak E, Budak Y\u0131ld\u0131ran FA. Elevated Tear Human Neutrophil Peptides 1\u20133, Human Beta Defensin-2 Levels and Conjunctival Cathelicidin LL-37 Gene Expression in Ocular Rosacea.\u00a0Ocul Immunol Inflamm.\u00a02019;27:1174\u201383.\u00a0\u00a0  28.\u00a0Wladis EJ, Carlson JA, Wang MS, Bhoiwala DP, Adam AP. Toll-like receptors and vascular markers in ocular rosacea.\u00a0Ophthal Plast Reconstr Surg.\u00a02013;29:290\u20133.\u00a0\u00a0  29.\u00a0Randon M, Liang H, El Hamdaoui M, Tahiri R, Batellier L, Denoyer A, Labb\u00e9 A, Baudouin C. In vivo confocal microscopy as a novel and reliable tool for the diagnosis of Demodex eyelid infestation.\u00a0Br J Ophthalmol.\u00a02015;99:336\u201341.\u00a0\u00a0","keywords":"","datePublished":"2017-08-24T18:50:54+00:00","dateModified":"2023-06-27T23:01:44+00:00","author":{"@type":"Person","name":"Lily Yang","url":"https:\/\/www.theralife.com\/author\/lcyang\/","sameAs":[],"image":{"@type":"ImageObject","url":"https:\/\/secure.gravatar.com\/avatar\/3d4a76817ece99959861175f3c01b69dc8deb7d95165e49389e942eda2c0f1c9?s=96&d=mm&r=g","height":96,"width":96}},"editor":{"@type":"Person","name":"Lily Yang","url":"https:\/\/www.theralife.com\/author\/lcyang\/","sameAs":[],"image":{"@type":"ImageObject","url":"https:\/\/secure.gravatar.com\/avatar\/3d4a76817ece99959861175f3c01b69dc8deb7d95165e49389e942eda2c0f1c9?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"TheraLife","url":"https:\/\/www.theralife.com"},"image":[{"@type":"ImageObject","@id":"https:\/\/www.theralife.com\/effective-treatment-ocular-rosacea\/#primaryimage","url":"https:\/\/www.theralife.com\/wp-content\/uploads\/2021\/11\/Blepharitis-1200x800.jpg","width":"1200","height":"800","caption":"Dry Eyes At Night"},{"@type":"ImageObject","url":"https:\/\/www.theralife.com\/wp-content\/uploads\/2021\/11\/Blepharitis-1200x900.jpg","width":"1200","height":"900","caption":"Dry Eyes At Night"},{"@type":"ImageObject","url":"https:\/\/www.theralife.com\/wp-content\/uploads\/2021\/11\/Blepharitis-1200x675.jpg","width":"1200","height":"675","caption":"Dry Eyes At Night"},{"@type":"ImageObject","url":"https:\/\/www.theralife.com\/wp-content\/uploads\/2021\/11\/Blepharitis-600x600.jpg","width":"600","height":"600","caption":"Dry Eyes At Night"},{"@type":"ImageObject","url":"https:\/\/www.theralife.com\/wp-content\/uploads\/2020\/07\/Theralife-image-1-300x167.png","width":300,"height":167,"caption":"Ocular rosacea dry eyes"}]}]
</script><style type="text/css" id="custom-background-css">body.custom-background { background-color: #f7f7f7; }</style> <link data-href="https://www.theralife.com/wp-content/cache/w3-cache/css/358/wp-content/et-cache/global/et-divi-customizer-global.min.css" rel='stylesheet' id='et-divi-customizer-global-cached-inline-styles'>  <script type="lazyJs" > !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1766608480226082'); fbq('track', "PageView");</script> <noscript><img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1766608480226082&ev=PageView&noscript=1"/></noscript>  <script type="lazyJs" >
var _smartsupp = _smartsupp || {};
_smartsupp.key = 'a3631091ec149716cc7441afe26bf09331e6beeb';window.smartsupp||(function(d) {
var s,c,o=smartsupp=function(){ o._.push(arguments)};o._=[];
s=d.getElementsByTagName('script')[0];c=d.createElement('script');c.type='text/javascript';c.charset='utf-8';c.async=true;c.src='https://www.smartsuppchat.com/loader.js?';s.parentNode.insertBefore(c,s);
})(document);
</script>  <style id="w3speedster-custom-css">html:not(.jsload) .arconix-faq-content.faq-closed {   display:none; } .page-id-457 .et_pb_image_0, .page-id-2153 .et_pb_image_0, .page-id-876 .et_pb_image_0, .page-id-107 .et_pb_image_0, .page-id-1998 .et_pb_image_0, .page-id-466 .et_pb_image_0, .page-id-899 .et_pb_image_0, .page-id-748 .et_pb_image_0, .page-id-901 .et_pb_image_0, .page-id-321 .et_pb_image_0{   opacity:1 !important; animation:none !important; transform:none !important; } .page-id-2127 .et_pb_image_1, .page-id-1974 .et_pb_image_1{   opacity:1 !important;   animation:none !important; transform:none !important; } @media(min-width:1200px){ header#main-header {   top:36px !important; } .page-id-1998 .et_builder_inner_content > .et_pb_section.et_pb_section_0:first-child .et_pb_column.et_pb_column_1, .page-id-8429 .et_builder_inner_content > .et_pb_section.et_pb_section_0:first-child .et_pb_column.et_pb_column_1 {   padding-top:2.855%; } .page-id-55 .entry-content .et_pb_section_0 .et_pb_row_0 .et_pb_video_0 .et_pb_video_box, .page-id-55 .entry-content .et_pb_section_0 .et_pb_row_0 .et_pb_video_0 .et_pb_video_box iframe{ max-height:525px; } .page-id-331 .et_builder_inner_content > .et_pb_section.et_pb_section_0 .et_pb_column_1, .page-id-109 .et_builder_inner_content > .et_pb_section.et_pb_section_0 .et_pb_column_1{   padding-bottom:2.855%; } .page-id-901 .et_pb_section_0 {   min-height:163px; } .page-id-321 .et_pb_section_0 {   min-height:261px; } } @media(max-width:767px){ .page-id-55 .entry-content .et_pb_section_0 .et_pb_row_0 .et_pb_video_0 .et_pb_video_box, .page-id-55 .entry-content .et_pb_section_0 .et_pb_row_0 .et_pb_video_0 .et_pb_video_box iframe{ max-height:234px; } .page-id-901 .et_pb_section_0 {   min-height:239px; } }</style></head><body class="wp-singular post-template-default single single-post postid-6262 single-format-standard custom-background wp-theme-Divi wp-child-theme-Divi-Child-2015 et_bloom et_monarch et_pb_button_helper_class et_fullwidth_nav et_fixed_nav et_show_nav et_pb_show_title et_secondary_nav_enabled et_secondary_nav_two_panels et_primary_nav_dropdown_animation_fade et_secondary_nav_dropdown_animation_fade et_header_style_left et_pb_footer_columns_1_2__1_4 et_cover_background et_pb_gutter et_pb_gutters3 et_right_sidebar et_divi_theme et-db"  > <div data-bglz=1 id="page-container"> <div data-bglz=1 id="top-header"> <div data-bglz=1 class="container clearfix"> <div data-bglz=1 id="et-info"> <span id="et-info-phone">877-917-1989</span> <a href="/cdn-cgi/l/email-protection#6d04030b022d1905081f0c01040b08430e0200"><span id="et-info-email"><span class="__cf_email__" data-cfemail="7e171018113e0a161b0c1f1217181b501d1113">[email protected]</span></span></a>  <a class="et-cart-login" href="https://www.theralife.com/cgi-theralife/sb/order.cgi?func=2&storeid=*16d4c5d9ca8140121747ab5ff2&html_reg=html" target="_blank"><span> Login</span></a> </span>  <span>  <a class="et-cart-info" href="https://www.theralife.com/cgi-theralife/sb/order.cgi?storeid=*16d4c5d9ca8140121747ab5ff2&function=show"><span> View Cart</span></a> </span>  </div>  <div data-bglz=1 id="et-secondary-menu"> <ul id="et-secondary-nav" class="menu"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-300"><a href="https://www.theralife.com/about/" >About</a></li><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1499"><a href="https://www.theralife.com/why-theralife-works/" >Why It Works</a></li><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1498"><a href="https://www.theralife.com/faqs/" >FAQs</a></li><li class="menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-5763"><a href="https://www.theralife.com/articles-blogs/" >Blogs- Awesome Articles</a></li><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-299"><a href="https://www.theralife.com/contact/" >Contact</a></li></ul> </div>  </div>  </div>  <header id="main-header" data-height-onload="45"> <div data-bglz=1 class="container clearfix et_menu_container"> <div data-bglz=1 class="logo_container"> <span class="logo_helper"></span> <a  href="https://www.theralife.com/"> <img fetchpriority="high" loading="eager" src="https://www.theralife.com/wp-content/w3-webp/uploads/2016/12/TheraLife-Logo.webp" alt="TheraLife" id="logo"/> </a> </div> <div data-bglz=1 id="et-top-navigation"> <nav id="top-menu-nav"> <ul id="top-menu" class="nav"><li id="menu-item-8129" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-has-children menu-item-8129"><a href="https://www.theralife.com/" >Dry Eye Relief – Home</a><ul class="sub-menu"> <li id="menu-item-8132" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8132"><a href="https://www.theralife.com/about/" >About</a> <ul class="sub-menu"> <li id="menu-item-8121" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8121"><a href="https://www.theralife.com/theralife-publication/" >Theralife Publication</a></li> <li id="menu-item-8151" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8151"><a href="https://www.theralife.com/dosage-instructions-theralife-eye-enhanced/" >Dosage Instructions – TheraLife Eye Enhanced</a></li> <li id="menu-item-8150" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8150"><a href="https://www.theralife.com/dosage-instructions-theralife-eye-autoimmune/" >Dosage Instructions – TheraLife Eye Autoimmune</a></li> <li id="menu-item-8177" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8177"><a href="https://www.theralife.com/privacy-policy/" >Privacy Policy</a></li> <li id="menu-item-8169" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8169"><a href="https://www.theralife.com/legal/" >Legal</a></li> <li id="menu-item-8179" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8179"><a href="https://www.theralife.com/return-policy/" >Return Policy</a></li> </ul></li> <li id="menu-item-8200" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8200"><a href="https://www.theralife.com/why-theralife-works/" >Why TheraLife Works</a></li> <li id="menu-item-8162" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8162"><a href="https://www.theralife.com/faqs/" >FAQs</a></li> <li id="menu-item-8130" class="menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-8130"><a href="https://www.theralife.com/articles-blogs/" >Blogs- Awesome Articles</a></li> <li id="menu-item-8145" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8145"><a href="https://www.theralife.com/contact/" >Contact</a></li></ul></li><li id="menu-item-8234" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8234"><a href="https://www.theralife.com/theralife-products/" >TheraLife Products</a><ul class="sub-menu"> <li id="menu-item-8209" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8209"><a href="https://www.theralife.com/all-in-one-dry-eye-enhanced-starter-kit/" >All-in-One Eye Enhanced Starter Kit</a></li> <li id="menu-item-8210" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8210"><a href="https://www.theralife.com/all-in-one-autoimmune-starter-kit/" >All-in-One Autoimmune Starter Kit</a></li> <li id="menu-item-8213" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8213"><a href="https://www.theralife.com/oral-dry-eye-relief-that-works/" >Powerful Dry Eye Oral Therapy-TheraLife Eye Enhanced</a> <ul class="sub-menu"> <li id="menu-item-8300" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8300"><a href="https://www.theralife.com/eye-enhanced-ingredients/" >Eye Enhanced Ingredients</a></li> </ul></li> <li id="menu-item-8212" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8212"><a href="https://www.theralife.com/autoimmune-dry-eye/" >Autoimmune Dry Eye</a></li> <li id="menu-item-8215" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8215"><a href="https://www.theralife.com/fish-oil/" >TheraLife Fish Oil</a></li> <li id="menu-item-8421" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8421"><a href="https://www.theralife.com/warm-compress-for-eyes/" >Warm Compress for Eyes</a></li> <li id="menu-item-8214" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8214"><a href="https://www.theralife.com/eye-lid-cleanser/" >Eye Lid Cleanser</a></li> <li id="menu-item-8216" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8216"><a href="https://www.theralife.com/menopause-dry-eyes/" >TheraLife Eye Menopause</a></li> <li id="menu-item-8222" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8222"><a href="https://www.theralife.com/products/" >Products-All</a></li></ul></li><li id="menu-item-8227" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8227"><a href="https://www.theralife.com/customer-reviews/" >Customer Reviews</a><ul class="sub-menu"> <li id="menu-item-8208" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8208"><a href="https://www.theralife.com/testimonials/" >Testimonials</a> <ul class="sub-menu"> <li id="menu-item-8134" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8134"><a href="https://www.theralife.com/autoimmune-dry-eyes-testimonials/" >Autoimmune Dry Eyes -Testimonials</a></li> <li id="menu-item-8138" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8138"><a href="https://www.theralife.com/blepharitis-mgd-dry-eyes-testimonials/" >Blepharitis MGD Dry Eyes Testimonials</a></li> <li id="menu-item-8141" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8141"><a href="https://www.theralife.com/chalazion-stye-testimonials/" >Chalazion/Stye Testimonials</a></li> <li id="menu-item-8142" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8142"><a href="https://www.theralife.com/chronic-dry-eyes-testimonials/" >Chronic Dry Eyes & Dry Eye Syndrome Testimonials</a></li> <li id="menu-item-8120" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8120"><a href="https://www.theralife.com/chalazion-stye-testimonials/" >Chalazion/Stye Testimonials</a></li> <li id="menu-item-8146" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8146"><a href="https://www.theralife.com/contact-lens-dry-eyes-testimonials/" >Contact Lens Dry Eyes Testimonials</a></li> <li id="menu-item-8164" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8164"><a href="https://www.theralife.com/graft-versus-host-testimonials/" >Graft versus Host, Chemotherapy Dry Eyes Testimonials</a></li> <li id="menu-item-8168" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8168"><a href="https://www.theralife.com/lasik-dry-eyes-testimonials/" >LASIK Dry Eyes Testimonials</a></li> <li id="menu-item-8170" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8170"><a href="https://www.theralife.com/age-related-macular-degeneration-testimonials/" >Macular Degeneration Testimonials</a></li> <li id="menu-item-8172" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8172"><a href="https://www.theralife.com/menopause-dry-eyes-testimonials/" >Menopause Dry Eyes Testimonials</a></li> <li id="menu-item-8531" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8531"><a href="https://www.theralife.com/uveitis-dry-eyes-testimonial/" >Uveitis Dry Eyes Testimonial- Powerful Relief</a></li> </ul></li></ul></li><li id="menu-item-8152" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8152"><a href="https://www.theralife.com/dry-eye-syndrome/" >Dry Eye Syndrome</a><ul class="sub-menu"> <li id="menu-item-8206" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8206"><a href="https://www.theralife.com/what-causes-dry-eyes/" >What Causes Dry Eyes?</a> <ul class="sub-menu"> <li id="menu-item-8153" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8153"><a href="https://www.theralife.com/dry-eyes-and-aging/" >Dry Eyes and Aging</a></li> <li id="menu-item-8154" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8154"><a href="https://www.theralife.com/dry-eyes-and-allergies/" >Dry Eyes and Allergies</a></li> <li id="menu-item-8155" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8155"><a href="https://www.theralife.com/dry-eyes-and-computer-vision-syndrome-cvs/" >Powerful Dry Eyes and Computer Vision Syndrome Relief</a></li> <li id="menu-item-8156" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8156"><a href="https://www.theralife.com/dry-eyes-and-high-altitudes/" >Powerful Dry Eyes and High Altitudes Relief</a></li> <li id="menu-item-8157" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8157"><a href="https://www.theralife.com/dry-eyes-and-menopause/" >Dry Eyes and Menopause</a></li> <li id="menu-item-8158" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8158"><a href="https://www.theralife.com/dry-eyes-and-stress/" >Dry Eyes and Stress</a></li> <li id="menu-item-8159" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8159"><a href="https://www.theralife.com/dry-eyes-at-night-treatment/" >Dry Eyes at Night</a></li> <li id="menu-item-8160" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8160"><a href="https://www.theralife.com/dry-eyes-in-winter/" >Dry Eyes in Winter</a></li> <li id="menu-item-8161" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8161"><a href="https://www.theralife.com/dry-eyes-with-contacts/" >Dry Eyes with Contacts</a></li> </ul></li> <li id="menu-item-8309" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8309"><a href="https://www.theralife.com/blepharitis/" >Blepharitis Relief</a></li> <li id="menu-item-8148" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8148"><a href="https://www.theralife.com/crusty-eyes-treatment/" >Crusty Eyes Treatment</a></li> <li id="menu-item-8236" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8236"><a href="https://www.theralife.com/dry-eye-treatment/" >Dry Eye Treatment</a></li> <li id="menu-item-8441" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8441"><a href="https://www.theralife.com/glaucoma-dry-eyes/" >Glaucoma And Dry Eyes</a></li> <li id="menu-item-8167" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8167"><a href="https://www.theralife.com/lasik-and-dry-eyes/" >LASIK And Dry Eyes</a></li> <li id="menu-item-8171" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8171"><a href="https://www.theralife.com/meibomian-gland-dysfunction/" >Meibomian Gland Dysfunction</a></li> <li id="menu-item-8207" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8207"><a href="https://www.theralife.com/watery-eyes-treatment/" >Watery Eyes Treatment</a></li> <li id="menu-item-8711" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8711"><a href="https://www.theralife.com/dry-eyes-at-night-treatment/" >Dry Eyes at Night</a></li></ul></li><li id="menu-item-8133" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8133"><a href="https://www.theralife.com/autoimmune-dry-eye/" >Autoimmune Dry Eye</a><ul class="sub-menu"> <li id="menu-item-8242" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8242"><a href="https://www.theralife.com/sjogrens-treatment/" >Sjogren’s Treatment</a> <ul class="sub-menu"> <li id="menu-item-8631" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8631"><a href="https://www.theralife.com/sjogrens-syndrome/" >Sjogren’s Syndrome</a></li> <li id="menu-item-8634" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8634"><a href="https://www.theralife.com/sjogrens-syndrome-symptoms/" >Sjogren’s Syndrome Symptoms</a></li> <li id="menu-item-8636" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8636"><a href="https://www.theralife.com/natural-remedies-for-sjogrens-syndrome-demo/" >Best Sjogren’s Syndrome-Natural Remedies</a></li> <li id="menu-item-8632" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8632"><a href="https://www.theralife.com/sjogrens-syndrome-diagnosis/" >Sjogren’s Syndrome Diagnosis</a></li> <li id="menu-item-8638" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8638"><a href="https://www.theralife.com/whos-at-risk-for-sjogrens-syndrome/" >Who’s At Risk for Sjogren’s Syndrome</a></li> <li id="menu-item-8637" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8637"><a href="https://www.theralife.com/types-of-sjogrens-syndrome-primary-and-secondary/" >Types of Sjogren’s Syndrome: Primary and Secondary</a></li> <li id="menu-item-8630" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8630"><a href="https://www.theralife.com/sjogrens-statistics/" >Sjogren’s Statistics</a></li> <li id="menu-item-8633" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8633"><a href="https://www.theralife.com/sjogrens-syndrome-prevention/" >Sjogren’s Syndrome Prevention</a></li> <li id="menu-item-8629" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8629"><a href="https://www.theralife.com/sjogrens-diet/" >Sjogren’s Diet</a></li> <li id="menu-item-8635" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8635"><a href="https://www.theralife.com/sjogrens-syndrome-with-lupus/" >Sjogren’s Syndrome with Lupus</a></li> </ul></li> <li id="menu-item-8176" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8176"><a href="https://www.theralife.com/ocular-rosacea/" >Ocular Rosacea</a></li> <li id="menu-item-8180" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8180"><a href="https://www.theralife.com/rheumatoid-arthritis-dry-eyes/" >Rheumatoid Arthritis</a></li> <li id="menu-item-8163" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8163"><a href="https://www.theralife.com/graft-versus-host-disease/" >Graft Versus Host Disease</a></li> <li id="menu-item-8165" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8165"><a href="https://www.theralife.com/graves-disease/" >Graves’ Disease</a></li></ul></li><li id="menu-item-8128" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8128"><a href="https://www.theralife.com/chalazion-chalazia/" >Treating a Chalazion (Chalazia)</a></li><li id="menu-item-8127" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8127"><a href="https://www.theralife.com/stye/" >Stye Relief</a></li><li id="menu-item-8166" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8166"><a href="https://www.theralife.com/iritis-treatment/" >Iritis Treatment Naturally</a></li><li id="menu-item-8114" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8114"><a href="https://www.theralife.com/uveitis-treatment/" >Uveitis</a></li><li id="menu-item-8140" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8140"><a href="https://www.theralife.com/causes-of-chalazion-2/" >Causes of Chalazion</a></li></ul> </nav> <div data-bglz=1 id="et_mobile_nav_menu"> <div data-bglz=1 class="mobile_nav closed"> <span class="select_page">Select Page</span> <span class="mobile_menu_bar mobile_menu_bar_toggle"></span> </div> </div> </div>  </div>  <div data-bglz=1 class="et_search_outer"> <div data-bglz=1 class="container et_search_form_container"> <form role="search" method="get" class="et-search-form" action="https://www.theralife.com/"> <input type="search" class="et-search-field" placeholder="Search …" name="s" title="Search for:"/> </form> <span class="et_close_search_field"></span> </div> </div> <div data-bglz=1 id="element_to_pop_up" style="display: none"> <div data-bglz=1 class="b-close"><span id="close">x</span></div> <div data-bglz=1 class="card-wrapper" > <div data-bglz=1 class="pop-heading p-pad"> <h3>Get 9 Tips for Dry Eye Relief!</h3> </div>  <div data-bglz=1 class="pop-body">  <img loading="lazy" src="https://www.theralife.com/wp-content/w3-webp/themes/Divi-Child-2015/beautiful-eyes-1200.webp" alt="monogram"> </div>  <div data-bglz=1 class="pop-footer p-pad"><form accept-charset="UTF-8" action="https://theralife.infusionsoft.com/app/form/process/4c87ad849bf7a03d348b7afa3edfafcd" class="infusion-form" id="inf_form_4c87ad849bf7a03d348b7afa3edfafcd" method="POST"> <input name="inf_form_xid" type="hidden" value="4c87ad849bf7a03d348b7afa3edfafcd"/> <input name="inf_form_name" type="hidden" value="20 - Copy of TheraLife Main Site Web Form - 9 Free Tips"/> <input name="infusionsoft_version" type="hidden" value="1.70.0.245520"/> <div> <div> <p> <strong> <em> <font color="#008080" size="5">Get 9 Simple Tips for Dry Eye Relief!</font> </em> </strong> </p> </div> </div> <div> <div> <div data-bglz=1 class="title"> Person Information </div> </div> </div> <div data-bglz=1 class="infusion-field"> <label for="inf_field_FirstName">First Name *</label> <input class="infusion-field-input" id="inf_field_FirstName" name="inf_field_FirstName" placeholder="First Name *" type="text"/> </div> <div data-bglz=1 class="infusion-field"> <label for="inf_field_Email">Email *</label> <input class="infusion-field-input" id="inf_field_Email" name="inf_field_Email" placeholder="Email *" type="text"/> </div> <div data-bglz=1 class="infusion-submit"> <button class="infusion-recaptcha" id="recaptcha_4c87ad849bf7a03d348b7afa3edfafcd" type="submit">Submit</button> </div></form><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="lazyJs" src="https://theralife.infusionsoft.app/app/webTracking/getTrackingCode"></script><script type="lazyJs" src="https://theralife.infusionsoft.com/resources/external/recaptcha/production/recaptcha.js?b=1.70.0.245520-hf-202006111452"></script><script src="https://www.google.com/recaptcha/api.js?onload=onloadInfusionRecaptchaCallback&render=explicit" async="async" defer="defer" type="lazyJs"></script><script type="lazyJs" src="https://theralife.infusionsoft.com/app/timezone/timezoneInputJs?xid=4c87ad849bf7a03d348b7afa3edfafcd"></script><style> .infusion-recaptcha{ color: #fff; padding: 10px 20px; background: #2D8701; border: 0 none; margin: 10px 0 0 0; cursor: pointer; -webkit-border-radius: 5px; border-radius: 5px; border: 1px solid gray; border-radius: 4px; padding: 3px; width: 100%; /* padding: 8px 5px; */ box-shadow: 0 0 0 2px #dbdcde inset; height: 40px; } </style> </div> </div> </div> </header>  <div data-bglz=1 id="et-main-area"   > <script type="lazyJs" >
				document.documentElement.className = 'js';

				function setCookie(popwithcokkie, cvalue, exdays) {
					var d = new Date();
					d.setTime(d.getTime() + (exdays * 24 * 60 * 60 * 1000));
					var expires = "expires=" + d.toUTCString();
					var path = "/";
					document.cookie = popwithcokkie + "=" + cvalue + "; " + expires + "; path=" + path;

				}

				function getCookie(popwithcokkie) {
					var name = popwithcokkie + "=";
					var ca = document.cookie.split(';');
					for (var i = 0; i < ca.length; i++) {
						var c = ca[i];
						while (c.charAt(0) == ' ') {
							c = c.substring(1);
						}
						if (c.indexOf(name) == 0) {
							return c.substring(name.length, c.length);
						}
					}
					return "";
				}
			</script><div data-bglz=1 id="main-content"> <div data-bglz=1 class="container"> <div data-bglz=1 id="content-area" class="clearfix"> <div data-bglz=1 id="left-area"> <article id="post-6262" class="et_pb_post post-6262 post type-post status-publish format-standard has-post-thumbnail hentry category-autoimmune category-blepharitis category-bloodshot-eyes category-blurred-vision category-bump-in-eyelid category-crusty-eyes category-dry-eyes category-ocular-rosacea"   > <div data-bglz=1 class="et_post_meta_wrapper"> <h1 class="entry-title">New Treatment for Ocular Rosacea-TheraLife</h1> <p class="post-meta"> by <span class="author vcard"><a href="https://www.theralife.com/author/lcyang/" title="Posts by Lily Yang" rel="author">Lily Yang</a></span> | <span class="published">Aug 24, 2017</span> | <a href="https://www.theralife.com/category/autoimmune/" rel="category tag">autoimmune</a>, <a href="https://www.theralife.com/category/blepharitis/" rel="category tag">blepharitis</a>, <a href="https://www.theralife.com/category/bloodshot-eyes/" rel="category tag">bloodshot eyes</a>, <a href="https://www.theralife.com/category/blurred-vision/" rel="category tag">blurred vision</a>, <a href="https://www.theralife.com/category/bump-in-eyelid/" rel="category tag">bump in eyelid</a>, <a href="https://www.theralife.com/category/crusty-eyes/" rel="category tag">crusty eyes</a>, <a href="https://www.theralife.com/category/dry-eyes/" rel="category tag">dry eyes</a>, <a href="https://www.theralife.com/category/ocular-rosacea/" rel="category tag">Ocular Rosacea</a> | <span class="comments-number"><a href="https://www.theralife.com/effective-treatment-ocular-rosacea/#respond">0 comments</a></span></p><img fetchpriority="high" loading="eager" src="https://www.theralife.com/wp-content/w3-webp/uploads/2021/11/Blepharitis.webp" alt="New Treatment for Ocular Rosacea-TheraLife" width="1080" height="675" srcset="https://www.theralife.com/wp-content/w3-webp/uploads/2021/11/Blepharitis.webp 1080w, https://www.theralife.com/wp-content/w3-webp/uploads/2021/11/Blepharitis-480x320.webp 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw"/> </div>  <div data-bglz=1 class="entry-content"> <h2>Do you have ocular rosacea</h2><p><span style="font-weight: 400;">Ocular rosacea is an inflammatory skin condition that causes acne-like bumps and the face to become red and flushed.  Commonly found on the cheeks and nose, people who experience symptoms from Rosacea can experience eye problems.  Those who suffer from Rosacea also have a high level of inflammation on their cheeks and nose which can affect the eyes.  When the eyes are affected, Ocular Rosacea can progress from mild discomfort to possible vision loss.</span></p><h2><b>How TheraLife Can Relief Ocular Rosacea Symptoms</b></h2><p>With a complete line of natural products that promote healthy eyes, TheraLife is a leader in chronic dry eye relief. Going to the source of <a class="wpil_keyword_link " title="dry eyes" href="https://www.theralife.com/dry-eye-treatment/" data-wpil-keyword-link="linked">dry eyes</a>, underactive tear secretion, TheraLife Eye targets the problem from the inside out. TheraLife Eye provides a natural solution to dry eye relief by promoting the production of the body’s own healing tears.</p><p>TheraLife gives the body the ability to heal itself with the ability to make tears, eliminating painful inflammation and dryness. Restore comfortable vision and end reliance on eye drops with TheraLife Eye. Some of the TheraLife products include:</p><p><b>TheraLife Eye Enhanced Starter Kit – With everything included to provide dry eye relief, this all-in-one kit includes:  4 bottles of TheraLife Eye Enhanced, 1 bottle of Omega-3 Fish Oil, 1 Eye Lid Cleanser, and 1 Hot Compress.  Highly recommended for Ocular Rosacea sufferers.  </b></p><ul><li>TheraLife Eye Starter Kit – Including everything needed to start treating chronic dry eyes related to autoimmune conditions, this starter kit includes:  4 bottles of TheraLife Eye Enhanced, 1 bottle of Omega-3 Fish Oil, 1 Eyelid Cleanser, and 1 hot Compress.</li></ul><div data-bglz=1 id="attachment_7556" style="width: 310px" class="wp-caption alignnone"><a href="https://www.theralife.com/ocular-rosacea/"><img fetchpriority="high" loading="eager" decoding="async" aria-describedby="caption-attachment-7556" class="size-medium wp-image-7556" src="https://www.theralife.com/wp-content/w3-webp/uploads/2020/07/Theralife-image-1-300x167.webp" alt="Ocular rosacea dry eyes" width="300" height="167" title="New Treatment for Ocular Rosacea-TheraLife 2" srcset="https://www.theralife.com/wp-content/w3-webp/uploads/2020/07/Theralife-image-1-300x167.webp 300w, https://www.theralife.com/wp-content/w3-webp/uploads/2020/07/Theralife-image-1.webp 320w" sizes="(max-width: 300px) 100vw, 300px"/></a><p id="caption-attachment-7556" class="wp-caption-text"><a href="https://www.theralife.com/ocular-rosacea/">Ocular Rosacea and dry eyes treatment when drops don’t work.</a></p></div><p><b>For those who suffer from Ocular Rosacea, the TheraLife Eye Enhanced Starter Kit is recommended.  Don’t delay in beginning your path to healthier, pain-free eyes with TheraLife.</b></p><p><b>Call and talk to a doctor toll free 1-877-917-1989 US/Canada.  International  (650) 949-6080  Email inquiries to:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1b72757d745b6f737e697a77727d7e35787476">[email protected]</a></b></p><h3>Customer Stories</h3><p><a href="https://www.theralife.com/testimonials/"><strong>click link here</strong></a></p><h2><a href="http://www.mayoclinic.org/diseases-conditions/ocular-rosacea/basics/symptoms/con-20035058" rel="nofollow noopener" target="_blank"><b>Ocular Rosacea Symptoms</b></a></h2><p><span style="font-weight: 400;">Causing a number of eye complications, Rosacea can be the basis for the eyes to:</span></p><ul><li style="font-weight: 400;"><span style="font-weight: 400;">Dry</span></li><li style="font-weight: 400;"><span style="font-weight: 400;">Bloodshot</span></li><li style="font-weight: 400;"><span style="font-weight: 400;">Watery</span></li><li style="font-weight: 400;"><span style="font-weight: 400;">Experience frequent styes</span></li><li style="font-weight: 400;"><span style="font-weight: 400;">Become red and swollen</span></li><li style="font-weight: 400;"><span style="font-weight: 400;">Create blurry vision or difficulty seeing</span></li><li style="font-weight: 400;"><span style="font-weight: 400;">Become sensitive to light</span></li><li style="font-weight: 400;"><span style="font-weight: 400;">Form a crust on the eyelids and eyelashes</span></li><li style="font-weight: 400;"><span style="font-weight: 400;">Burn or sting</span></li><li style="font-weight: 400;"><span style="font-weight: 400;">Develop little pimples, called styes, in the rim of the eye or eyelid</span></li></ul><h2><b>Causes of Ocular Rosacea</b></h2><p><span style="font-weight: 400;">Research has discovered that 85% of people with Ocular Rosacea have blocked oil glands on the edges of their eyelids (<a href="https://www.theralife.com/meibomian-gland-dysfunction/">Meibomian Gland Dysfunction</a>).   If these glands become blocked, the eyes become dry, swollen, and irritated.  This leads to redness and itching in the eyes and crust on the eyelashes.</span></p><p><span style="font-weight: 400;">Although definitely unknown, some scientists believe that tiny spider-like creatures called mites live in the hair follicles on the eyelashes and can block the glands (<a href="https://www.theralife.com/blepharitis/">Blepharitis – </a>Demodex) .  </span></p><p><span style="font-weight: 400;">Other scientists believe that there may be a link between rosacea and the bacteria that cause infections in the digestive system.  Still, other scientists believe that rosacea is caused by a problem with the body’s blood vessels.  Finally, some believe that genes or the environment can play a part in developing the skin condition.</span></p><p><span style="font-weight: 400;">Those who are fair-skinned are more prone to develop rosacea.  Some women develop rosacea during menopause.  Thirteen million Americans have been diagnosed with rosacea, and half of those patients have ocular rosacea. </span></p><h3><b>Complications from Ocular Rosacea</b></h3><p><span style="font-weight: 400;">Beginning with mild discomfort and irritation, if left untreated, Ocular Rosacea can cause serious eye complications.  The cornea of the eye may become damaged, resulting in the loss of vision.  Treating Ocular Rosacea helps relieve symptoms in addition to preventing serious eye complications such as vision loss or blindness.</span></p><h4><b>Symptom Relief for Ocular Rosacea</b></h4><p><span style="font-weight: 400;">Seeking a firm prognosis from an ophthalmologist or dermatologist is advised.  If the Rosacea is affecting the eyes, an ophthalmologist is a good place to start.  Otherwise, consult with a dermatologist.  If symptoms are severe, such as light sensitivity, very red eyes, or a burning sensation, it is highly important to go to an ophthalmologist quickly. </span></p><p><span style="font-weight: 400;">Ocular Rosacea can be treated with a simple hygiene regime.  Done regularly, the symptoms usually subside and clear up quickly.  In addition to any medications that a doctor may prescribe, other steps taken to help ease the discomfort and symptoms include:</span></p><ul><li style="font-weight: 400;"><span style="font-weight: 400;">Place a hot compress over the eyes for at least 10 minutes twice a day to ease discomfort.</span></li><li style="font-weight: 400;"><span style="font-weight: 400;">Clean eye lids with a gentle cleanser, such as Avenova or Hypochlor from TheraLife.  Gently rub the eyelids with the cleanser to remove any crust and clean them thoroughly.   Do not wash off eye lid cleanser afterwards. </span></li></ul><h2>Frequently Asked Questions</h2><h3><span class="Text__StyledText-sc-8gmuv2-0 kOuKlh">What is the best treatment for ocular rosacea?</span></h3><p>Ocular rosacea can be relieved by ocular hygiene, cleaning eyelids with eyelid cleanser like Avenova,  If you also have facial rosacea, it is important to visit a dermatologist and get it under control.  TheraLife  also has a complete protocol for ocular rosacea recovery.  <a href="https://www.theralife.com/ocular-rosacea/">Click here to learn more. </a></p><h3><span class="Text__StyledText-sc-8gmuv2-0 kOuKlh">How serious is ocular rosacea?</span></h3><p>Ocular rosacea can lead to serious complications such as cornea damage and vision loss.  It is very important that you seek help from your eye doctors right away.</p><h3><span class="Text__StyledText-sc-8gmuv2-0 kOuKlh">Is ocular rosacea an autoimmune disease?</span></h3><p>Ocular rosacea is an autoimmune disease, which means your own body is attacking its own cells, in this case cells that are in your eyes.  Ocular rosacea involve a lot of inflammation, and therefore, a treatment like TheraLife will greatly reduce inflammation and help you get ocular rosacea under control.</p><h3><span class="Text__StyledText-sc-8gmuv2-0 kOuKlh">What is the first line treatment for ocular rosacea?</span></h3><p>First line of treatment for ocular rosacea is warm compress and eyelid cleansing.  If that does not work, your eye doctor will prescribe a steroid eye drop for a short period of time. Follow your eye doctors instructions closely to recover faster.  Any questions, call TheraLife and talk to a doctor.</p><h3><span class="Text__StyledText-sc-8gmuv2-0 kOuKlh">How do you know if you have ocular rosacea?</span></h3><p>Symptoms of ocular rosacea are:  red eyes, light sensitivity, sandy gritty feeling in the eyes, crusty eyelashes, swollen and red eyelids, development of styes and <a class="wpil_keyword_link" href="https://www.theralife.com/chalazion-chalazia/" title="chalazion" data-wpil-keyword-link="linked" data-wpil-monitor-id="167">chalazion</a>.  Visit your eye doctor immediately.</p><h2>Conclusion</h2><p>Overall, the outlook for ocular rosacea is<b> positive</b>. Even though it can be uncomfortable and annoying, it is not a life-threatening disease, and it won’t cause you to lose your vision. Once you learn the best ways to manage your symptoms and avoid your triggers, you should be able to minimize how much ocular rosacea impacts your life.</p><h3>References</h3><div data-bglz=1 id="b1" class="ref-cit-blk half_rhythm">1. <span class="element-citation">Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology:a review of recent findings. <span class="ref-journal">J Am Acad Dermatol. </span>2013;<span class="ref-vol">69</span>:15–26. </span></div><div data-bglz=1 id="b2" class="ref-cit-blk half_rhythm">2. <span class="element-citation">Vieira AC, Höfling-Lima AL, Mannis MJ. Ocular rosacea-a review. <span class="ref-journal">Arq Bras Oftalmol. </span>2012;<span class="ref-vol">75</span>(5):363–369. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23471336" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Arq+Bras+Oftalmol&title=Ocular+rosacea-a+review&author=AC+Vieira&author=AL+H%C3%B6fling-Lima&author=MJ+Mannis&volume=75&issue=5&publication_year=2012&pages=363-369&pmid=23471336&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="b3" class="ref-cit-blk half_rhythm">3. <span class="element-citation">Michel JL, Cabibel F. Frequency, severity and treatment of ocular rosacea during cutaneous rosacea. <span class="ref-journal">Ann Dermatol Venereol. </span>2003;<span class="ref-vol">130</span>(1):20–24. </span></div><div data-bglz=1 id="b4" class="ref-cit-blk half_rhythm">4. <span class="element-citation">Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F, National Rosacea Society Expert Committee Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. <span class="ref-journal">J Am Acad Dermatol. </span>2004;<span class="ref-vol">50</span>(6):907–912.</span></div><div data-bglz=1 id="b5" class="ref-cit-blk half_rhythm">5. <span class="element-citation">Eiseman AS. The ocular manifestations of atopic dermatitis and rosacea. <span class="ref-journal">Curr Allergy Asthma Rep. </span>2006;<span class="ref-vol">6</span>(4):292–298. [</span></div><div data-bglz=1 id="b6" class="ref-cit-blk half_rhythm">6. <span class="element-citation">Oltz M, Check J. Rosacea and its ocular manifestations. <span class="ref-journal">Optometry. </span>2011;<span class="ref-vol">82</span>(2):92–103.</span></div><div data-bglz=1 id="b7" class="ref-cit-blk half_rhythm">7. <span class="element-citation">Dahl MV. Rosacea subtypes: a treatment algorithm. <span class="ref-journal">Cutis. </span>2004;<span class="ref-vol">74</span><span class="ref-vol">21-27</span>(3 Suppl):32–34. </span></div><div data-bglz=1 id="b8" class="ref-cit-blk half_rhythm">8. <span class="element-citation">Suzuki T. Meibomitis-related keratoconjunctivitis: implications and clinicalsignificance of meibomian gland inflammation. <span class="ref-journal">Cornea. </span>2012;<span class="ref-vol">31</span>(Suppl 1):S41–44.</span></div><div data-bglz=1 id="b9" class="ref-cit-blk half_rhythm">9. <span class="element-citation">Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. <span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2001;<span class="ref-vol">42</span>(10):2283–2292. </span></div><div data-bglz=1 id="b10" class="ref-cit-blk half_rhythm">10. <span class="element-citation">Vieira AC, Mannis MJ. Ocular rosacea: common and commonly missed. <span class="ref-journal">J Am Acad Dermatol. </span>2013;<span class="ref-vol">69</span>(6 Suppl 1):S36–41. </span></div><div data-bglz=1 id="b11" class="ref-cit-blk half_rhythm">11. <span class="element-citation">Määttä M, Kari O, Tervahartiala T, Peltonen S, Kari M, Saari M, Sorsa T. Tear fluid levels of MMP-8 are elevated in ocular rosacea-treatment effect of oral doxycycline. <span class="ref-journal">Graefes Arch Clin Exp Ophthalmol. </span>2006;<span class="ref-vol">244</span>(8):957–962. </span></div><div data-bglz=1 id="b12" class="ref-cit-blk half_rhythm">12. <span class="element-citation">Gupta AK, Chaudhry MM. Rosacea and its management: an overview. <span class="ref-journal">J Eur AcadDermatol Venereol. </span>2005;<span class="ref-vol">19</span>(3):273–285.</span></div><div data-bglz=1 id="b13" class="ref-cit-blk half_rhythm">13. <span class="element-citation">Iovieno A, Lambiase A, Micera A, Stampachiacchiere B, Sgrulletta R, Bonini S. <em>In vivo</em> characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis. <span class="ref-journal">Eur J Ophthalmol. </span>2009;<span class="ref-vol">19</span>(5):708–716.</span></div><div data-bglz=1 id="b14" class="ref-cit-blk half_rhythm">14. <span class="element-citation">Monk E, Shalita A, Siegel DM. Clinical applications of non-antimicrobial tetracyclines in dermatology. <span class="ref-journal">Pharmacol Res. </span>2011;<span class="ref-vol">63</span>(2):130–145.</span></div><div data-bglz=1 id="b15" class="ref-cit-blk half_rhythm">15. <span class="element-citation">Pfeffer I, Borelli C, Zierhut M, Schaller M. Treatment of ocular rosacea with 40 mg doxycycline in a slow release form. <span class="ref-journal">J Dtsch Dermatol Ges. </span>2011;<span class="ref-vol">9</span>(11):904–907. </span></div><div data-bglz=1 id="b16" class="ref-cit-blk half_rhythm">16. <span class="element-citation">Bikowski JB. Subantimicrobial dose doxycycline for acne and rosacea. <span class="ref-journal">Skinmed. </span>2003;<span class="ref-vol">2</span>(4):234–245. [</span></div><div data-bglz=1 id="b17" class="ref-cit-blk half_rhythm">17. <span class="element-citation">Donnenfeld E, Pflugfelder SC. Topical ophthalmic cyclosporine: pharmacology and clinical uses. <span class="ref-journal">Surv Ophthalmol. </span>2009;<span class="ref-vol">54</span>(3):321–338. </span></div><div data-bglz=1 id="b18" class="ref-cit-blk half_rhythm">18. <span class="element-citation">Durrani K, Zakka FR, Ahmed M, Memon M, Siddique SS, Foster CS. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease. <span class="ref-journal">Surv Ophthalmol. </span>2011;<span class="ref-vol">56</span>(6):474–510.</span></div><div data-bglz=1 id="b19" class="ref-cit-blk half_rhythm">19. <span class="element-citation">Shimazaki J, Den S, Omoto M, Satake Y, Shimmura S, Tsubota K. Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation. <span class="ref-journal">Am J Ophthalmol. </span>2011;<span class="ref-vol">152</span>(1):33–39. </span></div><div data-bglz=1 id="b20" class="ref-cit-blk half_rhythm">20. <span class="element-citation">Utine CA, Stern M, Akpek EK. Clinical review: topical ophthalmic use of cyclosporin A. <span class="ref-journal">Ocul Immunol Inflamm. </span>2010;<span class="ref-vol">18</span>(5):352–361. [</span></div><div data-bglz=1 id="b21" class="ref-cit-blk half_rhythm">21. <span class="element-citation">Bikowski JB. Rosacea: a tiered approach to therapy. <span class="ref-journal">Cutis. </span>2000;<span class="ref-vol">66</span>(4 Suppl):3–6. </span></div><div data-bglz=1 id="b22" class="ref-cit-blk half_rhythm">22. <span class="element-citation">Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. <span class="ref-journal">J Am Acad Dermatol. </span>2004;<span class="ref-vol">51</span>(3):327–341. </span></div><div data-bglz=1 id="b23" class="ref-cit-blk half_rhythm">23. <span class="element-citation">Lazaridou E, Fotiadou C, Ziakas NG, Giannopoulou C, Apalla Z, Ioannides D. Clinical and laboratory study of ocular rosacea in northern Greece. <span class="ref-journal">J Eur Acad Dermatol Venereol. </span>2011;<span class="ref-vol">25</span>(12):1428–1431. </span></div><div data-bglz=1 id="b24" class="ref-cit-blk half_rhythm">24. <span class="element-citation">Bakar O, Demircay Z, Toker E, Cakir S. Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin. <span class="ref-journal">J EurAcad Dermatol Venereol. </span>2009;<span class="ref-vol">23</span>(5):544–549.</span></div><div data-bglz=1 id="b25" class="ref-cit-blk half_rhythm">25. <span class="element-citation">Vieira AC, An HJ, Ozcan S, Kim JH, Lebrilla CB, Mannis MJ. Glycomic analysis of tear and saliva in ocular rosacea patients: the search for a biomarker. <span class="ref-journal">Ocul Surf. </span>2012;<span class="ref-vol">10</span>(3):184–192</span></div><div data-bglz=1 id="b26" class="ref-cit-blk half_rhythm">26. <span class="element-citation">Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. <span class="ref-journal">Cornea. </span>2003;<span class="ref-vol">22</span>(3):230–233. [</span></div><div data-bglz=1 id="b27" class="ref-cit-blk half_rhythm">27. <span class="element-citation">Yaylali V, Ozyurt C. Comparison of tear function tests and impression cytology with the ocular findings in acne rosacea. <span class="ref-journal">Eur J Ophthalmol. </span>2002;<span class="ref-vol">12</span>(1):11–17. </span></div><div data-bglz=1 id="b28" class="ref-cit-blk half_rhythm">28. <span class="element-citation">Baudouin C. A new approach for better comprehension of diseases of the ocularsurface. <span class="ref-journal">J Fr Ophtalmol. </span>2007;<span class="ref-vol">30</span>(3):239–246. </span></div><div data-bglz=1 id="b29" class="ref-cit-blk half_rhythm">29. <span class="element-citation">Wladis EJ, Carlson JA, Wang MS, Bhoiwala DP, Adam AP. Toll-like receptors and vascular markers in ocular rosacea. <span class="ref-journal">Ophthal Plast Reconstr Surg. </span>2013;<span class="ref-vol">29</span>(4):290–293.</span></div><div data-bglz=1 id="b30" class="ref-cit-blk half_rhythm">30. <span class="element-citation">Turner K, Pflugfelder SC, Ji Z, Feuer WJ, Stern M, Reis BL. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. <span class="ref-journal">Cornea. </span>2000;<span class="ref-vol">19</span>(4):492–496. </span></div><div data-bglz=1 id="b31" class="ref-cit-blk half_rhythm">31. <span class="element-citation">Perry HD, Doshi-Carnevale S, Donnenfeld ED, Solomon R, Biser SA, Bloom AH. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. <span class="ref-journal">Cornea. </span>2006;<span class="ref-vol">25</span>(2):171–175.</span></div><div data-bglz=1 id="b32" class="ref-cit-blk half_rhythm">32. <span class="element-citation">Schechter BA, Katz RS, Friedman LS. Efficacy of topical cyclosporine for the treatment of ocular rosacea. <span class="ref-journal">Adv Ther. </span>2009;<span class="ref-vol">26</span>(6):651–659. </span></div><div data-bglz=1 id="b33" class="ref-cit-blk half_rhythm">33. <span class="element-citation">Fallen RS, Gooderham M. Rosacea: update on management and emerging therapies. <span class="ref-journal">Skin Therapy Lett. </span>2012;<span class="ref-vol">17</span>(10):1–4. [</span></div><div data-bglz=1 id="b34" class="ref-cit-blk half_rhythm">34. <span class="element-citation">Valentín S, Morales A, Sánchez JL, Rivera A. Safety and efficacy of doxycycline in the treatment of rosacea. <span class="ref-journal">Clin Cosmet Investig Dermatol. </span>2009;<span class="ref-vol">2</span>:129–140. <span class="nowrap">[</span></span></div><div data-bglz=1 id="b35" class="ref-cit-blk half_rhythm">35. <span class="element-citation">Korting HC, Schöllmann C. Tetracycline actions relevant to rosacea treatment. <span class="ref-journal">Skin Pharmacol Physiol. </span>2009;<span class="ref-vol">22</span>(6):287–294. [</span></div><div><div data-bglz=1 id="r1" class="ref-cit-blk half_rhythm">1. <span class="element-citation">Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: A review of recent findings. <span class="ref-journal">J Am Acad Dermatol. </span>2013;<span class="ref-vol">69</span>(Supplement 1):S15–26. [<a href="https://pubmed.ncbi.nlm.nih.gov/24229632" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&title=New+insights+into+rosacea+pathophysiology:+A+review+of+recent+findings.&author=M+Steinhoff&author=J+Schauber&author=JJ+Leyden&volume=69&issue=Supplement+1&publication_year=2013&pages=S15-26&pmid=24229632&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r2" class="ref-cit-blk half_rhythm">2. <span class="element-citation">Steinhoff M, Schmelz M, Schauber J. Facial Erythema of Rosacea – Aetiology, Different Pathophysiologies and Treatment Options. <span class="ref-journal">Acta Derm Venereol. </span>2016;<span class="ref-vol">96</span>:579–86. [<a href="https://pubmed.ncbi.nlm.nih.gov/26714888" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Acta+Derm+Venereol&title=Facial+Erythema+of+Rosacea+-+Aetiology,+Different+Pathophysiologies+and+Treatment+Options.&author=M+Steinhoff&author=M+Schmelz&author=J+Schauber&volume=96&publication_year=2016&pages=579-86&pmid=26714888&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r3" class="ref-cit-blk half_rhythm">3. <span class="element-citation">Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, Thiboutot D. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. <span class="ref-journal">J Am Acad Dermatol. </span>2018;<span class="ref-vol">78</span>:148–55. [<a href="https://pubmed.ncbi.nlm.nih.gov/29089180" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&title=Standard+classification+and+pathophysiology+of+rosacea:+The+2017+update+by+the+National+Rosacea+Society+Expert+Committee.&author=RL+Gallo&author=RD+Granstein&author=S+Kang&author=M+Mannis&author=M+Steinhoff&volume=78&publication_year=2018&pages=148-55&pmid=29089180&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r4" class="ref-cit-blk half_rhythm">4. <span class="element-citation">Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, Powell F. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. <span class="ref-journal">J Am Acad Dermatol. </span>2002;<span class="ref-vol">46</span>:584–7. [<a href="https://pubmed.ncbi.nlm.nih.gov/11907512" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&title=Standard+classification+of+rosacea:+Report+of+the+National+Rosacea+Society+Expert+Committee+on+the+Classification+and+Staging+of+Rosacea.&author=J+Wilkin&author=M+Dahl&author=M+Detmar&author=L+Drake&author=A+Feinstein&volume=46&publication_year=2002&pages=584-7&pmid=11907512&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r5" class="ref-cit-blk half_rhythm">5. <span class="element-citation">Gold LM, Draelos ZD. New and Emerging Treatments for Rosacea. <span class="ref-journal">Am J Clin Dermatol. </span>2015;<span class="ref-vol">16</span>:457–61. [<a href="https://pubmed.ncbi.nlm.nih.gov/26396117" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Clin+Dermatol&title=New+and+Emerging+Treatments+for+Rosacea.&author=LM+Gold&author=ZD+Draelos&volume=16&publication_year=2015&pages=457-61&pmid=26396117&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r6" class="ref-cit-blk half_rhythm">6. <span class="element-citation">Alexis AF, Callender VD, Baldwin HE, Desai SR, Rendon MI, Taylor SC. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: Review and clinical practice experience. <span class="ref-journal">J Am Acad Dermatol. </span>2019;<span class="ref-vol">80</span>:1722–1729.e7. [<a href="https://pubmed.ncbi.nlm.nih.gov/30240779" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&title=Global+epidemiology+and+clinical+spectrum+of+rosacea,+highlighting+skin+of+color:+Review+and+clinical+practice+experience.&author=AF+Alexis&author=VD+Callender&author=HE+Baldwin&author=SR+Desai&author=MI+Rendon&volume=80&publication_year=2019&pages=1722-1729.e7&pmid=30240779&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r7" class="ref-cit-blk half_rhythm">7. <span class="element-citation">Alinia H, Tuchayi SM, James SM, Cardwell LA, Nanda S, Bahrami N, Awosika O, Richardson I, Huang KE, Feldman SR. Measurement of Disease Severity in a Population of Rosacea Patients. <span class="ref-journal">Dermatol Clin. </span>2018;<span class="ref-vol">36</span>:97–102. [<a href="https://pubmed.ncbi.nlm.nih.gov/29499805" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Dermatol+Clin&title=Measurement+of+Disease+Severity+in+a+Population+of+Rosacea+Patients.&author=H+Alinia&author=SM+Tuchayi&author=SM+James&author=LA+Cardwell&author=S+Nanda&volume=36&publication_year=2018&pages=97-102&pmid=29499805&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r8" class="ref-cit-blk half_rhythm">8. <span class="element-citation">Patiño-Ramírez BE, Rodríguez-García A, Díaz JC, Perfecto Ávalos Y. Alteraciones de la superficie ocular en pacientes con rosácea ocular. <span class="ref-journal">Rev Mex Oftalmol. </span>2012;<span class="ref-vol">86</span>:86–96. <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Rev+Mex+Oftalmol.&title=Alteraciones+de+la+superficie+ocular+en+pacientes+con+ros%C3%A1cea+ocular.&author=BE+Pati%C3%B1o-Ram%C3%ADrez&author=A+Rodr%C3%ADguez-Garc%C3%ADa&author=JC+D%C3%ADaz&author=Y+Perfecto+%C3%81valos&volume=86&publication_year=2012&pages=86-96&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r9" class="ref-cit-blk half_rhythm">9. <span class="element-citation">Vieira AC, Mannis MJ. Ocular rosacea: common and commonly missed. <span class="ref-journal">J Am Acad Dermatol. </span>2013;<span class="ref-vol">69</span>(Suppl 1):S36–41. [<a href="https://pubmed.ncbi.nlm.nih.gov/24229635" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&title=Ocular+rosacea:+common+and+commonly+missed.&author=AC+Vieira&author=MJ+Mannis&volume=69&issue=Suppl+1&publication_year=2013&pages=S36-41&pmid=24229635&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r10" class="ref-cit-blk half_rhythm">10. <span class="element-citation">Rainer BM, Kang S, Chien AL. Rosacea: Epidemiology, pathogenesis, and treatment. <span class="ref-journal">Dermatoendocrinol. </span>2017;<span class="ref-vol">9</span>:e1361574. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821167/" rel="nofollow noopener" target="_blank">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29484096" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Dermatoendocrinol&title=Rosacea:+Epidemiology,+pathogenesis,+and+treatment.&author=BM+Rainer&author=S+Kang&author=AL+Chien&volume=9&publication_year=2017&pages=e1361574&pmid=29484096&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r11" class="ref-cit-blk half_rhythm">11. <span class="element-citation">López-Valverde G, Garcia-Martin E, Larrosa-Povés JM, Polo-Llorens V, Pablo-Júlvez LE. Therapeutical Management for Ocular Rosacea. <span class="ref-journal">Case Rep Ophthalmol. </span>2016;<span class="ref-vol">7</span>:237–42. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943766/" rel="nofollow noopener" target="_blank">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27462249" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Case+Rep+Ophthalmol&title=Therapeutical+Management+for+Ocular+Rosacea.&author=G+L%C3%B3pez-Valverde&author=E+Garcia-Martin&author=JM+Larrosa-Pov%C3%A9s&author=V+Polo-Llorens&author=LE+Pablo-J%C3%BAlvez&volume=7&publication_year=2016&pages=237-42&pmid=27462249&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r12" class="ref-cit-blk half_rhythm">12. <span class="element-citation">Oltz M, Check J. Rosacea and its ocular manifestations. <span class="ref-journal">Optometry. </span>2011;<span class="ref-vol">82</span>:92–103. [<a href="https://pubmed.ncbi.nlm.nih.gov/21276570" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Optometry&title=Rosacea+and+its+ocular+manifestations.&author=M+Oltz&author=J+Check&volume=82&publication_year=2011&pages=92-103&pmid=21276570&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r13" class="ref-cit-blk half_rhythm">13. <span class="element-citation">Alvarenga LS, Mannis MJ. Ocular Rosacea. <span class="ref-journal">Ocul Surf. </span>2005;<span class="ref-vol">3</span>:41–58. [<a href="https://pubmed.ncbi.nlm.nih.gov/17131004" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Ocul+Surf&title=Ocular+Rosacea.&author=LS+Alvarenga&author=MJ+Mannis&volume=3&publication_year=2005&pages=41-58&pmid=17131004&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r14" class="ref-cit-blk half_rhythm">14. <span class="mixed-citation">Rodriguez-Garcia A. Ocular Rosacea: Recent Advances in Pathogenesis and Therapy. In 2015. p. 175–199. <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar?q=Rodriguez-Garcia+A.+Ocular+Rosacea:+Recent+Advances+in+Pathogenesis+and+Therapy.+In+2015.+p.+175%E2%80%93199.+" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r15" class="ref-cit-blk half_rhythm">15. <span class="element-citation">Aldrich N, Gerstenblith M, Fu P, Tuttle MS, Varma P, Gotow E, Cooper KD, Mann M, Popkin DL. Genetic vs Environmental Factors That Correlate With Rosacea: A Cohort-Based Survey of Twins. <span class="ref-journal">JAMA Dermatol. </span>2015;<span class="ref-vol">151</span>:1213–9. [<a href="https://pubmed.ncbi.nlm.nih.gov/26307938" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=JAMA+Dermatol&title=Genetic+vs+Environmental+Factors+That+Correlate+With+Rosacea:+A+Cohort-Based+Survey+of+Twins.&author=N+Aldrich&author=M+Gerstenblith&author=P+Fu&author=MS+Tuttle&author=P+Varma&volume=151&publication_year=2015&pages=1213-9&pmid=26307938&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r16" class="ref-cit-blk half_rhythm">16. <span class="element-citation">Woo YR, Lim JH, Cho DH, Park HJ. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition. <span class="ref-journal">Int J Mol Sci. </span>2016;<span class="ref-vol">17</span> <a href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27649161&dopt=Abstract" target="_blank" rel="noopener nofollow" data-ga-action="click_feat_suppl">https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27649161&dopt=Abstract</a> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037831/" rel="nofollow noopener" target="_blank">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27649161" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Sci&title=Rosacea:+Molecular+Mechanisms+and+Management+of+a+Chronic+Cutaneous+Inflammatory+Condition.&author=YR+Woo&author=JH+Lim&author=DH+Cho&author=HJ+Park&volume=17&publication_year=2016&pmid=27649161&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r17" class="ref-cit-blk half_rhythm">17. <span class="element-citation">Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, Mess C, Cevikbas F, Rivier M, Carlavan I, Déret S, Rosignoli C, Metze D, Luger TA, Voegel JJ. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. <span class="ref-journal">J Investig Dermatol Symp Proc. </span>2011;<span class="ref-vol">15</span>:2–11. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704130/" rel="nofollow noopener" target="_blank">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22076321" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=J+Investig+Dermatol+Symp+Proc&title=Clinical,+cellular,+and+molecular+aspects+in+the+pathophysiology+of+rosacea.&author=M+Steinhoff&author=J+Buddenkotte&author=J+Aubert&author=M+Sulk&author=P+Novak&volume=15&publication_year=2011&pages=2-11&pmid=22076321&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r18" class="ref-cit-blk half_rhythm">18. <span class="element-citation">Tschopp J, Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? <span class="ref-journal">Nat Rev Immunol. </span>2010;<span class="ref-vol">10</span>:210–5. [<a href="https://pubmed.ncbi.nlm.nih.gov/20168318" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Immunol&title=NLRP3+inflammasome+activation:+the+convergence+of+multiple+signalling+pathways+on+ROS+production?&author=J+Tschopp&author=K+Schroder&volume=10&publication_year=2010&pages=210-5&pmid=20168318&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r19" class="ref-cit-blk half_rhythm">19. <span class="element-citation">Yamasaki K, Kanada K, Macleod DT, Borkowski AW, Morizane S, Nakatsuji T, Cogen AL, Gallo RL. TLR2 Expression Is Increased in Rosacea and Stimulates Enhanced Serine Protease Production by Keratinocytes. <span class="ref-journal">J Invest Dermatol. </span>2011;<span class="ref-vol">131</span>:688–97. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085277/" rel="nofollow noopener" target="_blank">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21107351" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&title=TLR2+Expression+Is+Increased+in+Rosacea+and+Stimulates+Enhanced+Serine+Protease+Production+by+Keratinocytes.&author=K+Yamasaki&author=K+Kanada&author=DT+Macleod&author=AW+Borkowski&author=S+Morizane&volume=131&publication_year=2011&pages=688-97&pmid=21107351&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r20" class="ref-cit-blk half_rhythm">20. <span class="element-citation">Holmes AD, Steinhoff M. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. <span class="ref-journal">Exp Dermatol. </span>2017;<span class="ref-vol">26</span>:659–67. [<a href="https://pubmed.ncbi.nlm.nih.gov/27376863" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&title=Integrative+concepts+of+rosacea+pathophysiology,+clinical+presentation+and+new+therapeutics.&author=AD+Holmes&author=M+Steinhoff&volume=26&publication_year=2017&pages=659-67&pmid=27376863&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r21" class="ref-cit-blk half_rhythm">21. <span class="element-citation">Moura AKA, Guedes F, Rivitti-Machado MC, Sotto MN. Inate immunity in rosacea. Langerhans cells, plasmacytoid dentritic cells, Toll-like receptors and inducible oxide nitric synthase (iNOS) expression in skin specimens: case-control study. <span class="ref-journal">Arch Dermatol Res. </span>2018;<span class="ref-vol">310</span>:139–46. [<a href="https://pubmed.ncbi.nlm.nih.gov/29330632" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol+Res&title=Inate+immunity+in+rosacea.+Langerhans+cells,+plasmacytoid+dentritic+cells,+Toll-like+receptors+and+inducible+oxide+nitric+synthase+(iNOS)+expression+in+skin+specimens:+case-control+study.&author=AKA+Moura&author=F+Guedes&author=MC+Rivitti-Machado&author=MN+Sotto&volume=310&publication_year=2018&pages=139-46&pmid=29330632&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r22" class="ref-cit-blk half_rhythm">22. <span class="element-citation">Brown TT, Choi E-YK, Thomas DG, Hristov AC, Chan MP. Comparative analysis of rosacea and cutaneous lupus erythematosus: Histopathologic features, T-cell subsets, and plasmacytoid dendritic cells. <span class="ref-journal">J Am Acad Dermatol. </span>2014;<span class="ref-vol">71</span>:100–7. [<a href="https://pubmed.ncbi.nlm.nih.gov/24656728" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&title=Comparative+analysis+of+rosacea+and+cutaneous+lupus+erythematosus:+Histopathologic+features,+T-cell+subsets,+and+plasmacytoid+dendritic+cells.&author=TT+Brown&author=E-YK+Choi&author=DG+Thomas&author=AC+Hristov&author=MP+Chan&volume=71&publication_year=2014&pages=100-7&pmid=24656728&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r23" class="ref-cit-blk half_rhythm">23. <span class="element-citation">Buhl T, Sulk M, Nowak P, Buddenkotte J, McDonald I, Aubert J, Carlavan I, Déret S, Reiniche P, Rivier M, Voegel JJ, Steinhoff M. Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways. <span class="ref-journal">J Invest Dermatol. </span>2015;<span class="ref-vol">135</span>:2198–208. [<a href="https://pubmed.ncbi.nlm.nih.gov/25848978" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&title=Molecular+and+Morphological+Characterization+of+Inflammatory+Infiltrate+in+Rosacea+Reveals+Activation+of+Th1/Th17+Pathways.&author=T+Buhl&author=M+Sulk&author=P+Nowak&author=J+Buddenkotte&author=I+McDonald&volume=135&publication_year=2015&pages=2198-208&pmid=25848978&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r24" class="ref-cit-blk half_rhythm">24. <span class="element-citation">Smith JR, Lanier VB, Braziel RM, Falkenhagen KM, White C, Rosenbaum JT. Expression of vascular endothelial growth factor and its receptors in rosacea. <span class="ref-journal">Br J Ophthalmol. </span>2007;<span class="ref-vol">91</span>:226–9. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857639/" rel="nofollow noopener" target="_blank">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17244661" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Ophthalmol&title=Expression+of+vascular+endothelial+growth+factor+and+its+receptors+in+rosacea.&author=JR+Smith&author=VB+Lanier&author=RM+Braziel&author=KM+Falkenhagen&author=C+White&volume=91&publication_year=2007&pages=226-9&pmid=17244661&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r25" class="ref-cit-blk half_rhythm">25. <span class="element-citation">Sulk M, Seeliger S, Aubert J, Schwab VD, Cevikbas F, Rivier M, Nowak P, Voegel JJ, Buddenkotte J, Steinhoff M. Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea. <span class="ref-journal">J Invest Dermatol. </span>2012;<span class="ref-vol">132</span>:1253–62. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305847/" rel="nofollow noopener" target="_blank">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22189789" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&title=Distribution+and+expression+of+non-neuronal+transient+receptor+potential+(TRPV)+ion+channels+in+rosacea.&author=M+Sulk&author=S+Seeliger&author=J+Aubert&author=VD+Schwab&author=F+Cevikbas&volume=132&publication_year=2012&pages=1253-62&pmid=22189789&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r26" class="ref-cit-blk half_rhythm">26. <span class="element-citation">Ghanem VC, Mehra N, Wong S, Mannis MJ. The Prevalence of Ocular Signs in Acne Rosacea: Comparing Patients From Ophthalmology and Dermatology Clinics. <span class="ref-journal">Cornea. </span>2003;<span class="ref-vol">22</span>:230–3. [<a href="https://pubmed.ncbi.nlm.nih.gov/12658088" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Cornea&title=The+Prevalence+of+Ocular+Signs+in+Acne+Rosacea:+Comparing+Patients+From+Ophthalmology+and+Dermatology+Clinics.&author=VC+Ghanem&author=N+Mehra&author=S+Wong&author=MJ+Mannis&volume=22&publication_year=2003&pages=230-3&pmid=12658088&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r27" class="ref-cit-blk half_rhythm">27. <span class="element-citation">Gökçınar NB, Karabulut AA, Onaran Z, Yumuşak E, Budak Yıldıran FA. Elevated Tear Human Neutrophil Peptides 1–3, Human Beta Defensin-2 Levels and Conjunctival Cathelicidin LL-37 Gene Expression in Ocular Rosacea. <span class="ref-journal">Ocul Immunol Inflamm. </span>2019;<span class="ref-vol">27</span>:1174–83. [<a href="https://pubmed.ncbi.nlm.nih.gov/30142005" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Ocul+Immunol+Inflamm&title=Elevated+Tear+Human+Neutrophil+Peptides+1%E2%80%933,+Human+Beta+Defensin-2+Levels+and+Conjunctival+Cathelicidin+LL-37+Gene+Expression+in+Ocular+Rosacea.&author=NB+G%C3%B6k%C3%A7%C4%B1nar&author=AA+Karabulut&author=Z+Onaran&author=E+Yumu%C5%9Fak&author=FA+Budak+Y%C4%B1ld%C4%B1ran&volume=27&publication_year=2019&pages=1174-83&pmid=30142005&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r28" class="ref-cit-blk half_rhythm">28. <span class="element-citation">Wladis EJ, Carlson JA, Wang MS, Bhoiwala DP, Adam AP. Toll-like receptors and vascular markers in ocular rosacea. <span class="ref-journal">Ophthal Plast Reconstr Surg. </span>2013;<span class="ref-vol">29</span>:290–3. [<a href="https://pubmed.ncbi.nlm.nih.gov/23839635" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Ophthal+Plast+Reconstr+Surg&title=Toll-like+receptors+and+vascular+markers+in+ocular+rosacea.&author=EJ+Wladis&author=JA+Carlson&author=MS+Wang&author=DP+Bhoiwala&author=AP+Adam&volume=29&publication_year=2013&pages=290-3&pmid=23839635&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r29" class="ref-cit-blk half_rhythm">29. <span class="element-citation">Randon M, Liang H, El Hamdaoui M, Tahiri R, Batellier L, Denoyer A, Labbé A, Baudouin C. In vivo confocal microscopy as a novel and reliable tool for the diagnosis of Demodex eyelid infestation. <span class="ref-journal">Br J Ophthalmol. </span>2015;<span class="ref-vol">99</span>:336–41. [<a href="https://pubmed.ncbi.nlm.nih.gov/25253768" rel="nofollow noopener" target="_blank">PubMed</a>] <span class="nowrap">[<a role="button" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Ophthalmol&title=In+vivo+confocal+microscopy+as+a+novel+and+reliable+tool+for+the+diagnosis+of+Demodex+eyelid+infestation.&author=M+Randon&author=H+Liang&author=M+El+Hamdaoui&author=R+Tahiri&author=L+Batellier&volume=99&publication_year=2015&pages=336-41&pmid=25253768&" target="_blank" rel="noopener noreferrer" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div data-bglz=1 id="r80" class="ref-cit-blk half_rhythm"></div></div><div data-bglz=1 id="abqa-widget"></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="https://theralife.services.answerbase.com/javascript/widget/cta-widget.min.js" data-insert-after="h1.entry-title" data-text="Have a question?" defer="defer" type="lazyJs"></script><script type="lazyJs" src="https://theralife.services.answerbase.com/javascript/widget/full-featured-widget.min.js" data-page-url="https://www.theralife.com/effective-treatment-ocular-rosacea/" data-page-specific-content="true" data-page-association="true" data-insert-after="#abqa-widget" data-open-ask="expand" data-on-page-search-elements=".entry-content, Description;" defer="defer">
      </script><style> #abqa-widget{ height: 2em; }#ab-tiny-widget{ margin-top: 10px !important; margin-bottom: 10px !important; display: inline-block !important; font-size: 16px !important; vertical-align: 3px !important;}#ab-tiny-widget a{ text-decoration: underline;}#ab-tiny-widget a:hover{ text-decoration: none;}#ab-tiny-widget a ~ span { display: none !important;}#ab-tiny-widget > a:nth-child(3) { display: none !important;}.answerbase-widget h5, .answerbase-widget, .answerbase-widget [type='text'], .answerbase-widget [type='password'], .answerbase-widget [type='date'], .answerbase-widget [type='datetime'], .answerbase-widget [type='datetime-local'], .answerbase-widget [type='month'], .answerbase-widget [type='week'], .answerbase-widget [type='email'], .answerbase-widget [type='number'], .answerbase-widget [type='search'], .answerbase-widget [type='tel'], .answerbase-widget [type='time'], .answerbase-widget [type='url'], .answerbase-widget [type='color'], .answerbase-widget textarea, .answerbase-widget .button{font-size: 16px !important;}.answerbase-widget h5, .answerbase-widget a{ font-weight: bold !important;}.answerbase-widget [type="checkbox"]{ width: 1em; height: auto; vertical-align: -12px; display: inline-block; }</style><div data-bglz=1 class="et_social_inline et_social_mobile_on et_social_inline_bottom"> <div data-bglz=1 class="et_social_networks et_social_autowidth et_social_slide et_social_circle et_social_top et_social_no_animation et_social_outer_dark"> <ul class="et_social_icons_container"><li class="et_social_facebook"> <a href="https://www.facebook.com/sharer.php?u=https%3A%2F%2Fwww.theralife.com%2Feffective-treatment-ocular-rosacea%2F&t=New%20Treatment%20for%20Ocular%20Rosacea-TheraLife" class="et_social_share" rel="nofollow" data-social_name="facebook" data-post_id="6262" data-social_type="share" data-location="inline"> <i class="et_social_icon et_social_icon_facebook"></i><span class="et_social_overlay"></span> </a> </li><li class="et_social_twitter"> <a href="https://twitter.com/share?text=New%20Treatment%20for%20Ocular%20Rosacea-TheraLife&url=https%3A%2F%2Fwww.theralife.com%2Feffective-treatment-ocular-rosacea%2F&via=theralife" class="et_social_share" rel="nofollow" data-social_name="twitter" data-post_id="6262" data-social_type="share" data-location="inline"> <i class="et_social_icon et_social_icon_twitter"></i><span class="et_social_overlay"></span> </a> </li><li class="et_social_googleplus"> <a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.theralife.com%2Feffective-treatment-ocular-rosacea%2F&t=New%20Treatment%20for%20Ocular%20Rosacea-TheraLife" class="et_social_share" rel="nofollow" data-social_name="googleplus" data-post_id="6262" data-social_type="share" data-location="inline"> <i class="et_social_icon et_social_icon_googleplus"></i><span class="et_social_overlay"></span> </a> </li><li class="et_social_pinterest"> <a href="#" class="et_social_share_pinterest" rel="nofollow" data-social_name="pinterest" data-post_id="6262" data-social_type="share" data-location="inline"> <i class="et_social_icon et_social_icon_pinterest"></i><span class="et_social_overlay"></span> </a> </li><li class="et_social_linkedin"> <a href="http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.theralife.com%2Feffective-treatment-ocular-rosacea%2F&title=New%20Treatment%20for%20Ocular%20Rosacea-TheraLife" class="et_social_share" rel="nofollow" data-social_name="linkedin" data-post_id="6262" data-social_type="share" data-location="inline"> <i class="et_social_icon et_social_icon_linkedin"></i><span class="et_social_overlay"></span> </a> </li><li class="et_social_printfriendly"> <a href="http://www.printfriendly.com/print?url=https%3A%2F%2Fwww.theralife.com%2Feffective-treatment-ocular-rosacea%2F&title=New%20Treatment%20for%20Ocular%20Rosacea-TheraLife" class="et_social_share" rel="nofollow" data-social_name="printfriendly" data-post_id="6262" data-social_type="share" data-location="inline"> <i class="et_social_icon et_social_icon_printfriendly"></i><span class="et_social_overlay"></span> </a> </li></ul> </div> </div><span class="et_bloom_bottom_trigger"></span> </div>  <div data-bglz=1 class="et_post_meta_wrapper"> <section data-bglz=1 id="comment-wrap"> <div data-bglz=1 id="comment-section" class="nocomments"> </div> <div data-bglz=1 id="respond" class="comment-respond"> <h3 id="reply-title" class="comment-reply-title"><span>Submit a Comment</span> <small><a rel="nofollow" id="cancel-comment-reply-link" href="/effective-treatment-ocular-rosacea/#respond" style="display:none;">Cancel reply</a></small></h3><form action="https://www.theralife.com/wp-comments-post.php" method="post" id="commentform" class="comment-form"><p class="comment-notes"><span id="email-notes">Your email address will not be published.</span> <span class="required-field-message">Required fields are marked <span class="required">*</span></span></p><p class="comment-form-comment"><label for="comment">Comment <span class="required">*</span></label> <textarea id="comment" name="comment" cols="45" rows="8" maxlength="65525" required="required">
Name *
Email *
Website
JCAMP-DX To SVG Converter
&
SWGDRUG IR-Library

Search

Products

Recent post

Subscribe To Our Newsletter

You have Successfully Subscribed!

Pin It on Pinterest

JCAMP-DX To SVG Converter&SWGDRUG IR-Library

Search

Products

Recent post

Subscribe To Our Newsletter

You have Successfully Subscribed!

Pin It on Pinterest

JCAMP-DX To SVG Converter
&
SWGDRUG IR-Library
